ryan-20250403

April [17], 2025

Dear fellow stockholders:

It is my privilege to present Ryan Specialty’s 2025 Proxy Statement.

On behalf of the entire Board of Directors of Ryan Specialty, we

invite you to attend Ryan Specialty’s 2025 Annual Meeting of

Stockholders to be held on May 30, 2025 at 2:00 p.m. Eastern

Time.

2024 was another outstanding year for Ryan Specialty, marking our

sixth consecutive year growing our topline revenue by over 20%

and our 14th consecutive year of double-digit organic growth. We

delivered on all our strategic priorities and had the largest year of

M&A activity in our history, significantly bolstering our delegated

authority offerings in the U.S. and abroad. Our strong results are a

testament to our conviction to put our clients first, focus on

specialized expertise and innovation, commitment to rewarding top

talent, and our team’s dedication to excellence.

Beyond our outstanding performance, we were pleased to seamlessly complete our recent leadership transition. On October

1, 2024, I transitioned to Executive Chairman, while Tim Turner became our Chief Executive Officer, and Jeremiah Bickham

and Janice Hamilton were promoted to President and Chief Financial Officer, respectively.

Tim, Jeremiah and Janice are all experienced, remarkable leaders who have earned deep respect within Ryan Specialty and

the industry. Their advancement is proof-positive of the quality and depth of the team we have assembled over the years,

with top talent and future leaders throughout the firm. I am confident we have the right people in place to lead Ryan

Specialty into the future.

Along with our strong 2024 performance, rapid growth and effective succession planning, our management and Board

continued to actively and directly engage with stockholders throughout the year. This dialogue included constructive

feedback that helped to inform the proposals that we are making in this year’s proxy statement, which include modifications

to our governance structure that we trust will be well received by our stockholders. The details of these proposals are

provided within this Proxy Statement for your review.

The Board appreciates the regular feedback we receive from stockholders, which will continue to be taken into consideration

and inform our corporate governance practices moving forward.

We thank you for your investment and continued support of Ryan Specialty.

Respectfully yours,

Patrick G. Ryan

Founder and Executive Chairman of the Board

Preliminary Proxy Statement Dated April [4], 2025 - Subject to Completion

NOTICE OF 2025 ANNUAL MEETING

OF STOCKHOLDERS AND PROXY STATEMENT

Dear stockholder:

You are cordially invited to attend the Annual Meeting of Stockholders (the “Annual Meeting”) of Ryan Specialty Holdings,

Inc. (the “Company”) on:


	DATE:	Tuesday, May 30, 2025.

	TIME:	2:00 p.m. Eastern Time.

	PLACE:	The meeting will be a virtual-only meeting, conducted exclusively via webcast at www.proxydocs.com/RYAN. There will not be a physical location for the meeting, and you will not be able to attend the meeting in person. Stockholders will be able to attend, vote, and submit questions (both before and during a portion of the meeting) virtually.

	RECORD DATE:	April 1, 2025 (“Record Date”).

WHO CAN VOTE:		Holders of the Class A common stock and Class B common stock of the Company as of the close of business on the Record Date.

WHO CAN ATTEND:		All stockholders are invited to attend the virtual Annual Meeting. To attend the meeting at www.proxydocs.com/RYAN, you must enter the control number on your Notice of Internet Availability of Proxy Materials, Proxy Card, or voting instruction form. The virtual meeting room will open at 1:45 p.m. Eastern Time.

DATE OF MAILING:		A Notice of how to access the Proxy Statement and 2024 Annual Report to stockholders and a form of proxy are first being sent to stockholders on or about April [17], 2025.

Items of Business to be Conducted:

1.To elect the four director nominees presented in the accompanying Proxy Statement to serve as Class I directors for

a three-year term until the 2028 annual meeting of stockholders and until their successors are duly elected and

qualified;

2.To approve an amendment to the Company’s Amended and Restated Certificate of Incorporation (the “Certificate”)

to declassify our Board of Directors (the “Board”) and phase-in annual director elections;

3.To approve an amendment to the Certificate to implement a majority voting standard in uncontested director

elections;

4.To approve an amendment to the Certificate to eliminate the springing supermajority voting standard with respect to

the removal of a director from our Board;

5.To approve an amendment to the Certificate to provide for a specific outside date, September 30, 2029, by which

the ten-to-one vote disparity of the Class B common stock to the Class A common stock will sunset;

6.To approve an amendment to the Certificate to provide stockholders with the ability to take action by written consent;

7.To approve an amendment to the Certificate to provide stockholders with the ability to call special meetings of

stockholders;

8.To approve an amendment to the Certificate to eliminate the springing supermajority voting standard with respect to

the amendment of the Company's Amended and Restated Bylaws (the “Bylaws”) and certain provisions of the

Certificate;

9.To approve an amendment to the Certificate to provide for the exculpation of certain officers of the Company to the

fullest extent provided under Delaware law;

10.To approve certain non-substantive amendments to the Certificate (the “Non-Substantive Amendments”) as set forth

in the proposed amended and restated Certificate of Incorporation (the “Proposed Amended and Restated

Certificate”);

11.To ratify the selection of Deloitte & Touche LLP (“Deloitte”) as our independent registered public accounting firm for

the fiscal year ending December 31, 2025;

12.To approve, by a non-binding advisory vote, the compensation of our named executive officers (i.e., “say-on-pay

proposal”); and

13.To conduct any other business that may properly come before the meeting or any adjournment thereof.

Please note that there is no in-person Annual Meeting for you to attend. Stockholders will be able to listen, vote, and submit

questions during the virtual Annual Meeting from any remote location with Internet connectivity. Information on how to

participate in the virtual Annual Meeting can be found on page 4 of this Proxy Statement.

Important Notice Regarding the Availability of Proxy Materials for the Annual Meeting

of Stockholders to be held on May 30, 2025

The Proxy Statement and our 2024 Annual Report are available directly at the following website: www.proxydocs.com/RYAN

YOUR VOTE IS VERY IMPORTANT

If you were a stockholder at the close of business on the Record Date (i.e., April 1, 2025), you are eligible to vote at this

year’s Annual Meeting. Regardless of whether you plan to attend the virtual Annual Meeting, your vote is very important. We

urge you to participate in the election of our directors and in deciding the other items on the agenda for the Annual Meeting.

Stockholders are strongly encouraged to vote their shares by proxy in advance of the Annual Meeting. Stockholders who

wish to attend the Annual Meeting virtually may do so via webcast at www.proxydocs.com/RYAN. Please note that attending

the Annual Meeting virtually will not necessarily allow you to vote at the Annual Meeting. Accordingly, we strongly advise you

to vote in advance by one of the methods described on page 4 of the Proxy Statement.

Our Board recommends that you vote:


Proposals	Board Recommendation	Page Reference

1.Election of four Class I directors	FOR each nominee	17

2.Approval of an amendment to the Certificate to declassify our Board and phase-in annual director elections	FOR	28

3.Approval of an amendment to the Certificate to implement a majority voting standard in uncontested director elections	FOR	30

4.Approval of an amendment to the Certificate to eliminate the springing supermajority voting standard with respect to the removal of a director from our Board	FOR	32

5.Approval of an amendment to the Certificate to provide for a specific outside date, September 30, 2029, by which the ten-to-one vote disparity of the Class B common stock to the Class A common stock will sunset	FOR	34

6.Approval of an amendment to the Certificate to provide stockholders with the ability to take action by written consent	FOR	36

7.Approval of an amendment to the Certificate to provide stockholders with the ability to call special meetings of stockholders	FOR	37

8.Approval of an amendment to the Certificate to eliminate the springing supermajority voting standard with respect to the amendment of the Bylaws and certain provisions of the Certificate	FOR	39

9.Approval of an amendment to the Certificate to provide for the exculpation of certain officers of the Company to the fullest extent provided under Delaware law	FOR	41

10.Approval of certain Non-Substantive Amendments as set forth in the Proposed Amended and Restated Certificate	FOR	43

11.Ratification of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025	FOR	44

12.Advisory (non-binding) vote to approve executive compensation	FOR	47

The matters to be acted upon at the Annual Meeting are more fully described in the Proxy Statement and related materials.

Please read the materials carefully.

All holders of Class A common stock, $0.001 par value per share, and Class B common stock, $0.001 par value per share,

at the close of business on the Record Date can vote. A stockholder of record entitled to attend and vote at the Annual

Meeting may appoint one or more proxies to attend, speak, and vote on their behalf by any of the procedures set out on

page 4 of the Proxy Statement. A proxy holder need not be a stockholder of record.

We will provide access to our proxy materials via the Internet at www.proxydocs.com/RYAN rather than in hard copy. We will

mail a notice containing instructions on how to access this Proxy Statement and our Annual Report on or about April [17],

2025, to all stockholders entitled to vote at the Annual Meeting. Stockholders who prefer a paper copy of the proxy materials

may request one, at no cost, by following the instructions provided in the notice we will send.

Only stockholders that owned Class A common stock or Class B common stock at the close of business on the Record Date

are entitled to notice. A list of our stockholders of record will be available at our principal executive offices, 155 North Wacker

Drive, Suite 4000, Chicago, Illinois 60606 for examination by any stockholder for any purpose relevant to the meeting during

ordinary business hours for at least ten days prior to May 30, 2025, and will be available online on the virtual annual meeting

platform during the Annual Meeting. Your vote is important. Regardless of whether you plan to attend the Annual Meeting,

we urge you to vote. You may vote by proxy over the Internet, by telephone, or by mail by following the instructions on your

Notice of Internet Availability of Proxy Materials, Proxy Card, or voting instruction form. Voting by proxy will ensure your

representation at the Annual Meeting regardless of whether you attend online.

By Order of the Board of Directors,

Mark S. Katz

Corporate Secretary

Chicago, Illinois

April [17], 2025


		2024 Proxy Statement 1
		2024 Proxy Statement 1

IMPORTANT NOTICE REGARDING THE AVAILABILITY OF

PROXY MATERIALS FOR THE STOCKHOLDER MEETING

The Board of Directors (the “Board”) of Ryan Specialty Holdings, Inc. is soliciting your proxy to vote at our 2025

Annual Meeting of Stockholders to be held on May 30, 2025, at 2:00 p.m. Eastern Time in a virtual-only meeting

online at www.proxydocs.com/RYAN, and any adjournment or postponement of that meeting (the “Annual

Meeting”). This Proxy Statement is dated as of April 17, 2025. As used in this Proxy Statement henceforward, unless

otherwise stated or the context clearly indicates otherwise, the terms the “Company,” the “Registrant,” “Ryan Specialty,”

“we,” “us,” and “our” refer to Ryan Specialty Holdings, Inc., a Delaware corporation.

In addition to solicitations by mail, our directors, officers, and regular employees, without additional remuneration, may solicit

proxies by telephone, e-mail, and personal interviews. All costs of solicitation of proxies will be borne by us. Brokers,

custodians, and fiduciaries will be requested to forward proxy soliciting material to the owners of stock held in their names as

of the close of business on April 1, 2025 (the “Record Date”), and we will reimburse them for their reasonable out-of-pocket

expenses incurred in connection with the distribution of proxy materials.

We have elected to provide access to our proxy materials on the Internet. Accordingly, we are sending a Notice of Internet

Availability of Proxy Materials to our stockholders of record as of Record Date, while brokers and other nominees who hold

shares on behalf of beneficial owners will be sending their own similar notice. All stockholders will have the ability to access

the proxy materials on the website referred to in the Notice of Internet Availability of Materials or to request a printed set of

the proxy materials. Instructions on how to request a printed copy by mail or e-mail may be found in the Notice of Internet

Availability of Materials and on the website referred to in the Notice of Internet Availability of Materials, including an option to

request paper copies, at no cost, on an ongoing basis. We are making this Proxy Statement available on the Internet on or

about April 17, 2025, and are mailing the Notice of Internet Availability of Materials to all stockholders entitled to vote at the

Annual Meeting on or about April 17, 2025. We intend to mail or e-mail this Proxy Statement, together with a Proxy Card, to

those stockholders entitled to vote at the Annual Meeting who have properly requested copies of such materials by mail or e-

mail, within three business days of such request.

The Company has two classes of voting securities, Class A common stock, $0.001 par value per share (“Class A common

stock”), and Class B common stock, $0.001 par value per share (“Class B common stock,” and, collectively with the Class A

common stock the “common stock”). Holders of Class A common stock are entitled to one vote per share on all matters

submitted to a vote of the Company’s stockholders and the holders of Class B common stock are entitled to ten votes per

share on all matters submitted to a vote of the Company’s stockholders. As of the Record Date, there were 262,381,686

shares of common stock outstanding consisting of 126,422,600 shares of Class A common stock and 135,959,086 shares of

Class B common stock. We need the holders of a majority in voting power of the outstanding capital stock entitled to vote at

the Annual Meeting, present in person (including virtually), or represented by proxy, to hold the Annual Meeting.

The Company’s Annual Report, which contains financial statements for fiscal year 2024 (the “Annual Report”),

accompanies this Proxy Statement. Stockholders that receive the Notice of Internet Availability of Materials can

access this Proxy Statement and the Annual Report at the website referred to in the Notice of Internet Availability of

Materials. The Annual Report and this Proxy Statement are also available on the “SEC Filings” section of our

investor relations website at https//ir.ryanspecialty.com and at the website of the Securities and Exchange

Commission (the “SEC”) at www.sec.gov. Please note that the information on our website is not part of or incorporated

into this Proxy Statement. You also may obtain a copy of Ryan Specialty’s Proxy Statement and Annual Report, without

charge, by writing to our Investor Relations department at ir@ryanspecialty.com.


		2024 Proxy Statement 2
		2024 Proxy Statement 2

QUESTIONS AND ANSWERS ABOUT THIS PROXY

MATERIAL AND VOTING

Q: Why did I receive these materials?

The Board of Ryan Specialty is soliciting your proxy to vote at our Annual Meeting (or at any postponement or adjournment

of the meeting). Stockholders who own shares of our common stock as of the Record Date are entitled to vote at the Annual

Meeting. You should review these proxy materials carefully as they provide important information about the proposals that

will be voted on at the Annual Meeting, as well as other important information about Ryan Specialty.

Notice of Internet Availability of Proxy Statement and Annual Report. As permitted by SEC rules, we are making this Proxy

Statement and our Annual Report available to our stockholders electronically via the Internet. The notice of internet

availability of proxy materials contains instructions on how to access this Proxy Statement and our Annual Report and vote

online. If you received the notice of internet availability of proxy materials by mail, you will not receive a printed copy of the

proxy materials in the mail. Instead, the notice of internet availability of proxy materials instructs you on how to access and

review all of the important information contained in this Proxy Statement and Annual Report. The notice of internet

availability of proxy materials also instructs you on how you may submit your proxy over the Internet or by telephone. If you

received a notice of internet availability of proxy materials by mail and would like to receive a printed copy of our proxy

materials, at no cost, you should follow the instructions for requesting such materials contained in the notice.

Householding. The SEC’s rules permit us to print an individual’s multiple accounts on a single notice or set of Annual

Meeting materials. To take advantage of this opportunity, we have summarized on one notice or set of Annual Meeting

materials all of the accounts registered with the same tax identification number or duplicate name and address, unless we

received contrary instructions from the impacted stockholder prior to the mailing date. We agree to deliver promptly, upon

written or oral request, a separate copy of the notice or Annual Meeting materials, as requested, to any stockholder to which

a single copy of those documents was delivered. If a single copy of the notice or Annual Meeting materials was delivered

and you prefer to receive separate copies, or if multiple copies were delivered and you prefer to receive a single copy of the

materials in the future, contact our Investor Relations department at ir@ryanspecialty.com. A number of brokerage firms

have instituted householding. They will have their own procedures for stockholders who wish to receive individual copies of

the proxy materials.

Q: Who can vote at the Annual Meeting?

Only stockholders of record at the close of business on the Record Date will be entitled to vote at the Annual Meeting. At the

close of business on the Record Date, there were 262,381,686 shares of common stock outstanding consisting of

126,422,600 shares of Class A common stock and 135,959,086 shares of Class B common stock.

Stockholder of Record: Shares Registered in Your Name

If, on the Record Date, your shares of Class A common stock were registered directly in your name with our transfer agent,

Equiniti Trust Company, LLC, or if you hold shares of Class B common stock, then you are a stockholder of record. As a

stockholder of record, you may: vote virtually at the Annual Meeting; vote by proxy on the Internet or by telephone; or vote

by signing and returning a Proxy Card, if you request and receive one. Regardless of whether you plan to attend the virtual

Annual Meeting, to ensure your vote is counted, we urge you to vote by proxy on the Internet as instructed in the Notice of

Internet Availability of Materials, by telephone as instructed on the website referred to in the Notice of Internet Availability of

Materials, or (if you request and receive a Proxy Card by mail or e-mail) by signing, dating, and returning the Proxy Card

sent to you or by following the instructions on such Proxy Card to vote on the Internet or by telephone.

Beneficial Owner: Shares Registered in the Name of a Broker, Bank or Other Agent

If, on the Record Date, your shares were held in an account at a brokerage, bank, or other agent, then you are the beneficial

owner of shares held in “street name” and these proxy materials are being forwarded to you by that organization. The

organization holding your account is considered the stockholder of record for purposes of voting at the Annual Meeting. As a

beneficial owner, you have the right to direct your broker or other agent on how to vote the shares in your account. You are

also invited to attend the virtual Annual Meeting. However, since you are not the stockholder of record, you may not vote

your shares at the virtual Annual Meeting, unless you request and obtain a legal proxy from your broker or other agent who

is the record holder of the shares, authorizing you to vote at the Annual Meeting.


		2024 Proxy Statement 3
		2024 Proxy Statement 3

Q: What am I being asked to vote on?

You are being asked to vote on the following twelve management proposals:

Proposal No. 1: the election of four Class I director nominees for a three-year term until the 2028 annual meeting of

stockholders and until their successors are duly elected and qualified (“Proposal 1”);

Proposal No. 2: the approval of an amendment to the Certificate to declassify our Board and phase-in annual director

elections (“Proposal 2”);

Proposal No. 3: the approval of an amendment to the Certificate to implement a majority voting standard in uncontested

director elections (“Proposal 3”);

Proposal No. 4: the approval of an amendment to the Certificate to eliminate the springing supermajority voting standard

with respect to the removal of a director from our Board (“Proposal 4”);

Proposal No. 5: the approval of an amendment to the Certificate to provide for a specific outside date, September 30, 2029,

by which the ten-to-one vote disparity of the Class B common stock to the Class A common stock will sunset (“Proposal 5”);

Proposal No. 6: the approval of an amendment to the Certificate to provide stockholders with the ability to take action by

written consent (“Proposal 6”);

Proposal No. 7: the approval of an amendment to the Certificate to provide stockholders with the ability to call special

meetings of stockholders (“Proposal 7”);

Proposal No. 8: the approval of an amendment to the Certificate to eliminate the springing supermajority voting standard

with respect to the amendment of the Company’s Bylaws and certain provisions of the Certificate (“Proposal 8”);

Proposal No. 9: the approval of an amendment to the Certificate to provide for the exculpation of certain officers of the

Company to the fullest extent provided under Delaware law (“Proposal 9”);

Proposal No. 10: the approval of certain other Non-Substantive Amendments as set forth in the proposed amended and

restated Certificate of Incorporation (the "Proposed Amended and Restated Certificate") (“Proposal 10”);

Proposal No. 11: the ratification of the selection, by the Audit Committee of our Board, of Deloitte & Touche LLP as the

Company’s independent registered public accounting firm for the Company’s fiscal year ending December 31, 2025

(“Proposal 11”); and

Proposal No. 12: the non-binding advisory approval of the compensation of our named executive officers (“Proposal 12”).

In addition, you are entitled to vote on any other matters that are properly brought before the Annual Meeting.

Q: How does the Board recommend I vote on the proposals?

The Board recommends that you vote:

•FOR each of the four director nominees in Proposal 1;

•FOR Proposal 2;

•FOR Proposal 3;

•FOR Proposal 4;

•FOR Proposal 5;

•FOR Proposal 6;

•FOR Proposal 7;

•FOR Proposal 8;

•FOR Proposal 9;

•FOR Proposal 10;

•FOR Proposal 11; and

•FOR Proposal 12.


		2024 Proxy Statement 4
		2024 Proxy Statement 4

Q: Who can attend the Annual Meeting?

The Annual Meeting is being held as a virtual-only meeting. If you are a stockholder of record as of the Record Date, you

may attend, vote, and ask questions virtually at the meeting by logging in at www.proxydocs.com/RYAN and registering by

providing your control number.

If you are a stockholder holding your shares in “street name” as of the Record Date, you may gain access to the meeting by

following the instructions in the voting instruction card provided by your broker, bank, or other nominee holder. You may not

vote your shares at the Annual Meeting unless you receive a valid proxy from your brokerage, bank, or other nominee

holder. You may attend and ask questions virtually at the meeting by logging in at www.proxydocs.com/RYAN and registering

by providing your control number.

The control number is included in the notice or on your Proxy Card. Upon completing your registration, you will receive

further instructions via email, including your unique link that will allow you to access the Annual Meeting and to submit

questions during the meeting and, if you are either the (i) record holder or (ii) a beneficial holder with a valid proxy, vote

during the meeting. Please be sure to follow the instructions found on your Proxy Card and/or voting authorization form and

subsequent instructions that will be delivered to you via email after you register.

If you have questions, you may type them into the dialog box provided at any point during the Annual Meeting (until the floor

is closed to questions). Recording of the Annual Meeting will not be permitted.

Q: Why is the Annual Meeting virtual only?

Our Annual Meeting will be a virtual meeting format only in which stockholders will participate by accessing a website using

the Internet. There will not be a physical meeting location. We believe that hosting a virtual meeting will facilitate

stockholders’ attendance and participation at our Annual Meeting by enabling stockholders to participate remotely from any

location around the world. We have designed the virtual Annual Meeting to provide stockholders the same rights and

opportunities to participate as they would have at an in-person meeting, including the right to vote and ask questions through

the virtual meeting platform. A virtual meeting also provides an additional opportunity for stockholders to communicate with

the Board by submitting questions before and during the meeting through the virtual meeting platform. A virtual meeting also

eliminates many of the costs associated with hosting a physical meeting, which will benefit both our stockholders and the

Company.

Q: What are my voting options?

•For Proposal 1, you may either vote “For,” or choose that your vote be “Withheld” from, any of the nominees to the

Board.

•For Proposals 2 through 12, you may either vote “For” or “Against” the proposal or “Abstain” from voting.

Please note that by casting your vote by proxy you are authorizing the individuals listed on the proxy card to vote your

shares in accordance with your instructions and in their discretion with respect to any other matter that properly comes

before the Annual Meeting or any adjournments or postponements thereof. The procedures for voting, depending on

whether you are a stockholder of record or a beneficial owner, are as follows:

Stockholder of Record: Shares Registered in Your Name

If you are a stockholder of record, you may vote in any of the following manners:

•To personally vote during the Annual Meeting prior to the close of the polls, log into the virtual Annual Meeting and

follow the instructions on how to vote at the Annual Meeting.

•To vote over the Internet prior to and during the Annual Meeting, follow the instructions provided on the Notice of

Internet Availability of Materials or on the Proxy Card that you request and receive by mail or e-mail. We provide

Internet proxy voting to allow you to vote your shares online, with procedures designed to ensure the authenticity

and correctness of your proxy vote instructions.

•To vote by telephone, call the toll-free number found on the Proxy Card you request and receive by mail or e-mail

or the toll-free number that you can find on the website referred to on the Notice of Internet Availability of Materials.

•To vote by mail, complete, sign, and date the Proxy Card you request and receive by mail or e-mail and return it

promptly. As long as your signed Proxy Card is received prior to the Annual Meeting, we will vote your shares as

you direct.


		2024 Proxy Statement 5
		2024 Proxy Statement 5

Regardless of whether you plan to attend the virtual Annual Meeting, we urge you to vote by proxy by mail, Internet, or

telephone to ensure your vote is counted. Even if you have submitted your vote before the Annual Meeting, you may still

attend the virtual Annual Meeting and vote during the Annual Meeting. In such case, your previously submitted vote will be

disregarded.

Beneficial Owner: Shares Registered in the Name of Broker, Bank, or Other Agent

If you are a beneficial owner of shares registered in the name of your broker, bank, or other agent, you should have received

a voting instruction card and voting instructions with these proxy materials from that organization, rather than from us.

Simply complete and mail the voting instruction card to ensure that your vote is counted or follow the instructions to submit

your vote by the Internet or telephone, if those instructions provide for Internet and telephone voting. To vote during the

Annual Meeting, you must obtain a valid proxy from your broker, bank, or other agent. Follow the instructions from your

broker, bank, or other agent included with these proxy materials, or contact your broker, bank, or other agent to request a

proxy form.

Q: Who counts the votes?

Mediant, a BetaNXT Inc. business, has been engaged as our independent agent to tabulate stockholder votes, also known

as the Inspector of Election. If you are a stockholder of record, and you choose to vote over the Internet prior to the Annual

Meeting or by telephone, Mediant will access and tabulate your vote electronically, and if you request and receive proxy

materials via mail or e-mail and choose to sign and mail your Proxy Card, your executed Proxy Card is returned directly to

Mediant for tabulation. As noted above, if you hold your shares through a broker, bank, or other nominee, they (or its agent

for tabulating votes of shares held in “street name”) return one Proxy Card to Mediant on behalf of all of its clients.

Q: How are votes counted?

Votes will be counted by the Inspector of Election appointed for the Annual Meeting. For Proposal 1, the Inspector of

Election will separately count “For” and “Withheld” votes and broker non-votes for each nominee. For Proposals 2 through

12, the Inspector of Election will separately count “For” and “Against” votes, abstentions, and broker non-votes. If you do not

give instructions to your broker, bank, or other nominee, they can vote your shares with respect to “routine” items, but not

with respect to “non-routine” items. See below for more information regarding: “What are ‘broker non-votes’”? and “Which

ballot measures are considered ‘routine’ and ‘non-routine’”?

Q: What are “broker non-votes”?

Broker non-votes occur when a beneficial owner of shares held in “street name” does not give instructions to the broker,

bank, or other nominee holding the shares as to how to vote on matters deemed “non-routine.” Generally, if shares are held

in “street name”, the beneficial owner of the shares is entitled to give voting instructions to the broker, bank, or other

nominee holding the shares. If the beneficial owner does not provide voting instructions, the broker, bank, or other nominee

holder can still vote the shares with respect to matters that are considered to be “routine,” but not with respect to “non-

routine” matters. In the event that a broker, bank, or other nominee holder indicates on a proxy that it does not have

discretionary authority to vote certain shares on a particular proposal, then those shares will be treated as broker non-votes

with respect to that proposal. Accordingly, if you own shares through a broker, bank, or other nominee, please be sure to

instruct your nominee how to vote to ensure that your vote is counted on each of the proposals. Under the listing rules of the

New York Stock Exchange (“NYSE”), abstentions will be treated in accordance with our Bylaws and Delaware state law.

Q: Which ballot measures are considered “routine” or “non-routine”?

The ratification of the selection of Deloitte & Touche LLP as our independent registered public accounting firm for the year

ending December 31, 2025 (Proposal 11) is considered routine under the NYSE rules. A broker, bank, or other nominee

holder may generally vote on routine matters, and therefore, no broker non-votes are expected to exist in connection with

Proposal 11. The election of directors (Proposal 1), the governance proposals relating to proposed amendments to the

Certificate (Proposals 2 through 10), and the non-binding approval of the compensation of our named executive officers

(Proposal 12) are considered non-routine under the NYSE rules. A broker, bank, or other nominee cannot vote without

instructions on non-routine matters, and therefore, there may be broker non-votes on Proposals 1 though 10 and on

Proposal 12.


		2024 Proxy Statement 6
		2024 Proxy Statement 6

Q: How many votes are needed to approve each proposal?

With respect to Proposal 1, directors will be elected by a plurality of the votes cast of the shares present or represented by

proxy at the virtual Annual Meeting and entitled to vote. This means that the four nominees receiving the highest number of

votes at the virtual Annual Meeting will be elected, even if those votes do not constitute a majority of the votes cast.

“Withhold” votes and broker non-votes are not considered votes cast for the foregoing purpose, and will have no effect on

the election of nominees.

With respect to Proposals 2, 3, 6, 7, 9, and 10, the affirmative vote of the majority of the holders of the voting power of the

outstanding shares of capital stock of the Company entitled to vote generally thereon, voting together as a single class, is

required for approval of the amendment to our Certificate to provide for these proposals. Votes to “Abstain” and broker non-

votes are treated as cast “Against” these proposals.

With respect to Proposals 4 and 8 the affirmative vote of sixty-six and two-thirds percent (66⅔%) of the voting power of the

outstanding shares of capital stock of the Company entitled to vote generally thereon, voting together as a single class, is

required for approval of the amendment to our Certificate to provide for these proposals. Votes to “Abstain” and broker non-

votes are treated as cast “Against” these proposals.

With respect to Proposal 5, the affirmative vote of each of (i) the majority of the holders of the voting power of the

outstanding shares of capital stock of the Company entitled to vote generally thereon, voting together as a single class, and

(ii) the majority of the holders of the voting power of the outstanding shares of Class B common stock of the Corporation

entitled to vote generally thereon are required for approval of this proposal. Votes to “Abstain” and broker non-votes are

treated as cast “Against” this proposal.

With respect to Proposal 11, the affirmative vote of the majority of voting power of the capital stock present or represented

by proxy at the virtual Annual Meeting and entitled to vote thereon is required for ratification. Votes to “Abstain” are treated

as cast “Against” this proposal. We do not expect there to be any broker non-votes with respect to this proposal.

With respect to Proposal 12, the affirmative vote of the majority of voting power of the capital stock present or represented

by proxy at the virtual Annual Meeting and entitled to vote thereon is required for approval. Votes to “Abstain” are treated as

cast “Against” this proposal and broker non-votes will have no effect on the vote for this proposal.

Q: How many votes do I have?

On each matter to be voted upon, each share of Class A common stock that you own as of the Record Date has one vote

and each share of Class B common stock that you own as of the Record Date has ten votes.

Q: What if I return a Proxy Card but do not make specific choices?

If we receive a signed and dated Proxy Card that does not specify how your shares are to be voted, your shares will be

voted “For” the election of each of the four nominees for director in Proposal 1 and “For” the approval or ratification, as

applicable, of each of Proposals 2 through 12. If any other matter is properly presented at the Annual Meeting or any

adjournment thereof, your proxy (one of the individuals named on your Proxy Card) is authorized to vote your shares using

their best judgment.

Q: Who is paying for this proxy solicitation?

We will pay for the entire cost of soliciting proxies. In addition to those proxy materials received by mail or on the Internet,

our directors, officers, and employees may also solicit proxies in person, by telephone, or by other means of communication.

Directors, officers, and employees will not be paid any additional compensation for soliciting proxies. We may also reimburse

brokerage firms, banks, and other agents for the cost of forwarding proxy materials to beneficial owners.

Q: What does it mean if I receive more than one Notice of Internet Availability of

Materials or more than one set of printed materials?

If you receive more than one Notice of Internet Availability of Materials or more than one set of printed materials, your shares

are registered in more than one name or are registered in different accounts. In order to vote all the shares you own, you

must follow the instructions for voting on each Notice of Internet Availability of Materials or Proxy Card you receive via mail

or e-mail upon your request, which include voting over the Internet, telephone or by signing and returning any of the Proxy

Cards you request and receive.


		2024 Proxy Statement 7
		2024 Proxy Statement 7

Q: Can I change or revoke my proxy after submitting my proxy vote?

Yes, you can revoke your proxy vote at any time before the Annual Meeting by:

•submitting a new vote on the Internet or by telephone or submitting a properly completed Proxy Card with a later

date; or

•sending a written notice that you are revoking your proxy, which is received prior to the Annual Meeting, to Ryan

Specialty’s Corporate Secretary at 155 North Wacker Drive, Suite 4000, Chicago, IL 60606.

If you are the record holder of your shares, you may also revoke your proxy vote by:

•attending the virtual Annual Meeting and personally voting during the Annual Meeting prior to the close of the polls.

Simply attending the virtual Annual Meeting without voting during the meeting will not, by itself, revoke your proxy.

Q: How will voting on any business not described in this Proxy Statement be

conducted?

We are not aware of any business to be considered at the Annual Meeting other than the items described in this Proxy

Statement. If any other matter is properly presented at the Annual Meeting, your proxy will vote your shares using their best

judgment.

Q: What is the quorum requirement?

A quorum of stockholders is necessary to hold a valid meeting of stockholders. A quorum will be present if the holders of a

majority in voting power of the outstanding capital stock entitled to vote at the Annual Meeting are present in person

(including virtually) or are represented by proxy at the virtual Annual Meeting. On the Record Date, there were 126,422,600

shares of Class A common stock, with one vote each, and 135,959,086 shares of Class B common stock, with 10 votes

each. Accordingly, shares representing 743,006,731 votes must be represented by stockholders present in person or by

proxy at the virtual Annual Meeting to have a quorum.

If you are a stockholder of record, your shares will be counted towards the quorum only if you submit a valid proxy vote or

vote at the virtual Annual Meeting. If you are a beneficial owner of shares held in “street name,” your shares will be counted

towards the quorum if your broker or nominee submits a proxy for your shares at the Annual Meeting, even a proxy which

result in a broker non-vote due to the absence of voting instructions from you. Abstentions and broker non-votes will be

counted towards the quorum requirement. If a quorum is not present, either the chairperson of the Annual Meeting or a

majority in voting power of the voting stock present in person (including virtually) or represented by proxy at the Annual

Meeting and entitled to vote thereon, may adjourn the Annual Meeting to another time or place.

Q: How can I find out the results of the voting at the Annual Meeting?

The preliminary voting results will be announced at the Annual Meeting. Final voting results will be announced by the filing of

a Current Report on Form 8-K within four business days after the Annual Meeting. If final voting results are unavailable at

that time, we will file an amended Current Report on Form 8-K within four business days of the day the final results are

available.

Q: What is the deadline for submitting a stockholder proposal or director nomination for

the 2026 Annual Meeting?

Stockholder proposals pursuant to SEC Rule 14a-8 for inclusion in our Proxy Statement and form of proxy for our 2026

annual meeting of stockholders, to be held in 2026, must be received by us at our principal executive offices at 155 North

Wacker Drive, Suite 4000, Chicago, IL 60606 no later than the close of business on December 18, 2025. Stockholders

wishing to make a director nomination or bring a proposal before the annual meeting to be held in 2026 (but not include it in

our proxy materials) must provide written notice of such proposal to the Corporate Secretary at our principal executive

offices no later than the close of business on March 1, 2026, and not earlier than the close of business on January 30, 2026,

assuming we do not change the date of the 2026 annual meeting of stockholders by more than 30 days before or after the

anniversary of this Annual Meeting. If so, we will release an updated timeframe for stockholder proposals. Any stockholder

proposal or director nomination must comply with the other provisions of our Bylaws and be submitted in writing to the

Corporate Secretary at our principal executive offices. To comply with the universal proxy rules, stockholders who intend to

solicit proxies in support of director nominees, other than the Company’s nominees, must also provide notice that sets forth

the information required by Rule 14a-19 under the Securities Exchange Act of 1934, as amended (the “Exchange Act”) no


		2024 Proxy Statement 9
		2024 Proxy Statement 9

BOARD OF DIRECTORS AND CORPORATE

GOVERNANCE

Our business and affairs are managed under the direction of our Board. Our current Amended and Restated Certificate of

Incorporation (the “Certificate”) provides that the authorized number of directors may be changed only by resolution of our

Board. Pursuant to our Certificate, our Board is currently classified into three classes, each comprising as nearly as possible

one-third of the total number of directors, to serve three-year terms. At this Annual Meeting, a class of directors will be

elected for a three-year term to succeed the class whose term is then expiring. Separately, we are presenting a proposal to

declassify the Board and phase-in annual director elections (Proposal 2). If Proposal 2 receives sufficient stockholder

support, beginning with the 2026 annual meeting of stockholders, directors will be elected to one-year terms. Therefore, the

full Board will stand for annual election starting at the 2028 annual meeting of stockholders. Directors elected at this Annual

Meeting will serve a three-year term regardless of the outcome of the vote with respect to Proposal 2.

Board Composition

Pursuant to the Company’s Certificate, the Board adopted resolutions to set the size of the Board at thirteen members. The

Board currently consists of thirteen members divided into three classes, two classes with four members and one class with

five members. The members of the three classes are elected to serve for staggered terms of three years.

Director Nomination Agreement

In connection with the Company’s initial public offering in July of 2021 (the “IPO”), the Company entered into a Director

Nomination Agreement with Patrick G. Ryan, our founder, Chairman, and Chief Executive Officer and certain members of his

family and various entities and trusts over which Patrick G. Ryan and his family exercise control (collectively, the “Ryan

Parties”) and Onex RSG Holdings LP, a Delaware limited partnership (“Onex”), an affiliate of Onex Corporation.

The Director Nomination Agreement currently provides the Ryan Parties the right to nominate certain members of our Board

based on the number of shares of the Company’s common stock held by the Ryan Parties. The Director Nomination

Agreement provides the Ryan Parties the right to designate (in each instance, rounded up to the nearest whole number if

necessary): (i) all of the nominees for election to our Board for so long as the Ryan Parties control, in the aggregate, 50% or

more of the total number of shares of our common stock beneficially owned by the Ryan Parties upon completion of the IPO,

as adjusted for any reorganization, recapitalization, stock dividend, stock split, reverse stock split or similar changes in our

capitalization (the “Original Amount”); (ii) 50% of the nominees for election to our Board for so long as the Ryan Parties

control, in the aggregate, more than 40%, but less than 50% of the Original Amount; (iii) 40% of the nominees for election to

our Board for so long as the Ryan Parties control, in the aggregate, more than 30%, but less than 40% of the Original

Amount; (iv) 30% of the nominees for election to our Board for so long as the Ryan Parties control, in the aggregate, more

than 20%, but less than 30% of the Original Amount; and (v) 20% of the nominees for election to our Board for so long as

the Ryan Parties control, in the aggregate, more than 10%, but less than 20% of the Original Amount, which could result in

representation on our Board that is disproportionate to the Ryan Parties’ beneficial ownership. Upon the death or disability of

Patrick G. Ryan, or at such time that he is no longer on the Board or actively involved in the operations of the Company, the

Ryan Parties will no longer hold the nomination rights specified in clauses (i) through (v) above; however, the Ryan Parties

will have the right to designate one nominee for so long as the Ryan Parties control, in the aggregate, 10% or more of the

Original Amount. Onex’s right to designate one nominee for election to our Board fell away upon its sale of shares of our

Class A common stock in April 2023. See “Certain Relationships and Related Party Transactions — Director Nomination

Agreement” for more details with respect to the Director Nomination Agreement.

Classified Board

Our Certificate currently provides that our Board be divided into three classes of directors, with the classes as nearly equal

in number as possible. Our Certificate also currently provides that our directors may be removed with or without cause by

the affirmative vote of at least a majority of the voting power of our outstanding shares of common stock entitled to vote

thereon, voting together as a single class, for so long as the Ryan Parties beneficially own 40% or more, in the aggregate, of

the total number of shares of our common stock then outstanding. If the Ryan Parties’ aggregate beneficial ownership falls

below 40% of the total number of shares of our common stock outstanding, then our directors may be removed only for

cause upon the affirmative vote of at least 66 2/3% of the voting power of our outstanding shares of common stock entitled

to vote thereon. The Board has approved, subject to stockholder approval, amending the Certificate to declassify the Board

and to remove the springing supermajority voting standard with respect to the removal of directors. See “Proposal No. 2:

Amendment to the Certificate to Declassify the Board of Directors and Phase-in Annual Director Elections” and “Proposal

No. 4: Amendment to the Certificate to Eliminate the Springing Supermajority Voting Standard with Respect to the Removal

of Directors from our Board” for more details with respect to the above proposed changes to our Certificate. If the


		2024 Proxy Statement 10
		2024 Proxy Statement 10

stockholders approve the declassification of the Board, then current directors will continue to serve out the remainder of their

term and at the end of such term will stand for reelection, if nominated by the Board, for a term of one year until such time as

all directors are nominated for a term of one year.

The table below sets forth for each director nominee, and all continuing directors, their respective ages as of the Record

Date, the positions currently held with the Company (if any), the year each was first elected or appointed as a director of the

Company, the year their current term will expire, and their current class.


Nominee/Director Name	Age	Position	Director Since(1)	Current Term Expires	Director Class

Nomination for Class I Director
Henry S. Bienen	85	Director	2012	2025	I
Michael D. O’Halleran	74	Director	2018	2025	I
Timothy W. Turner	64	Chief Executive Officer and Director	2012	2025	I
Patrick G. Ryan, Jr.	57	Director	2024	2025	I
Continuing Directors
Patrick G. Ryan	87	Executive Chairman of the Board	2010	2027	III
David P. Bolger	67	Director	2012	2026	II
Michelle L. Collins	64	Director	2021	2027	III
Francesca Cornelli	62	Director	2023	2026	II
Nicholas D. Cortezi	58	Director	2021	2026	II
D. Cameron Findlay	65	Lead Director	2012	2027	III
Anthony J. Kuczinski	66	Director	2023	2026	II
Robert Le Blanc	58	Director	2018	2026	II
John W. Rogers, Jr.	66	Director	2014	2027	III

(1)For all directors other than Ms. Collins, Dr. Cornelli and Messrs. Cortezi, Kuczinski, and Ryan, Jr., this column reflects the date that

the director joined the Board of Ryan Specialty, LLC prior to the Company’s IPO on July 21, 2021, when the Board of Ryan Specialty

Holdings, Inc. was formed.

Board Leadership and Structure

The following section describes our Board leadership structure, the reasons why the structure is in place at this time, the

roles of various positions, and related key governance practices. We believe the mix of experienced independent and

management directors that make up our Board, along with the independent role of our Lead Director and our independent

board-committee composition, benefits us and our stockholders.

Director Independence; Board Mix

Our Board has an effective mix of independent and non-independent directors. It is composed of eight independent directors

and five non-independent directors including our Executive Chairman, Patrick G. Ryan; our Chief Executive Officer, Timothy

W. Turner; the retired Chairman of Ryan Specialty Underwriting Managers, Nicholas D. Cortezi; the Executive Chairman of

Geneva Re, Michael D. O’Halleran, and Patrick G. Ryan, Jr. We believe each of our independent and non-independent

directors adds value to our Board and benefits us and our stockholders.

The NYSE Listed Company Manual requires directors to satisfy certain criteria to be deemed “independent.” The Board

applies these standards in determining whether any director has a material relationship with the Company that would impair

their independence, as discussed below. As required by the NYSE Listed Company Manual, the Board considers all material

relevant facts and circumstances known to it in making an independence determination, from the standpoints of both the

director and persons or organizations with which the director has an affiliation.

Our Board has affirmatively determined that Drs. Bienen and Cornelli, Ms. Collins, and Messrs. Bolger, Findlay, Kuczinski,

Le Blanc, and Rogers meet the requirements to be independent directors. In making this determination, our Board

considered the relationships that each such non-employee director has with the Company and all other facts and

circumstances that our Board deemed relevant in determining their independence, including beneficial ownership of our

common stock. The NYSE does not take the position that ownership of equity in our Company by itself precludes the

Board’s finding of independence.


		2024 Proxy Statement 11
		2024 Proxy Statement 11

Lead Director and Executive Session

Our Board designates one of our non-employee independent directors as Lead Director of our Board (the “Lead Director”).

Mr. D. Cameron Findlay has served in the position of Lead Director since February 2023. The Board believes that it is

beneficial for us and our stockholders to have a Lead Director who serves a variety of roles, including presiding at the

executive sessions of independent directors, and at all other meetings of the Board at which the chairperson of the Board is

not present, and calling an executive session of independent directors at any time, consistent with our Corporate

Governance Guidelines.

Independent directors of the Board meet outside the presence of other directors in executive sessions, held in conjunction

with our regular Board meetings four times a year, and our Lead Director presides at all such executive sessions.

Chairperson and CEO

With respect to the roles of chairperson and CEO, the Corporate Governance Guidelines provide that the roles may be

separated or combined, and the Board will exercise its discretion in combining or separating these positions as it deems

appropriate in light of prevailing circumstances. Mr. Ryan, the founder of our Company, served as our chairperson and CEO

from our IPO until October 1, 2024 and has been at the helm of our business since its formation in 2010. On October 1,

2024, Mr. Ryan became our Executive Chairman, retaining his position as Chairman of the Board, and Mr. Turner assumed

the role of CEO, effectively separating the role of CEO and chairperson. The Board believes that separating the roles of

chairperson and CEO, while maintaining the separate, independent role of our Lead Director, is currently the most effective

leadership structure as it best utilizes the respective knowledge and experience of Mr. Ryan and Mr. Turner. Mr. Ryan has

extensive knowledge and industry leading experience in the area of insurance as the founder of our Company and through

his leadership at Aon Corporation. While Mr. Turner, as our current leader, has a strong understanding of our business and is

highly in tune with the industry and current market dynamics along with day-to-day operations.

Self-Evaluation

Pursuant to its charter, our Compensation and Governance Committee developed and oversees a process for an annual

evaluation of the Board, its committees, individual directors, and management. The Compensation and Governance

Committee completed the most recent annual evaluation in November of 2024.

As part of the annual Board self-evaluation, the Board evaluates whether the size, composition, and responsibilities of our

Board and its committees and our Corporate Governance Guidelines continue to be appropriate for us and our stockholders.

Our Corporate Governance Guidelines provide the flexibility for our Board to modify our leadership structure in the future as

appropriate.

Meetings and Attendance

During 2024, our Board held four regularly scheduled meetings and two special meetings. Each director, other than Mr.

O’Halleran, attended at least 75% of the aggregate number of Board meetings and committee meetings of which such

director is a member. Mr. O’Halleran was not able to attend the two special meetings of the Board. The Board expects, but

does not require, directors to attend the annual meeting of stockholders. Each of our directors attended the 2024 annual

meeting of stockholders.


		2024 Proxy Statement 12
		2024 Proxy Statement 12

Board Committees

Our Board has a standing Audit Committee, Compensation and Governance Committee, and Executive Committee. The

composition, duties, and responsibilities of these committees are as set forth below. In the future, our Board may establish

other committees, as it deems appropriate, to assist it with its responsibilities.


Board Member	Audit Committee	Compensation and Governance Committee	Executive Committee

Patrick G. Ryan			Chair
Henry S. Bienen	X	X
David P. Bolger	Chair
Michelle L. Collins	X
Francesca Cornelli	X
Nicholas D. Cortezi			X
D. Cameron Findlay		Chair	X
Anthony J. Kuczinski	X	X
Robert Le Blanc		X
Michael D. O’Halleran
John W. Rogers, Jr.		X	X
Timothy W. Turner			X
Patrick G. Ryan, Jr.

Audit Committee

Our Audit Committee is composed of Dr. Bienen, Mr. Bolger, Ms. Collins, Dr. Cornelli and Mr. Kuczinski, with Mr. Bolger

serving as chairperson of the committee. The Board has determined that all of the members of the Audit Committee are

independent directors and meet the independence requirements of Rule 10A-3 under the Exchange Act and the applicable

listing standards of the NYSE. Our Board has determined that all members of our Audit Committee are “financially literate”

under the applicable listing standards of the NYSE and that Mr. Bolger is an “audit committee financial expert” within the

meaning of SEC regulations and applicable listing standards of the NYSE. The Audit Committee held four regularly

scheduled meetings in 2024. The Audit Committee’s responsibilities include:

•appointing, approving the compensation of, and assessing the qualifications, performance, and independence of

our independent registered public accounting firm, including an evaluation of the lead audit partner;

•pre-approving audit and permissible non-audit services, and the terms of such services, to be provided by our

independent registered public accounting firm;

•reviewing and discussing, on a periodic basis or as appropriate, with management, our policies, programs and

controls with respect to risk assessment and risk management;

•reviewing and discussing with management procedures and internal controls relating to cybersecurity and the

enterprise risk function;

•reviewing and discussing with management and the independent registered public accounting firm our annual and

quarterly financial statements and related disclosures as well as critical accounting policies and practices used by

us;

•reviewing our Management’s Discussion and Analysis of Financial Condition and Results of Operations to be

included in our annual and quarterly reports to be filed with the SEC;

•reviewing and discussing with management our earnings releases;

•monitoring the rotation of partners of the independent registered public accounting firm on our engagement team in

accordance with requirements established by the SEC;

•monitoring and assessing the performance of the Company’s internal audit function and reviewing the scope and

results of the internal audit;


		2024 Proxy Statement 13
		2024 Proxy Statement 13

•reviewing management’s report on its assessment of the effectiveness of internal controls over financial reporting

and any changes thereto;

•reviewing the adequacy and effectiveness of our internal controls over financial reporting and disclosure controls

and procedures;

•establishing policies and procedures for the receipt, retention, follow-up, and resolution of accounting, internal

controls or auditing matters, complaints, and concerns;

•recommending, based upon the Audit Committee’s review and discussions with management and the independent

registered public accounting firm, whether our audited financial statements shall be included in our Annual Report

on Form 10-K;

•reviewing our compliance with legal and regulatory requirements as they relate to our financial statements,

applicable laws and regulations, and climate disclosure obligations;

•preparing the Audit Committee report required by the rules of the SEC to be included in our annual Proxy

Statement;

•reviewing and assessing annually tax and treasury functions, including cash management processes;

•investigating any alleged breaches or violations of the Company’s Code of Ethics, and reporting to the Board

periodically, with respect to ethics issues, complaints, and associated investigations;

•reviewing the Audit Committee charter and the committee’s performance at least annually; and

•reviewing all related party transactions for potential conflict of interest situations and disapproving, approving, or

ratifying all such transactions.

Our Audit Committee charter is available on our website at www.ryanspecialty.com. To access the charter, go to our website,

click on the “Investors” tab, and then click on “Governance/Governance Documents” to download or view the charter.

Compensation and Governance Committee

Our Compensation and Governance Committee is composed of Dr. Bienen, Mr. Findlay, Mr. Kuczinski, Mr. Le Blanc, and Mr.

Rogers, with Mr. Findlay serving as chairperson of the committee. The Board has determined that all the members of the

Compensation and Governance Committee are independent directors and meet the independence requirements of the

applicable listing standards of the NYSE. The Compensation and Governance Committee held five regularly scheduled

meetings in 2024. The Compensation and Governance Committee’s responsibilities include:

•recommending to our Board best practices relative to corporate governance principles;

•developing and recommending to our Board, and reviewing periodically, our set of corporate governance

guidelines;

•reviewing and discussing with management the Company’s Environmental, Social and Governance strategy,

initiatives, and policies;

•reviewing and recommending to our Board the functions, duties, and compositions of our Board committees;

•developing and recommending to our Board criteria for Board and committee membership;

•identifying and recommending to our Board the persons to be nominated for election as directors and appointed to

each of our Board’s committees;

•assisting our Board with orientation and continuing education of directors;

•overseeing the annual evaluations of our Board and our Board committees;

•establishing and overseeing the Company’s succession, leadership, and talent development planning and process;

•reviewing and approving periodically a group of peer companies against which to benchmark the compensation of

the Company’s executive officers;

•reviewing and approving corporate goals and objectives relevant to the compensation of our Chief Executive

Officer;

•evaluating the performance of our Chief Executive Officer in light of such corporate goals and objectives and

determining and approving the compensation of our Chief Executive Officer;

•reviewing and approving the compensation of our other executive officers;

•appointing, compensating, and overseeing the work of any compensation consultant, legal counsel, or other

advisors retained by the Compensation and Governance Committee;


		2024 Proxy Statement 14
		2024 Proxy Statement 14

•conducting the independence assessment outlined in the NYSE’s rules with respect to any compensation

consultant, legal counsel, or other advisor retained by the Compensation and Governance Committee;

•reviewing the Company’s incentive compensation arrangements to determine whether they encourage excessive

risk-taking;

•reviewing the Company’s human capital programs, policies, and practices to determine their effectiveness;

•reviewing and reassessing the adequacy of the committee charter in its compliance with the listing standards of the

NYSE;

•reviewing and establishing our overall management compensation philosophy and policies;

•overseeing our compensation and benefits programs and policies, including any equity incentive plans;

•reviewing and making recommendations to our Board with respect to director compensation;

•reviewing and discussing with management the Company’s corporate governance practices to be included in our

annual Proxy Statement or Annual Report on Form 10-K; and

•reviewing and discussing with management the Compensation Discussion and Analysis to be included in our

annual Proxy Statement or Annual Report on Form 10-K.

Our Compensation and Governance Committee charter is available on our website at www.ryanspecialty.com. To access the

charter, go to our website, click on the “Investors” tab, and then click on “Governance/Governance Documents” to download

or view the charter.

Executive Committee

Our Executive Committee is composed of Mr. Cortezi, Mr. Findlay, Mr. Rogers, Mr. Ryan, and Mr. Turner, with Mr. Ryan

serving as chairperson of the committee. During intervals between meetings of the Board, the Executive Committee has and

may exercise the power and authority of the Board in directing the management of the business and affairs of the Company,

including but not limited to the power and authority to declare dividends, except as may be limited by applicable law, our

Certificate, Bylaws, or by resolution of the Board.

Risk Oversight

The Board is responsible for reviewing the major risks facing the Company and helping develop and oversee strategies to

address these risks. The Board has delegated to the Audit Committee the role of overseeing our enterprise risk assessment

and risk management policies. Pursuant to its charter, our Audit Committee is responsible for reviewing and discussing with

management our enterprise risk management framework. Taking into consideration the allocation of responsibility for risk

oversight to the other committees of the Board, the Audit Committee is responsible for reviewing and discussing with

management, on a periodic basis or as appropriate, the risks faced by us and policies, guidelines, and processes by which

management assesses and manages our risks, including our major financial risk exposures and the steps management has

taken to monitor and control such exposures.

The Audit Committee is also responsible for reviewing and discussing with management the Company’s procedures and

internal controls relating to cybersecurity. The Board and Audit Committee set the tone at the top by providing oversight and

establishing expectations for the overall effectiveness and efficiency of the information security program.

Pursuant to its charter, the Compensation and Governance Committee is responsible for reviewing our incentive

compensation arrangements to determine whether they encourage excessive risk-taking, analyzing the relationship between

risk management policies and practices and compensation, and evaluating compensation policies and practices that could

mitigate any such risk. For more information, please see “Executive Compensation: Compensation Discussion and Analysis

— Compensation Decision Process and Methodology.”

Stockholder Nominations and Recommendations for Director Nominees

The Compensation and Governance Committee will consider stockholder nominations for membership on the Board that

conform to the requirements of our Bylaws. For the 2026 annual meeting, nominations may be submitted to Ryan Specialty

Holdings, Inc., 155 North Wacker Drive, Suite 4000, Chicago, IL 60606, Attn: Corporate Secretary, and such nominations will

then be forwarded to the chairperson of the Compensation and Governance Committee. Nominations must be in writing, and

we must receive the nomination no later than March 1, 2026, and not earlier than January 30, 2026, assuming we do not

change the date of the 2026 annual meeting of the stockholders by more than 30 days before or after the anniversary of this

Annual Meeting. Nominations must also satisfy certain other procedural requirements as specified in our Bylaws.


		2024 Proxy Statement 15
		2024 Proxy Statement 15

When filling a vacancy on the Board, the Compensation and Governance Committee identifies the desired skills and

experience of a new director and nominates individuals who it believes can strengthen the Board’s capabilities and further

diversify the collective experience represented by the then-current directors. The Compensation and Governance

Committee may engage third parties to assist in the search and provide recommendations. Also, directors are generally

asked to recommend candidates for the position. The Compensation and Governance Committee will consider candidates

recommended by a stockholder provided the stockholder notifies the committee in writing to Ryan Specialty Holdings, Inc.,

155 North Wacker Drive, Suite 4000, Chicago, IL 60606, Attn: Corporate Secretary, and such recommendation will then be

forwarded to the chairperson of the Compensation and Governance Committee. The candidates are then evaluated based

on the process outlined in our Corporate Governance Guidelines and the Compensation and Governance Committee

charter. The same process is used for all candidates, including candidates recommended by stockholders.

Compensation Committee Interlocks and Insider Participation

Patrick G. Ryan, our CEO, serves as a member of the Board and as a member of the compensation committee of Geneva

Re, a joint venture. The Executive Chairman of Geneva Re, Michael D. O’Halleran, serves on our Board. For more

information relating to Geneva Re, please see the section entitled “Certain Relationships and Related Party Transactions —

Related Party Transactions — Ryan Investment Holdings, Geneva Re and Ryan Re.”

Board Skills Matrix

Each director possesses certain personal qualities and attributes that we believe are essential for the proper functioning of

the Board to fulfill its duties to our stockholders. The following matrix provides information regarding each nominee for

election as a director and each continuing director, including certain types of experiences and skills that the Board has

determined are important. The matrix does not encompass all the experiences and skills of our directors, and the fact that a

particular experience or skill is not listed does not mean that a director does not possess it. In addition, the director

biographies below include a non-exhaustive list of other key experiences and qualifications that further qualify the individual

to serve on our Board. These collective qualities, skills, experiences, and attributes are essential to our Board’s ability to

exercise its oversight function for us and our stockholders and guide our long-term sustainable, dependable performance.


Director Name	Leadership Experience	Financial or Accounting Acumen	Enterprise Risk Management	Industry Experience	Operational Experience	Public Company Experience	Cyber- security

Patrick G. Ryan	ü	ü		ü	ü	ü
Henry S. Bienen	ü	ü	ü		ü	ü	ü
David P. Bolger	ü	ü	ü	ü	ü	ü
Michelle L. Collins	ü	ü			ü	ü
Francesca Cornelli	ü	ü		ü		ü
Nicholas D. Cortezi	ü			ü	ü	ü
D. Cameron Findlay	ü		ü	ü	ü	ü	ü
Anthony J. Kuczinski	ü	ü	ü	ü	ü	ü	ü
Robert Le Blanc	ü	ü	ü	ü	ü	ü
Michael D. O’Halleran	ü	ü		ü	ü	ü
John W. Rogers, Jr.	ü				ü	ü
Timothy W. Turner	ü			ü	ü	ü
Patrick G. Ryan, Jr.	ü	ü			ü	ü

Governance Policies

Corporate Governance Guidelines

We have adopted a set of Corporate Governance Guidelines, which are available on our website at www.ryanspecialty.com.

To access the Corporate Governance Guidelines, go to our website, click on the “Investors” tab and then click on

“Governance/Governance Documents” to download or view the Corporate Governance Guidelines.


		2024 Proxy Statement 16
		2024 Proxy Statement 16

Code of Conduct

We have adopted a Code of Conduct that applies to all of our employees, contractors, officers, and directors, including those

officers responsible for financial reporting. The Code of Conduct is available on our website at www.ryanspecialty.com. To

access our Code of Conduct, go to our website, click on the “Investors” tab and then click on “Governance/Governance

Documents” to download or view the code.

We intend to disclose any amendments to the code, or any waivers of its requirements, on our website. Since our IPO, we

have not amended the code or waived any of its provisions.

Insider Trading Policies

We have adopted an Insider Trading Policy governing all transactions in our securities, including our ordinary shares,

options to purchase our ordinary shares, or any other type of securities that we may issue, including (but not limited to)

preferred stock, convertible debentures, and warrants, as well as derivative securities that are not issued by us, such as

exchange-traded put or call options or swaps relating to our securities. Our Insider Trading Policy applies to our directors,

officers, employees and those of our subsidiaries, as well as other persons as we may determine, such as contractors or

consultants. A person covered by our Insider Trading Policy is prohibited from engaging in transactions of our securities

while aware of material nonpublic information, recommending the purchase or sale of any of our securities, and disclosing

such information to persons outside of the Company or whose jobs do not require them to have that information. We believe

our Insider Trading Policy is reasonably designed to promote compliance with insider trading laws, rules and regulations,

and NYSE listing rules. A copy of our Insider Trading Policy was filed as Exhibit 19.1 to our Annual Report on Form 10-K for

the fiscal year ended December 31, 2024.

Anti-Hedging and Anti-Pledging Policies

The Company prohibits directors and employees from pledging any Company shares and prohibits directors and employees

from engaging in hedging transactions with respect to ownership in the Company’s securities except as explicitly approved

in accordance with our Insider Trading Policy.

Clawback Policy

The Company has adopted a Clawback Policy that complies with Section 10D of the Exchange Act and the listing standards

of the NYSE. The Clawback Policy applies to the Company’s current and former executive officers subject to Section 16 of

the Exchange Act (“Section 16 Officers”). Under this policy, the Company must recover erroneously awarded incentive

compensation (as defined in the Clawback Policy) on a pre-tax basis within a specified lookback period, subject to limited

impracticability exceptions, in the event the Company is required to prepare an accounting restatement. The Clawback

Policy requires recovery of erroneously awarded incentive compensation regardless of whether a Section 16 Officer

engaged in any misconduct or is otherwise at fault.

Our Culture

The Company is committed to building, growing, and sustaining a diverse workforce, reflective of society throughout the

entirety of the organization. Our values reflect an inclusive culture of meritocracy and equality, where every employee is

recognized and assessed based on their performance and contributions. We strive to protect the invaluable attributes of

meritocracy in our culture, and are committed to purposefully reinforcing and refining our culture, through DEI initiatives

(defined as Diversity, Equality & Inclusion) and otherwise, so that our Company, and our industry, can reap the vast benefits

of diversity. Our values set the foundation for a workplace where people can be their best self and do their best work; but

more importantly, we harness our differences and similarities to better serve our clients, trading partners, workforce, and

communities.


		2024 Proxy Statement 17
		2024 Proxy Statement 17

PROPOSAL NO. 1: ELECTION OF DIRECTORS

The Board has nominated Henry S, Bienen, Michael D. O’Halleran, Timothy W. Turner, and Patrick G. Ryan, Jr. for election

as Class I directors at the Annual Meeting to serve until the 2028 annual meeting of stockholders and until their successors

are duly elected and qualified. Dr. Bienen and Messrs. O’Halleran, Turner, and Ryan, Jr. have each consented to be named

in this Proxy Statement and indicated their willingness to serve if elected.

Nomination of Directors

The Compensation and Governance Committee of our Board identifies, evaluates, and recommends to the Board potential

nominees for election to the Board. In reviewing potential nominees, the Compensation and Governance Committee

considers the qualifications of each potential nominee with the qualification standards set forth in its committee charter and

in our Corporate Governance Guidelines. Specifically, the Compensation and Governance Committee considers, among

other things, (i) each potential nominee’s past attendance and performance at Board meetings and committee meetings, if

applicable, (ii) the nominee’s ability to represent all stockholders without a conflict of interest, (iii) the nominee’s ability to

work in and promote a productive environment, (iv) whether the nominee has sufficient time and willingness to fulfill the

substantial duties and responsibilities of a director, (v) whether the nominee has demonstrated the high level of character,

ethics, and integrity expected by the Company, (vi) whether the nominee possesses the broad professional and leadership

experience and skills necessary to effectively respond to the complex issues encountered by a publicly-traded company, (vii)

the nominee’s ability to apply sound and independent business judgment, and (viii) the viewpoint and background of the

nominee. The Board membership criteria are set forth in our Corporate Governance Guidelines and Compensation and

Governance Committee charter, copies of which are available under the tabs “Investors > Governance > Governance

Documents” on our website at www.ryanspecialty.com. After reviewing the qualifications of potential Board candidates, the

Compensation and Governance Committee presents its recommendations to the Board, which selects the final director

nominees.

The Company did not pay any fees to any third parties to identify or assist in identifying or evaluating nominees for the

Annual Meeting. The Compensation and Governance Committee considers stockholder nominees using the same criteria

set forth above. Stockholders who wish to present a potential nominee to the Compensation and Governance Committee for

consideration for election at a future annual meeting of stockholders must provide the Compensation and Governance

Committee with notice of the nomination and certain information regarding the candidate as described in our Bylaws and

within the time periods set forth under the caption “Proposals of Stockholders and Communications with our Board.”

Pursuant to our Corporate Governance Guidelines, the Company endeavors to have a Board consisting of directors who

possess the highest personal and professional ethics, integrity and values and who are committed to representing the long-

term interests of the Company and its stockholders.

Nominees and Incumbent Directors

The Compensation and Governance Committee has recommended, and the Board has nominated, Dr. Bienen and Messrs.

O’Halleran, Turner, and Ryan, Jr. for election as Class I directors at the Annual Meeting to serve until the 2028 annual

meeting of stockholders and until their successors are duly elected and qualified.


		2024 Proxy Statement 18
		2024 Proxy Statement 18

Class I Directors: Nominees

HENRY S. BIENEN, PH.D

Henry S. Bienen has served on our Board since 2012 and is a member of both the Audit

Committee and the Compensation and Governance Committee. Dr. Bienen served as

Northwestern University’s president from 1995 through 2009 and currently serves as

president emeritus of Northwestern University. He was the James S. McDonnell

Distinguished University Professor and Dean of the Woodrow Wilson School of Public

and International Affairs at Princeton University prior to his appointment at Northwestern.

Dr. Bienen is Emeritus Trustee of the Chicago Council on Global Affairs. Additionally, Dr.

Bienen is on the boards of directors of Hedge Fund Guided Portfolio Solutions and

Grosvenor Multi Strategy Funds, chairs the Advisory Committee of The Vistria Group’s

Education Investments, is on the board of directors for Rasmussen University, for which

he served in the past as Chairman of the Board, and is a lifetime member of the board of

MetroSquash, an urban squash and education program in Chicago. Furthermore, Dr.

Bienen is a member of the board of the Lucas Museum of Narrative Art and was the chairman of the board of the Crown

Center on Middle East Studies at Brandeis University. Dr. Bienen is also a consultant for Academic Partnerships, an online

project manager for regional public universities. Dr. Bienen served on the board of the Council on Foreign Relations from

2001 to 2011 and Bear Stearns Companies, Inc. from 2004 to 2008. He earned a Bachelor of Arts from Cornell University

with honors, as well as a Master of Political Science and a PhD in Political Science from the University of Chicago. We

believe Dr. Bienen is qualified to serve on our Board due to his extensive experience as a director on the boards of other for-

profit companies.

MICHAEL D. O’HALLERAN

Michael D. O’Halleran has served on our Board since 2018. Mr. O’Halleran has been

Executive Chairman of Geneva Re Ltd. since 2019 and previously served as a senior

advisor at Ryan Specialty. Mr. O’Halleran was the founder, and for twenty-four years

served as Executive Chairman, of Aon Re, a reinsurance brokerage and capital advisory

firm. Additionally, Mr. O’Halleran was previously President and COO of Aon Corporation

from 1999 to 2005. He also served on the following boards of directors: NuVasive, Inc.,

CareFusion, Inc., Cardinal Health, Inc., and Allegiance Corp. Mr. O’Halleran earned his

Bachelor of Science from the University of Wisconsin - Whitewater. We believe Mr.

O’Halleran is qualified to serve on our Board due to his extensive insurance industry

experience.

TIMOTHY W. TURNER

Timothy W. Turner became our Chief Executive Officer on October 1, 2024. Prior to that,

he served as our President from March 2021 until October 1, 2024 and as the Chairman

and CEO of RT Specialty from RT’s founding in 2010 until October 1, 2024. Mr. Turner

has been a member of our Board of Directors since 2012 and is a member of the

Executive Committee. Prior to co-founding RT Specialty, Mr. Turner was with CRC

Insurance Services, Inc. (“CRC”) for 10 years and was President of CRC at the time of

his departure. Prior to CRC, Mr. Turner worked for the Crump Group and was named

President of its Chicago Office. Mr. Turner began his insurance career as a casualty

broker with A.J. Renner & Associates in 1987. He has received a number of awards, and

in 2020, one of the insurance industry’s most respected media outlets, the Insurance

Insider, named Mr. Turner the Distribution Leader of the Year, honoring him as the year's

most influential and outstanding individual in insurance distribution. In 2019, Mr. Turner

received the prestigious Insurance Industry "Good Scout" Award from the Boy Scouts of America, Greater New York

Councils. Additionally, Mr. Turner received the 2021 Spirit of Life Award from the City of Hope, National Insurance Industry

Counsel. Before joining the insurance industry, Mr. Turner graduated from the Detroit Police Academy, served on the Wayne

County SWAT Team, and was an undercover narcotics officer with the Narcotics Cocaine Task Force with the Michigan State

Police. Mr. Turner earned a Bachelor of Science in Criminal Justice from Madonna University. We believe that Mr. Turner’s

extensive and industry-leading experience in the area of insurance and his insight into our business as our President and

the Chairman and CEO of RT Specialty qualifies him to serve on our Board.


		2024 Proxy Statement 19
		2024 Proxy Statement 19

PATRICK G. RYAN, JR.

Patrick G. Ryan, Jr. has served on our Board since January of 2024 and is a technology

entrepreneur and investor. He is the Founder and CEO of Incisent Labs Group, a holding

company and incubator for creating new technology companies. Mr. Ryan also founded

two high growth software as a service (SaaS) companies, each of which was ranked by

Inc. Magazine as one of the four fastest growing software companies in the United

States and cofounded venture capital firm Chicago Ventures. Mr. Ryan served on the

board of directors of Penske Corporation, a $50 billion diversified transportation services

company, for 25 years. He is a Trustee of Northwestern University and serves on its

executive committee. He earned a Bachelor of Arts from Georgetown University and a

Master of Business Administration from Northwestern University’s Kellogg School, as

well as a Juris Doctorate cum laude from Northwestern School of Law. We believe Mr.

Ryan is qualified to serve on our Board due to his experience as a founder of two

successful technology companies and his financial experience as a CEO.

Class II Directors: Continuing in Office Until 2026

DAVID P. BOLGER

David P. Bolger has served on our Board since 2012 and is the chairperson of the Audit

Committee. Mr. Bolger served as Chief Operating Officer of Chicago 2016, the effort to

bring the 2016 Olympic and Paralympic Games to Chicago. From 2004 to 2019, Mr.

Bolger served on the board of directors of MB Financial, Inc. From 2003 to 2008, he

served as Executive Vice President and Chief Financial Officer of Aon Corporation. Prior

to joining Aon, Mr. Bolger served in multiple executive positions at Bank One Corporation

and its predecessor companies. He earned a Bachelor of Science in Accounting and

Finance from Marquette University and a Master of Management from Northwestern

University Kellogg School of Management. We believe Mr. Bolger is qualified to serve on

our Board due to his extensive insurance industry, accounting, and finance experience.

FRANCESCA CORNELLI

Francesca Cornelli has served as a member of our Board since July 2023 and is a

member of the Audit Committee. Dr. Cornelli is the dean of Northwestern University’s

Kellogg School of Management, a position she has held since August of 2019. She is

also a professor of finance and holds the Donald P. Jacobs Chair in Finance. Prior to

that, she was a professor of finance and deputy dean at London Business School from

1994 to 2019. Dr. Cornelli’s research interests include corporate governance, private

equity, privatization, bankruptcy, IPOs, and innovation policy. She has been an editor of

the Review of Financial Studies and previously served on the board of editors of the

Review of Economic Studies and as an associate editor at the Journal of Finance. She is

a research fellow at the Center for Economic and Policy Research, and previously served

as a director of the American Finance Association. Dr. Cornelli has previously taught at

the Wharton School of the University of Pennsylvania, the Fuqua School of Business at

Duke University, The London School of Economics, the Indian School of Business in Hyderabad and the New Economic

School in Moscow. Dr. Cornelli currently serves as a member of the board of directors of GCM Grosvenor Inc., a public

company, engaged in global alternative asset management. She has also served as an independent board member of

several global corporations, including GCP Capital Partners Limited, an investment company, from 2023 to 2024, which was

recently acquired, Banca Intesa San Paolo from 2016 to 2019, Telecom Italia from 2014 to 2018, American Finance

Association from 2013 to 2016, and Swiss Re International and Swiss Re Holdings from 2013 to 2019. In January 2016, she

helped create and became a board member of AFFECT, a committee of the American Finance Association designed to

promote the advancement of women academics in the field of finance. We believe Dr. Cornelli is well qualified to serve on

our Board due to her experience as an academic in finance and governance, and her experience on boards of directors of

other for-profit companies.


		2024 Proxy Statement 20
		2024 Proxy Statement 20

NICHOLAS D. CORTEZI

Nicholas D. Cortezi has served on our Board since our IPO in July 2021 and is a member

of the Executive Committee. He served as the Chairman of Ryan Specialty Underwriting

Managers from September 2020 through June 2023. In 1987, Mr. Cortezi joined All

Risks, Ltd. (“All Risks”) and was promoted to CEO in 1999, which he served as until its

acquisition by Ryan Specialty in September 2020. Mr. Cortezi has served on the boards

of the Independent Insurance Agents of Baltimore, Independent Insurance Agents of

Maryland, the National Association of Surplus Lines Offices (“NAPSLO”) (now known as

the Wholesale & Specialty Insurance Association (“WSIA”)) and was President of

NAPSLO between 2002 and 2003. Mr. Cortezi earned a Bachelor of Arts in International

Relations and a Masters in International Public Policy from Johns Hopkins University. We

believe that Mr. Cortezi’s extensive and industry-leading experience in the area of

insurance and his insight into our business as prior Chairman of Ryan Specialty

Underwriting Managers qualifies him to serve on our Board.

ANTHONY J. KUCZINSKI

Anthony J. Kuczinski has served on our Board since October 2023 and is a member of

both the Audit Committee and the Compensation and Governance Committee. Mr.

Kuczinski was the President and Chief Executive Officer of Munich Reinsurance US

Holdings from 2008 through 2023. Prior to that, he held numerous senior roles with

Munich Re starting in 1989. Prior to Munich Re, Mr. Kuczinski was Chief Operating

Officer of NY Marine and General Insurance Company (NYM), a publicly traded

insurance group now part of Pro-Sight Insurance Group, and he worked in the audit

practice for the public accounting firm of Coopers & Lybrand (now PwC). He currently

serves as executive advisor to the Munich Re Board of Management for Munich

Reinsurance US Holding, the North American property and casualty operations of Munich

Re. Mr. Kuczinski is a director of Skyward Specialty Insurance Group and Hagerty, Inc.

and also serves on the Penn Medicine Healthcare System (Penn Medicine) board and on

its executive committee. He is also a board member and executive committee chair for Penn Medicine Princeton Health, a

subsidiary of Penn Medicine. Mr. Kuczinski holds a Bachelor of Arts in Public Accounting from Pace University, Magna Cum

Laude, and holds a Certificate in Advanced Executive Education from the Wharton School. Mr. Kuczinski is a Certified Public

Accountant and a Chartered Property Casualty Underwriter. We believe Mr. Kuczinski is well qualified to serve on our Board

due to his extensive insurance industry and financial experience.

ROBERT (BOBBY) LE BLANC

Robert (Bobby) Le Blanc has served on our Board since 2018 and is a member of the

Compensation and Governance Committee. Mr. Le Blanc joined Onex Corporation in

1999 and currently serves as its Chief Executive Officer. Prior to joining Onex, Mr. Le

Blanc worked for Berkshire Hathaway and General Electric. He earned his Bachelor of

Science from Bucknell University and his Master of Business Administration from New

York University. We believe Mr. Le Blanc is qualified to serve on our Board due to his

extensive insurance and finance industry experience.


		2024 Proxy Statement 21
		2024 Proxy Statement 21

Class III Directors: Continuing in Office Until 2027

PATRICK G. RYAN

Patrick G. Ryan is a widely respected entrepreneur and global insurance leader who

founded Ryan Specialty in 2010. Mr. Ryan became our Executive Chairman on October

1, 2024. Prior to that, he served as the Chairman and Chief Executive Officer of Ryan

Specialty since its inception. Mr. Ryan is also a member and the chairperson of the

Executive Committee. Prior to launching Ryan Specialty, Mr. Ryan founded Aon

Corporation and served as its Chairman and/or CEO for 41 years. At the time of Mr.

Ryan’s retirement, Aon had more than 500 offices in 120 countries, generating revenues

then in excess of $7 billion. Mr. Ryan has received a number of accolades throughout his

career. In 1987, Mr. Ryan received the esteemed Horatio Alger Award, which honors

those who are dedicated to the principles of integrity, hard work, perseverance, and

compassion for others. In 2008, Mr. Ryan was inducted into the American Academy of

Arts and Sciences, one of the nation’s oldest and most prestigious honorary societies

and independent research centers, founded in 1780. Also in 2008, he was elected to the International Insurance Society Hall

of Fame and received the Ernst and Young Entrepreneur of the Year Lifetime Achievement Award. He was named by

Brigham Young University International Executive of the Year for Corporate Integrity. Other career tributes include the

College of Insurance’s Insurance Leader of the Year and the Insurance Federation of New York’s Free Enterprise Award.

Most recently, in July 2019, Mr. Ryan was inducted into the Automotive Hall of Fame for his contribution to the Finance and

Insurance Specialists sector of the automotive industry. Mr. Ryan has been a member of Northwestern University’s board of

trustees for 42 years, 14 years of which he served as Chairman. Mr. Ryan served on the boards of directors of 1st National

Bank of Chicago and its successors and the Tribune Company. Mr. Ryan earned a Bachelor of Business Administration from

Northwestern in 1959 and, in 2009, Northwestern awarded Mr. Ryan a Doctor of Humane Letters degree. Also in 2009, Mr.

Ryan was inducted into the Northwestern Athletic Hall of Fame. Four years later, in 2013, Mr. Ryan received the

Northwestern Alumni Association Medal of Honor. This award is the highest award granted by the Northwestern Alumni

Association to an alumnus who combines superior professional distinction and/or exemplary volunteer service to society,

with an outstanding record of service to Northwestern. Mr. Ryan also served as Chairman of Chicago 2016, the effort to

bring the 2016 Olympic and Paralympic Games to Chicago. We believe that Mr. Ryan’s extensive and industry-leading

experience in the area of insurance, his experience as the founder, Chairman and CEO of Aon, and his insight into our

business as our Founder and Chief Executive Officer qualifies him to serve on our Board.

MICHELLE L. COLLINS

Michelle L. Collins has served on our Board since our IPO in July 2021 and is a member

of the Audit Committee. Since 2007, she has served as the president of Cambium LLC, a

consulting firm. Ms. Collins was co-founder of Svoboda Capital Partners, LLC and served

as Managing Director from 1998 to 2006. Prior to that, Ms. Collins was a principal in the

Corporate Finance Department at William Blair & Company, LLC. Since 2014, Ms.

Collins has served on the board of Ulta Beauty, Inc. She has also served on the boards

of Canadian Imperial Bank of Commerce (“CIBC”) and CIBC Bancorp USA/CIBC Bank

U.S. since 2017. Previously, she was a member of the mutual fund boards of Columbia

Acorn and Wanger Advisors Trusts and the boards of directors of the following public and

private companies: PrivateBankcorp, Inc., Integrys Energy Group, Inc., Molex, Inc.,

Bucyrus International, CDW Corporation, Coldwater Creek, Inc., McWhorter

Technologies, Inc., and Health Care Service Corporation, a mutual reserve company.

She earned a Bachelor of Arts from Yale University and a Master of Business Administration from Harvard Business School.

We believe Ms. Collins is qualified to serve on our Board due to her extensive finance industry experience and experience

as a director on the boards of other for-profit companies.


		2024 Proxy Statement 22
		2024 Proxy Statement 22

D. CAMERON FINDLAY

D. Cameron Findlay has served on our Board since 2012 and is the chairperson of the

Compensation and Governance Committee, a member of the Executive Committee, and

our Lead Director. From 2013 until his retirement in 2023, Mr. Findlay was the Senior

Vice President, General Counsel, and Secretary of Archer Daniels Midland Company.

From 2009 to 2013, he was Senior Vice President and General Counsel of Medtronic,

Inc., and from 2003 to 2009 he served as Executive Vice President and General Counsel

of Aon Corporation. He earned his B.A. from Northwestern University, his Master of Arts

(Oxon.) from Oxford University, and his Juris Doctor from Harvard Law School. We

believe Mr. Findlay is qualified to serve on our Board due to his expertise in legal,

compliance, and government regulatory matters and his extensive insurance industry

experience.

JOHN W. ROGERS, JR.

John W. Rogers, Jr., has served on our Board since 2014 and is a member of both the

Compensation and Governance Committee and the Executive Committee. He is the

Founder, Chairman, Co-CEO (since 2019; from 1983-2019 he served as Chief Executive

Officer), and Chief Investment Officer of Ariel Investments. Mr. Rogers is a member of

the mutual fund board of Ariel Investments Trust, serves as vice chair of the board of

trustees of the University of Chicago, and as a member of the boards of directors of

NIKE, Inc. and The New York Times Company. From 2000 to 2019, he served on the

board of directors of Exelon Corp. and from 2003 to 2023 he served on the board of

directors of McDonalds Corporation. Following the election of President Barack Obama,

Mr. Rogers served as co-chair for the Presidential Inaugural Committee 2009, and in

2016 he joined the Barack Obama Foundation’s board of directors. He earned his

Bachelor of Arts from Princeton University and in 2008 was awarded Princeton

University's highest honor, the Woodrow Wilson Award, presented each year to the alumnus or alumna whose career

embodies a commitment to national service. We believe Mr. Rogers is qualified to serve on our Board due to his extensive

finance industry experience and experience as a director on the boards of other for-profit companies.

Vote Required

The four nominees who receive the greatest number of affirmative votes cast will be elected as Class I directors to hold

office until the 2028 annual meeting of stockholders and until their successors are elected and qualified, unless they resign,

or their seats become vacant due to removal or death. Abstentions and broker non-votes will not affect the election of

directors.

Holders of proxies solicited by this Proxy Statement will vote the proxies received by them as directed on the Proxy Card or,

if no direction is given, then FOR the election of each of the nominees named in this Proxy Statement.


	The Board recommends a vote “FOR” each of the four Class I director nominees identified above.


		2024 Proxy Statement 23
		2024 Proxy Statement 23

DIRECTOR COMPENSATION

The following table presents the total compensation for each person who served as a non-employee director on our Board

during 2024. Other than as set forth in the table and described more fully below, we did not pay any compensation, make

any equity or non-equity awards, or pay any other compensation to any of the non-employee directors on the Board. Patrick

G. Ryan and Timothy W. Turner, each of whom are employed by the Company, did not receive any additional compensation

for their service on the Board. Robert Le Blanc has agreed to forgo any cash or equity compensation for his service on the

Board. Michael D. O’Halleran is eligible to receive the annual equity grant in accordance with the Company’s Non-Employee

Director Compensation Policy, discussed below, but does not receive any additional cash payments for his service to the

Board in light of his role as Executive Chairman of Geneva Re.


Name	Fees Earned or Paid in Cash ($)	Stock Awards ($)(1)	Total ($)

Henry S. Bienen	100,000	122,500	222,500
David P. Bolger	125,000	122,500	247,500
Michelle L. Collins	100,000	122,500	222,500
Francesca Cornelli (2)	100,000	112,717	212,717
Nicholas D. Cortezi (3)	100,000	132,390	232,390
D. Cameron Findlay	145,000	122,500	267,500
Anthony J. Kuczinski (4)	100,000	83,043	183,043
Robert Le Blanc	—	—	—
Michael D. O’Halleran	—	122,500	122,500
John W. Rogers, Jr.	100,000	122,500	222,500
Patrick G. Ryan, Jr. (5)	100,000	62,500	162,500

(1)On April 30, 2024, each of the non-employee directors who were serving at that time, other than Dr. Cornelli and Messrs. Cortezi,

Kuczinski, Le Blanc, and Ryan, Jr., received a grant of 2,496 Restricted Stock Units (“RSUs”), rounded down to the nearest whole

share, with a grant date fair value of approximately $122,500, as compensation for their full year of service to the Company ending

at the 2024 annual meeting of stockholders. RSUs were fully vested as of the grant date and each RSU represents a right to receive

one fully vested share of Class A common stock within 30 days of grant (or, if elected by the director, upon the earlier of the

director’s “separation from service” or a “change in control,” each as defined in the applicable award agreement).

(2)Dr. Cornelli began her service to the Board on July 31, 2023 and her equity compensation for the third quarter of 2023 was prorated

for the days that she served resulting in the issuance of 2,297 RSUs, rounded down to the nearest whole share, with a grant date

fair value of approximately $112,717, as compensation for her time on the Board from her start date through the 2024 annual

meeting of stockholders.

(3)Mr. Cortezi retired from his position as the Chief Executive Officer of Ryan Specialty Underwriting Managers on May 31, 2023. Upon

his retirement he became a non-employee director and was eligible for compensation under the Company’s Non-Employee Director

Compensation Policy. Since he served as a director for 30 days during the second quarter of 2023, for which he did not receive

equity compensation at the 2023 annual meeting of stockholders, his equity compensation for 2024 was increased to compensate

him for his contributions to the Board during the second quarter of 2023. As a result, Mr. Cortezi was issued 2,697 RSUs, rounded

down to the nearest whole share, with a grant date fair value of approximately $132,390, as compensation for his time on the Board

from June 1, 2023 through the 2024 annual meeting of stockholders.

(4)Mr. Kuczinski began his service on the Board on October 30, 2023 and his equity compensation for the fourth quarter of 2023 was

prorated for the days that he served, resulting in the issuance of 1,692 RSUs, rounded down to the nearest whole share, with a grant

date fair value of approximately $83,043, as compensation for his time on the Board from his start date through the 2024 annual

meeting of stockholders.

(5)Mr. Ryan, Jr. began his service on the Board on January 1, 2024 and therefor received equity compensation for the first and second

quarters of 2024, resulting in the issuance of 1,273 RSUs, rounded down to the nearest whole share, with a grant date fair value of

approximately $62,500, as compensation for his time on the Board from his start date through the 2024 annual meeting of

stockholders.

In October 2023, after a detailed review of director compensation provided by our peers, the Board amended the Non-

Employee Director Compensation Policy to provide its members the following compensation to be effective January 1, 2024:

(i) an annual cash retainer of $100,000, (ii) an annual grant of equity with a grant date fair value of $125,000, (iii) an annual

fee for the Chair of the Audit Committee of $25,000, (iv) an annual fee for the Chair of the Compensation and Governance

Committee of $20,000, and (v) an annual fee for the Lead Director of the Board of $25,000. Other than the chairperson of

the respective Board committees, no participating committee members receive additional compensation for their

participation on such committees.


		2024 Proxy Statement 24
		2024 Proxy Statement 24

Mr. O’Halleran will continue to forgo any cash compensation as a director and Mr. Le Blanc will continue to forgo any cash or

equity compensation for his service as a director for the reasons stated above. The annual cash retainer, as well as the Lead

Director fee and committee chairperson fee, are all paid quarterly.

Our Non-Employee Director Compensation Policy provides that each of our non-employee directors will receive an annual

grant of equity. With the exception of Mr. Le Blanc, who has elected not to receive any compensation for his service on the

Board, we make an annual equity grant to our non-employee directors each year on the date of the Company’s annual

meeting of stockholders. The grants are compensation for a year of service comprising the third and fourth quarters of the

prior year and the first and second quarters of the current year. Should any director not serve for the full year covered by the

grant (from annual meeting to annual meeting), the grant will be prorated. Each director that served for the entire year

through the 2024 annual meeting of stockholders received a grant of equity on April 30, 2024 in the form of RSUs with a

grant date fair value equal to approximately $122,500, rounded down to the nearest whole share (which reflects two quarters

prorated at $120,000 and two quarters prorated at $125,000). The RSUs were fully vested as of the grant date and each

represents a right to receive one fully vested share of Class A common stock within 30 days of grant (or, at the election of

the director, upon the earlier of the director’s “separation from service” or a “change in control,” each as defined in the

applicable award agreement).

In October 2024, after a detailed review of director compensation provided by our peers, the Board amended the Non-

Employee Director Compensation Policy to increase (i) the annual cash retainer from $100,000 to $120,000, (ii) the annual

grant of equity from a grant date fair value of $125,000 to $200,000, (iii) the annual fee for the Chair of the Audit Committee

from $25,000 to $35,000, (iv) the annual fee for the Chair of the Compensation and Governance Committee from $20,000 to

$25,000, and (v) the annual fee for the Lead Director of the Board from $25,000 to $35,000. All increases became effective

on January 1, 2025.

Stock Ownership Guidelines

The Company has non-employee director stock ownership guidelines, under which the Company’s non-employee directors

are expected to accumulate Company stock with a value equivalent to five times their annual cash retainer, within five years

of the adoption of the requirement or within five years of a director joining the Board. If a non-employee director does not

hold sufficient shares of the Company’s stock to meet the guideline requirements, they will then be required to hold 100% of

their current Company stock plus any future grants until they have met the requirement.

The guidelines were adopted on April, 21, 2021, such that each non-employee director serving at that time has until April 21,

2026 to meet the guidelines. The table below sets forth the date by which each of our current non-employee directors is

required to meet the guidelines.


Director Name	Date Compliance is Required

Henry S. Bienen	April 21, 2026
David P. Bolger	April 21, 2026
Michelle L. Collins	July 21, 2026
Francesca Cornelli	July 31, 2028
Nicholas D. Cortezi (1)	June 1, 2028
D. Cameron Findlay	April 21, 2026
Anthony J. Kuczinski	October 30, 2028
Robert Le Blanc	April 21, 2026
Michael D. O’Halleran	April 21, 2026
John W. Rogers, Jr.	April 21, 2026
Patrick G. Ryan, Jr.	January 1, 2029

(1)Mr. Cortezi, who has been a director since the IPO, became a non-employee director on June 1, 2023 upon his retirement from his

position as Chief Executive Officer of Ryan Specialty Underwriting Managers.

Accordingly, all of our directors are currently in compliance with the guidelines.


		2024 Proxy Statement 25
		2024 Proxy Statement 25

EXECUTIVE OFFICERS

Below is a list of the names, ages as of the Record Date, positions, and brief accounts of the business experience of our

current Executive Officers.


Name	Age	Position

Patrick G. Ryan	87	Executive Chairman of the Board of Directors
Timothy W. Turner	64	Chief Executive Officer and Director
Jeremiah R. Bickham	39	President
Michael L. Conklin	56	Executive Vice President and Chief Human Resources Officer
Janice M. Hamilton	43	Chief Financial Officer
Mark S. Katz	56	Executive Vice President, General Counsel, and Corporate Secretary
Brendan M. Mulshine	59	Executive Vice President and Chief Revenue Officer
Benjamin M. Wuller	49	CEO Ryan Specialty Underwriting Managers

Patrick G. Ryan — See biography under “Proposal No. 1 Election of Directors — Class III Directors: Continuing in Office

Until 2027.”

Timothy W. Turner — See biography under “Proposal No. 1 Election of Directors – Class I Directors: Nominees.”

Jeremiah R. Bickham has served as our President since October 2024. Prior to that and since our IPO in 2021, Mr.

Bickham was Ryan Specialty’s Chief Financial Officer. Prior to our IPO, Mr. Bickham served as Treasurer and Head of

Corporate Development. Mr. Bickham joined the firm in 2011. Prior to joining Ryan Specialty, he worked at KPMG, LLP as a

research analyst in their Department of Professional Practice (DPP) in New York, New York and later worked for the audit

practice in Dallas, Texas. Mr. Bickham holds a Masters of Business Administration from the Kellogg School of Management

at Northwestern University. Additionally, he earned a Master of Professional Accounting (MPA) and a Bachelor of Business

Administration (BBA) from the University of Texas at Austin.

Michael L. Conklin has served as our Executive Vice President and Chief Human Resource Officer since August 2023.

From July 2020 through August 2023, Mr. Conklin served as the Executive Vice President and Chief Human Resource

Officer for WSFS Financial Corporation. From 2013 to 2020, Mr. Conklin served in numerous HR Leadership roles at US

Bank, supporting strategy and corporate affairs, communications, marketing, HR, consumer and business banking, legal and

global payments. In Mr. Conklin’s last assignment at US Bank, he served as Senior Vice President for Global Human

Resources, Global Payment Services and Strategy & Corporate Affairs. Mr. Conklin has served on several nonprofit boards,

including most recently the Community Education Building Board of Directors, chairing the Human Resources and

Leadership Committee, as well as serving as a board advisor to Drexel University’s Solutions Institute. Mr. Conklin served in

the Marine Corps Reserve and is a veteran of the Gulf War. He holds an M.B.A. from Regis University with a concentration

on general management and a Bachelor of Science in Political Science and Psychology from Augsburg University.

Janice M. Hamilton has served as our Chief Financial Officer since October 2024. From March 2021 to October 2024, she

served as Ryan Specialty’s Chief Accounting Officer. Prior to that, Ms. Hamilton served as our Controller from May 2018 to

March 2021. Prior to joining Ryan Specialty, Ms. Hamilton was based in London serving as the CFO for AmTrust

International, the non-US and Lloyds operations of AmTrust Financial Services Inc. Prior to her role with AmTrust, Ms.

Hamilton held positions as CFO of ANV Holdings BV, which was acquired by Am Trust, and prior to that was the Controller

and then Finance Director for Jubilee Group Holdings, a prior subsidiary of Ryan Specialty. Ms. Hamilton began her career

with EY in Chicago, Illinois providing audit services to insurance sector companies such as Aon Corporation. Ms. Hamilton

received her Bachelor of Science in Finance from Miami University in Ohio and her Masters of Science in Accounting at the

University of Virginia. She is a licensed CPA in the State of Illinois.

Mark S. Katz has served as our Executive Vice President, General Counsel, and Corporate Secretary since March 2020,

after first joining Ryan Specialty in 2019 as Counsel for Insurance Services. Prior to joining Ryan Specialty, Mr. Katz

practiced law with boutique Manhattan-based insurance litigation firm Mound Cotton Wollan & Greengrass LLP from 1993

through 2018, litigating complex insurance coverage disputes throughout the United States. He was a partner with the firm

from 2002 through 2018 and served as the firm’s Administrative Partner and on its hiring and compensation committees for

numerous years. Mr. Katz earned his Bachelor of Arts from Syracuse University, Maxwell School of Citizenship and Public

Affairs in 1990 and his Juris Doctor from Hofstra University School of Law in 1993, where he was an editor of the Hofstra

Law Review.


		2024 Proxy Statement 26
		2024 Proxy Statement 26

Brendan M. Mulshine has served as our Executive Vice President and Chief Revenue Officer since 2020 and previously

served as our Executive Vice President and Managing Director from 2012 through 2020. From 1995 to 2012, Mr. Mulshine

held various leadership positions at Aon Re, working with domestic and global insurance company clients on their

reinsurance capital needs. Mr. Mulshine began his career practicing law in New York City. He earned a Bachelor of Arts from

Yale College, a Juris Doctor from the University of Notre Dame School of Law, and a Master of Business Administration from

Northwestern University’s Kellogg School of Management.

Benjamin M. Wuller has served as the CEO of Ryan Specialty Underwriting Managers (“RSUM”) since October 2021 and

concurrently served as RSUM’s President from March 2021 to February 2025. Prior to that, he served as Executive Vice

President of RSUM from October 2020 to March 2021 and its Chief Operating Officer from June 2015 to October 2020. Mr.

Wuller joined Ryan Specialty in 2010, originally as Treasurer, leading capital activity and executing Ryan Specialty’s M&A

strategy across the specialty industry. Prior to joining Ryan Specialty, Mr. Wuller severed in various positions for Aon

Corporation over a ten-year period in corporate finance, financial risk management, and derivatives trading culminating as

Assistant Treasurer – Investments & Corporate Development. Mr. Wuller received his Bachelor of Architecture at the

University of Kansas and his Master of Business Administration at the University of Chicago, Graduate School of Business.

Family Relationships

There are no family relationship between any of our directors or executive officers, except as described below:

•Brendan M. Mulshine’s spouse is the niece of Patrick G. Ryan and a cousin of Patrick G. Ryan, Jr.

•Patrick G. Ryan, Jr., a director, is the son of Patrick G. Ryan.


		2024 Proxy Statement 27
		2024 Proxy Statement 27

PROPOSED CERTIFICATE AMENDMENTS

The Board, upon advice and recommendation from the Compensation and Governance Committee, reviews the corporate

governance practices and standards under which the Company operates and assesses trends, stockholder input, and best

practices on a regular basis. After careful consideration of our current governance structure, our Board has determined to

recommend a number of amendments to our Certificate, each of which requires stockholder approval. In making these

recommendations, our Board reviewed, considered, and discussed current corporate governance trends, communications

from our stockholders, and best practices followed by other public companies perceived to be market leaders in the area of

corporate governance and supported by institutional and retail investors.

The text of all the amendments is contained in our proposed amended and restated Certificate of Incorporation (the

“Proposed Amended and Restated Certificate”), which is set forth in its entirety in Appendix A to this Proxy Statement. If all

of the proposed amendments to our Certificate are approved by our stockholders (see “Proposals 2 - Proposals 10”) at the

Annual Meeting, we will file a current report on Form 8-K disclosing the Proposed Amended and Restated Certificate

promptly following the Annual Meeting. If fewer than all the proposed amendments are approved by our stockholders at the

Annual Meeting, we will file a revised amended and restated Certificate that includes only those amendments that are

approved by our stockholders, see “– Partial Stockholder Approval of Recommended Certificate Amendments.”

Partial Stockholder Approval of Recommended Certificate Amendments

We are submitting, and the Board unanimously recommends that you vote “FOR,” nine separate proposals to amend our

Certificate (the “Proposed Certificate Amendments”): Proposal 2 - the approval of an amendment to the Certificate to

declassify our Board and phase-in annual director elections; Proposal 3 - the approval of an amendment to the Certificate to

implement a majority voting standard in uncontested director elections; Proposal 4 - the approval of an amendment to the

Certificate to eliminate the springing supermajority voting standard with respect to the removal of a director from our Board;

Proposal 5 - the approval of an amendment to the Certificate to provide for a specific outside date, September 30, 2029, by

which the ten-to-one vote disparity of the Class B common stock to the Class A common stock will sunset; Proposal 6 - the

approval of an amendment to the Certificate to provide stockholders with the ability to take action by written consent;

Proposal 7 - the approval of an amendment to the Certificate to provide stockholders with the ability to call special meetings

of stockholders; Proposal 8 - the approval of an amendment to the Certificate to eliminate the springing supermajority voting

standard with respect to the amendment of the Company’s Bylaws and certain provisions of the Certificate; Proposal 9 - the

approval of an amendment to the Certificate to provide for the exculpation of certain officers of the Company to the fullest

extent provided under Delaware law; and Proposal 10 - the approval of certain other Non-Substantive Amendments as set

forth in the Proposed Amended and Restated Certificate. If all nine Board-recommended proposals to amend our Certificate

are approved by our stockholders, all of the changes contained in the Proposed Amended and Restated Certificate attached

to this Proxy Statement as Appendix A will be made. However, approval of each Board-recommended proposal to amend

our Certificate is not contingent on approval of the other proposals, and if only some, but not all, of the Board-recommended

proposals to amend our Certificate are approved by our stockholders, amendments to our Certificate contained in Appendix

A will be made as follows:

•Amendments to Article Five, Sections 4, 5, and 6 will be made as set forth in Appendix A if Proposal 2 is approved

by our stockholders;

•Amendments to Article Five, Section 3 will be made as set forth in Appendix A if Proposal 3 is approved by our

stockholders;

•Amendments to Article Five, Section 6 will be made as set forth in Appendix A if Proposal 4 is approved by our

stockholders;

•Amendments to Article Four, Section 3(a)(ii) will be made as set forth in Appendix A if Proposal 5 is approved by our

stockholders;

•Amendments to Article Seven, Section 1 will be made as set forth in Appendix A if Proposal 6 is approved by our

stockholders;

•Amendments to Article Seven, Section 2 will be made as set forth in Appendix A if Proposal 7 is approved by our

stockholders;

•Amendments to Article Ten, Sections 1 and 2 will be made as set forth in Appendix A if Proposal 8 is approved by

our stockholders;

•Amendments to Article Six, Sections 1(a) and 1(b) will be made as set forth in Appendix A if Proposal 9 is approved

by our stockholders; and

•All other amendments set forth in Appendix A will be made if Proposal 10 is approved by our stockholders.


		2024 Proxy Statement 28
		2024 Proxy Statement 28

PROPOSAL NO. 2: AMENDMENT TO THE CERTIFICATE

TO DECLASSIFY THE BOARD OF DIRECTORS AND

PHASE-IN ANNUAL DIRECTOR ELECTIONS

Our Certificate currently provides that the Board is divided into three classes, each comprising as nearly as possible one-

third of the total number of directors, with members of each class serving for staggered three-year terms. After considering

the advantages and disadvantages of the classification of the Board, on April 3, 2025 the Board unanimously approved and

declared advisable, and hereby recommends that stockholders approve, an amendment to our Certificate to

eliminate the classified board structure and provide for phase-in annual election of directors.

Pursuant to the amendment to eliminate the classified board structure and provide for the phase-in of annual director

elections, the annual election of directors would be phased in as follows: (i) at this Annual Meeting, stockholders will have

the opportunity to vote on the proposed amendment to our Certificate that would implement phased-in declassification, with

the Board recommending and soliciting in favor of the passage of such amendment, (ii) if the amendment is approved at this

Annual Meeting, then the directors to be elected at the 2026 annual meeting of our stockholders and thereafter will be

elected to one-year terms expiring at the subsequent annual meeting of our stockholders following their election, and (iii)

directors who were elected at this Annual Meeting, would serve out their full three-year terms expiring at the 2028 annual

meeting of stockholders. As a result, beginning with the election of directors at the 2028 annual meeting of stockholders, all

directors will be elected for one-year terms and the classification of the Board will cease.

As part of our continuous evaluation of corporate governance practices and standards, our Board regularly reviews our

governing documents and considers possible optimizations. While we believe our current governance structure has served

our stockholders well during a sustained period of growth, our Board has decided that it is in the best interests of the

Company and our stockholders to transition to a declassified Board to more closely align with best practices followed by

other public companies perceived to be market leaders in the area of corporate governance and supported by institutional

and retail investors. For the reasons discussed above, the Board believes it is in the best interests of the Company and our

stockholders to recommend the amendment to eliminate the classified board structure and provide for the phase-in of

annual director elections.

The amendment to eliminate the classified board structure and provide for phase-in annual election of directors also

provides that any director appointed to fill a vacancy prior to the 2028 annual meeting of stockholders will hold office for the

remaining term of the director being replaced and any director appointed to fill a vacancy that resulted from an increase in

the size of the Board prior to the 2028 annual meeting of stockholders will be elected to serve the remainder of the term of

the class to which they were appointed.

Under the General Corporation Law of the State of Delaware, directors of companies that have a classified board may be

removed only for cause, unless the certificate of incorporation provides otherwise, while directors of companies that do not

have a classified board may be removed with or without cause but only by a vote of the majority of the shares then entitled

to vote at an election of directors. Therefore, if the proposed amendment is adopted, our Certificate will also be amended to

provide that, prior to the 2028 annual meeting of stockholders, directors may be removed only for cause, and beginning with

the 2028 annual meeting of stockholders (that is, when the Board is no longer classified), a director may be removed from

office with or with or without cause by the affirmative vote of holders of at least a majority of the voting power of the then

outstanding shares of capital stock of the Company entitled to vote generally in an election of directors, voting together as a

single class. See Proposal 4 for more information.

The description of the proposed amendment to eliminate the classified board structure and provide for the phase-in of

annual director elections above is only a summary and is qualified in its entirety by reference to, and should be read in

conjunction with, the actual text of the amendment included in Appendix A to this Proxy Statement.

We intend to file the Proposed Amended and Restated Certificate attached to this Proxy Statement as Appendix A with the

Secretary of State of the State of Delaware promptly following the Annual Meeting if all the Proposed Certificate

Amendments are approved by our stockholders. If this Proposal 2 is approved, but less than all the Proposed Certificate

Amendments are approved, then we intend to file a revised amended and restated Certificate with the Secretary of State of

the State of Delaware that contains only those amendments that have been approved by our stockholders, see the section

entitled “Proposed Certificate Amendments - Partial Stockholder Approval of Recommended Certificate Amendments.”

Vote Required

The affirmative vote of the majority of the holders of the voting power of the outstanding shares of capital stock of the

Company entitled to vote generally thereon, voting together as a single class, is required for approval of the amendment to

our Certificate to declassify our Board and phase-in annual director elections. Votes to “Abstain” and broker non-votes are

treated as cast “Against” this proposal.


		2024 Proxy Statement 30
		2024 Proxy Statement 30

PROPOSAL NO. 3: AMENDMENT TO THE CERTIFICATE

TO IMPLEMENT A MAJORITY VOTING STANDARD IN

UNCONTESTED DIRECTOR ELECTIONS

Our Certificate currently provides for the election of directors by a plurality of votes cast. Under this standard, the nominees

who receive the highest number of “For” votes cast are elected as directors, up to the maximum number of directors to be

elected, regardless of the number of “Withhold” votes received. As a result, under a plurality voting standard in an

uncontested election, it is possible that a nominee might be elected or reelected so long as a single vote is cast in favor of

his or her election. The General Corporation Law of the State of Delaware provides for plurality voting as the default voting

standard, providing that, unless otherwise addressed in a company’s certificate of incorporation or bylaws, directors are

elected by a plurality of the votes cast by the shares entitled to vote at a meeting.

After considering the advantages and disadvantages, on April 3, 2025, the Board unanimously approved and declared

advisable, and hereby recommends that stockholders approve an amendment to our Certificate to implement, a majority

voting standard in uncontested elections of directors. The proposed amendment would provide that, in an uncontested

election of directors, a director nominee would be elected only if the director nominee receives a majority of the votes cast in

favor of such nominee’s election, meaning that, the number of shares voted “For” the director nominee must exceed the

number of shares voted “Against” the director nominee. Abstentions and broker non-votes would not be counted as votes

cast for or against a nominee. If, however, the Secretary of the Company were to determine that an election of directors is

“contested,” a plurality voting standard would apply and the director nominees receiving the greatest number of votes would

be elected. Under the Proposed Amended and Restated Certificate, a “contested” election would be an election in which the

number of director nominees exceeds the number of directors to be elected.

The Board believes that the adoption of a majority voting standard in uncontested director elections will give our

stockholders a greater voice in determining the composition of our Board. In addition, the proposed majority voting standard

is consistent with the belief of the Board that it is accountable to the interests of a majority of our stockholders. Our Board

believes that requiring directors to be elected by a majority of votes cast in uncontested elections both aids in ensuring that

only director nominees with broad acceptability among our voting stockholders will be elected and enhances the

accountability of each elected director to our stockholders. The Board also concluded that such an approach to director

elections is currently viewed as a “best practice” by other public companies perceived to be market leaders in the area of

corporate governance and institutional and retail investors. For these reasons the Board has decided that it is in the best

interests of the Company and our stockholders to recommend the adoption of the amendment to our Certificate to

implement a majority voting standard in uncontested director elections.

The Board also believes that a plurality voting standard should continue to apply in circumstances in which the number of

director nominees exceeds the number of directors to be elected (i.e., a “contested election”). If a majority voting standard is

used in that circumstance, it is possible that not all of the director positions up for election would be filled, since it is possible

that no director nominee would receive a majority of the votes cast in his or her election.

Certain conforming amendments will be made to our Bylaws (which do not require stockholder approval), contingent upon

the effectiveness of this proposed amendment to the Certificate. These amendments will include the adoption of a market

standard director resignation policy with respect to director nominees who do not receive a majority of the votes cast in favor

of such nominee’s election in an uncontested election, and will permit the Board to accept or reject such director’s

resignation after taking into account any factors or information the Board believes are appropriate and relevant. In

accordance with the amendments to the Bylaws, the Board will publicly disclose its decision regarding a director resignation

and, if such resignation is rejected, the rationale for its decision within 90 days following certification of the election results. If

the amendment to the Certificate recommended in this Proposal 3 is approved, the Board may adopt additional conforming

changes to the Bylaws, with such changes as the Board may approve consistent with the Proposed Amended and Restated

Certificate.

The description of the proposed amendment to implement a majority voting standard in uncontested elections above is only

a summary and is qualified in its entirety by reference to, and should be read in conjunction with, the actual text of the

proposed amendment included in Appendix A to this Proxy Statement.

We intend to file the Proposed Amended and Restated Certificate attached to this Proxy Statement as Appendix A with the

Secretary of State of the State of Delaware promptly following the Annual Meeting if all the Proposed Certificate

Amendments are approved by our stockholders. If this Proposal 3 is approved, but less than all the Proposed Certificate

Amendments are approved, then we intend to file a revised amended and restated Certificate with the Secretary of State of

the State of Delaware that contains only those amendments that have been approved by our stockholders, see the section

entitled “Proposed Certificate Amendments - Partial Stockholder Approval of Recommended Certificate Amendments.”


		2024 Proxy Statement 32
		2024 Proxy Statement 32

PROPOSAL NO. 4: AMENDMENT TO THE CERTIFICATE

TO ELIMINATE THE SPRINGING SUPERMAJORITY

VOTING STANDARD WITH RESPECT TO THE REMOVAL

OF A DIRECTOR FROM OUR BOARD

Our Certificate currently provides that prior to the “Trigger Date” (defined below) a director may be removed with or without

cause upon the affirmative vote of a majority of the voting power of the then outstanding shares of our capital stock entitled

to vote generally in an election of directors, voting together as a single class (the “Voting Stock”). The “Trigger Date” is the

date on which the Ryan Parties (defined below) cease to beneficially own and control at least forty percent (40%) of the

outstanding shares of Voting Stock. On and after the Trigger Date, a director may only be removed for cause and only upon

the affirmative vote of sixty-six and two-thirds percent (66⅔%) of the voting power of the then outstanding shares of Voting

Stock. The Trigger Date has not occurred and, as such, the supermajority voting standard is not currently in effect The

“Ryan Parties” consist of Patrick G. Ryan, certain members of his family and various entities, trusts and accounts over which

Mr. Ryan exercises control, individually or collectively with members of his family or others, or over which certain members

of his family exercise control.

After considering the advantages and disadvantages, on April 3, 2025, the Board unanimously approved and declared

advisable, and hereby recommends that the stockholders approve, an amendment to our Certificate to eliminate the

springing supermajority voting standard to remove a director from out Board that would have otherwise gone into effect upon

the Trigger Date, thereby providing stockholders the power to remove directors, with or without cause, by the affirmative vote

of a majority of the then outstanding shares of Voting Stock regardless of the number of shares of capital stock beneficially

owned by the Ryan Parties. However, as explained in Proposal 2, under the General Corporation Law of the State of

Delaware, directors of companies that have a classified board may be removed only for cause, unless the certificate of

incorporation provides otherwise, while directors of companies that do not have a classified board may be removed with or

without cause but only by a vote of the majority of the shares then entitled to vote at an election of directors. Therefore, even

though the elimination of the springing supermajority voting standard to remove directors would be effective promptly after

this proposal is approved, our Proposed Amended and Restated Certificate will provide that, prior to the 2028 annual

meeting of stockholders, directors may be removed only for cause, and beginning with the 2028 annual meeting of

stockholders (that is, when the Board is no longer classified), a director may be removed with or without cause.

Supermajority voting standard requirements are intended to, among other things, facilitate corporate governance stability

and protect the Company’s stockholders against potentially self-interested actions of short-term investors by requiring broad

stockholder consensus to make certain fundamental changes to corporate governance. While the Board recognizes these

protections are important, the Board also notes that many stockholders now view these provisions as limiting a board’s

accountability to stockholders and the ability of stockholders to participate in corporate governance. After considering

stockholder input and the arguments in favor of and against this springing supermajority voting standard requirement, the

Board concluded that stockholders should be afforded the opportunity to vote on the amendment to eliminate the springing

supermajority voting standard to remove directors. For these reasons, the Board has decided that it is in the best interests of

the Company and our stockholders to recommend the adoption of the amendment to eliminate the springing supermajority

voting standard with respect to the removal of a director from our Board.

The description of the proposed amendment to eliminate the springing supermajority voting standard with respect to the

removal of a director from our Board is only a summary and is qualified in its entirety by reference to, and should be read in

conjunction with, the actual text of the proposed amendment included in Appendix A to this Proxy Statement.

We intend to file the Proposed Amended and Restated Certificate attached to this Proxy Statement as Appendix A with the

Secretary of State of the State of Delaware promptly following the Annual Meeting if all the Proposed Certificate

Amendments are approved by our stockholders. If this Proposal 4 is approved, but less than all the Proposed Certificate

Amendments are approved, then we intend to file a revised amended and restated Certificate with the Secretary of State of

the State of Delaware that contains only those amendments that have been approved by our stockholders, see the section

entitled “Proposed Certificate Amendments - Partial Stockholder Approval of Recommended Certificate Amendments.”

Vote Required

The affirmative vote of holders of at least sixty-six and two-thirds percent (66⅔%) of the voting power of the outstanding

shares of capital stock of the Company entitled to vote generally thereon, voting together as a single class, is required for

approval of the amendment to our Certificate to eliminate the springing supermajority voting standard with respect to the

removal of a director from our Board. Votes to “Abstain” and broker non-votes are treated as cast “Against” this proposal.


		2024 Proxy Statement 34
		2024 Proxy Statement 34

PROPOSAL NO. 5: AMENDMENT TO THE CERTIFICATE

TO PROVIDE A SPECIFIC OUTSIDE DATE TO SUNSET

THE HIGH VOTE OF OUR CLASS B COMMON STOCK

Our Certificate currently provides for a dual-class structure in which shares of our Class B common stock have ten votes per

share without a time-based sunset provision, while shares of our Class A common stock have one vote per share. The Ryan

Parties owned 82.4% of the shares of Class B common stock, as of March 31, 2025, and the remainder of the shares of

Class B common stock are held by certain executive officers, directors, and other current and past employees of our

Company. As a result of the ownership of shares of Class B common stock entitled to ten votes per share, Patrick G. Ryan,

our founder and Executive Chairman (who controls the vote of the Ryan Parties), through the Ryan Parties’ ownership of

both Class A common stock and Class B common stock, controls a majority of the voting power of all of our outstanding

capital stock (76.5% as of March 31, 2025), see “Security Ownership of Certain Beneficial Owners and Management.” As

such, Mr. Ryan is able to control matters submitted to our stockholders for approval, including the election of directors and

amendments of our organizational documents.

Our current Certificate provides for the ten-to-one voting rights of the shares of Class B common stock (the “High-Low Vote”)

to sunset and convert to one-vote-per share “on the first to occur of (i) twelve (12) months following the date of the death or

disability of Patrick G. Ryan or (ii) upon the first trading day on or after such date as the outstanding shares of Class B

Common Stock represent less than ten percent (10%) of the then-outstanding Class A Common Stock and Class B

Common Stock, which, in either instance, may be extended to eighteen (18) months upon affirmative approval of a majority

of the independent directors of the Board.” When the High-Low Vote sunsets, each share of Class B common stock will be

entitled to one vote per share and will remain outstanding in respect of the Company’s “Up-C” organizational structure.

After considering the advantages and disadvantages, on April 3, 2025, the Board unanimously approved and declared

advisable, and hereby recommends that stockholders approve, an amendment to our Certificate to add to the provision of

our Certificate governing the sunset of the High-Low Vote, a specific outside date, September 30, 2029, by which the High-

Low Vote must sunset, in addition to other triggers governing the sunset described above. This outside date corresponds to

the last day of the quarter, eight years after the date of the closing of our IPO. Under this amendment, the High-Low Vote

would sunset “on the date that is the earliest of (i) twelve (12) months following the date of the death or disability of Patrick

G. Ryan, (ii) upon the first trading day on or after such date as the outstanding shares of Class B Common Stock represent

less than ten percent (10%) of the then-outstanding Class A Common Stock and Class B Common Stock, which, in either

instance, may be extended to eighteen (18) months upon affirmative approval of a majority of the independent directors of

the Board, or (iii) September 30, 2029.”

Our Board believes it is important to approve this amendment to provide for a specific outside date to sunset the High-Low

Vote of the Class B common stock to create alignment between economic interests and voting rights, reduce the

concentration of voting power, and incentivize stockholders to vote. By having a definitive outside date providing for High-

Low Vote of reasonable duration, we are attempting to further align our governance structure with best practices followed by

other public companies perceived to be market leaders in the area of corporate governance and supported by institutional

investors. In light of the foregoing, the Board believes it is in the best interests of the Company and its stockholders to

approve this amendment to provide for a specific outside date by which the High-Low Vote of the Class B common stock will

sunset.

The description of the proposed amendment to provide for a specific outside date by which the High-Low Vote will sunset is

only a summary and is qualified in its entirety by reference to, and should be read in conjunction with, the actual text of the

proposed amendment included in Appendix A to this Proxy Statement.

We intend to file the Proposed Amended and Restated Certificate attached to this Proxy Statement as Appendix A with the

Secretary of State of the State of Delaware promptly following the Annual Meeting if all the Proposed Certificate

Amendments are approved by our stockholders. If this Proposal 5 is approved, but less than all the Proposed Certificate

Amendments are approved, then we intend to file a revised amended and restated Certificate with the Secretary of State of

the State of Delaware that contains only those amendments that have been approved by our stockholders, see the section

entitled “Proposed Certificate Amendments - Partial Stockholder Approval of Recommended Certificate Amendments.”

Vote Required

The affirmative vote of each of (i) the majority of the holders of the voting power of the outstanding shares of capital stock of

the Company entitled to vote generally thereon, voting together as a single class, and (ii) the majority of the holders of the

voting power of the outstanding shares of Class B common stock entitled to vote generally thereon, is required for approval

of the amendment to our Certificate to provide for a specific outside date to sunset the high vote of the Class B common

stock. Votes to “Abstain” and broker non-votes are treated as cast “Against” this proposal.


		2024 Proxy Statement 36
		2024 Proxy Statement 36

PROPOSAL NO. 6: AMENDMENT TO THE CERTIFICATE

TO PROVIDE STOCKHOLDERS WITH THE ABILITY TO

TAKE ACTION BY WRITTEN CONSENT

Our Certificate currently provides that prior to the “Stockholders Consent Trigger Date” (as defined below), the holders of

outstanding capital stock of the Company having not less than the minimum number of votes that would be necessary to

authorize or take action at a meeting at which all shares of the Company’s capital stock entitled to vote thereon were present

in person or by proxy and voted, may take action by written consent. The “Stockholders Consent Trigger Date” is the date on

which the Ryan Parties (as previously defined) cease to beneficially own at least forty percent (40%) of the voting power of

the then outstanding Voting Stock. From and after a Stockholder Consent Trigger Date, any action required or permitted to

be taken by the Company’s stockholders at an annual or a special meeting of stockholders may be taken only at a duly

called annual or special meeting of the Company’s stockholders. The Stockholder Trigger Date has not yet occurred and, as

such, the limitation requiring shareholder action only at a duly called annual or special meeting is not currently in effect.

After considering the advantages and disadvantages, on April 3, 2025, our Board unanimously approved and declared

advisable, and hereby recommends that stockholders approve, an amendment to our Certificate to eliminate the removal of

the right of stockholders to take action by written consent once the Stockholders Consent Trigger Date has occurred,

thereby allowing stockholders the ability to continue to act by written consent regardless of the number of shares beneficially

owned by the Ryan Parties.

The Board considered that precluding stockholders to act by written consent generally is intended to promote corporate

stability by requiring stockholder action to occur at a duly called and convened stockholder meeting. Limitations prohibiting

stockholder action by written consent may provide anti-takeover protection to the Company. However, many stockholders

and commentators view prohibitions against stockholder action by written consent as conflicting with principles of good

corporate governance, as stockholders are precluded from fully exercising their voting rights due to the need to convene at

an annual or special meeting to effect change.

The Board concluded that the benefits of precluding stockholder action by written consent upon the occurrence of a

Stockholder Consent Trigger Date were outweighed by the Board’s belief that removing this springing inability is a

meaningful step towards achieving our goal of further aligning our corporate governance policies with best practices followed

by other public companies perceived to be market leaders in the area of corporate governance and supported by institutional

and retail investors, thereby enhancing the ability of our stockholders to participate in the affairs of the Company. For the

reasons described above, our Board believes that the amendment to provide stockholders with the ability to take action by

written consent is advisable and in the best interests of the Company and its stockholders.

The description of the proposed amendment to provide stockholders with the ability to take action by written consent above

is only a summary and is qualified in its entirety by reference to, and should be read in conjunction with, the actual text of the

proposed amendment included in Appendix A to this Proxy Statement.

We intend to file the Proposed Amended and Restated Certificate attached to this Proxy Statement as Appendix A with the

Secretary of State of the State of Delaware promptly following the Annual Meeting if all the Proposed Certificate

Amendments are approved by our stockholders. If this Proposal 6 is approved, but less than all the Proposed Certificate

Amendments are approved, then we intend to file a revised amended and restated Certificate with the Secretary of State of

the State of Delaware that contains only those amendments that have been approved by our stockholders, see the section

entitled “Proposed Certificate Amendments - Partial Stockholder Approval of Recommended Certificate Amendments.”

Vote Required

The affirmative vote of the majority of the holders of the voting power of the outstanding shares of capital stock of the

Company entitled to vote generally thereon, voting together as a single class, is required for approval of the amendment to

our Certificate to provide stockholders with the ability to take action by written consent. Votes to “Abstain” and broker non-

votes are treated as cast “Against” this proposal.

Holders of proxies solicited by this Proxy Statement will vote the proxies received by them as directed on the proxy card or, if

no direction is given, then FOR the amendment to our Certificate to provide stockholders with the ability to take action by

written consent.


	The Board recommends a vote “FOR” the amendment to our Certificate to provide stockholders with the ability to take action by written consent.


		2024 Proxy Statement 37
		2024 Proxy Statement 37

PROPOSAL NO. 7: AMENDMENT TO THE CERTIFICATE

TO PROVIDE STOCKHOLDERS WITH THE ABILITY TO

CALL SPECIAL MEETINGS OF STOCKHOLDERS

Our Certificate currently provides that prior to the Stockholder Consent Trigger Date (as previously defined), the Chairman of

the Board may call a special meeting of stockholders at the written request of Patrick G. Ryan or another authorized

representative of the Ryan Parties, but does not currently permit other stockholders to call a special meeting of stockholders.

After considering the advantages and disadvantages, on April 3, 2025, our Board unanimously approved and declared

advisable, and hereby recommends that stockholders approve, an amendment to our Certificate to provide the right to call a

special meeting of stockholders to any stockholders collectively holding at least 20% of the issued and outstanding shares of

Voting Stock entitled to vote on the matter or matters to be brought before the proposed special meeting, voting together as

a single class (the “Requisite Percent”), provided that in order to meet the Requisite Percent, as a condition to such right,

such stockholders shall have held continuously for one (1) year as of the date of the request an aggregate “net long

position” (as defined in Rule 14e-4 under the Exchange Act) of such shares and continue to own the Requisite Percent at all

times between such date and the date of the applicable meeting of stockholders and follow the procedures otherwise

contained in the Bylaws. This amendment to our Certificate also removes the ability of the Ryan Parties to call a special

meeting unless they meet the Requisite Percent and comply with the other requirements set forth in the Proposed Amended

and Restated Certificate and the Bylaws. The Board believes that establishing the Requisite Percent along with other

reasonable procedural and substantive safeguards strikes a reasonable and acceptable balance between enhancing

stockholder rights and protecting against the risk that a small minority of stockholders, including stockholders with special

interests that are not shared generally by all the Company’s stockholders, could request that the Company call one or more

special meetings that could result in unnecessary financial expense and disruption to our business operations.

Providing all stockholders with the ability to call special meetings of stockholders represents a meaningful increase in the

voting rights of our stockholders and is consistent with best practices of other public companies perceived to be market

leaders in the area of corporate governance and institutional and retail investors. However, the Board recognizes that the

power to call a special meeting of stockholders has historically been used by acquirors in the hostile merger and acquisition

context. Potential acquirors seeking to take over the Company for an inadequate price could threaten to call a special

meeting of stockholders to replace members of the Board, thereby increasing their negotiating leverage or creating a way to

avoid negotiating with the Board, frustrating the Board’s exercise of its duty to protect the interests of all stockholders.

Likewise, the Board believes that only stockholders with a true economic interest in the Company should be entitled to

request a special meeting and, after reviewing multiple factors, determined that the Requisite Percent and other safeguards

are appropriate.

In addiiton, if this Proposal 7 is approved, we would add certain procedural and substantive safeguards in the Bylaws (which

do not require stockholder approval) including to specify the requirements necessary to meet the Requisite Percent so that

stockholders can exercise their right to call a special meeting of the stockholders. These safeguards would include, among

others: (i) a requirement that the special meeting request must be delivered in writing to the Secretary of the Company by

the stockholders (“Requesting Stockholder(s)”) representing the Requisite Percent; (ii) a statement in the special meeting

request of the specific purpose or purposes of the special meeting, the matter(s) proposed to be acted on at the special

meeting, the reasons for conducting the special meeting, and any material interest that each Requesting Stockholder or its

affiliates has in such purpose; (iii) a representation in the special meeting request that each Requesting Stockholder, or one

or more representatives thereof, intends to appear in person or by proxy at the special meeting to present the proposal(s) or

business to be brought before the special meeting; (iv) such information, statements, representations, agreements and other

documents required by the Bylaws as though such Requesting Stockholder is intending to nominate a candidate for director

or propose other business to be brought before an annual meeting of stockholders; (v) an agreement in the special meeting

request by the Requesting Stockholder to notify the Company promptly in the event of any disposition of any shares of

capital stock of the Company and an acknowledgment that any such disposition prior to the date of the special meeting shall

be deemed to be a revocation of such special meeting request with respect to such disposed shares; and (vi) the

requirement to provide documentary evidence acceptable to the Secretary of the Company that the Requesting

Stockholders own the Requisite Percent.

For the reasons described above, our Board believes that the amendment to the Certificate to provide stockholders with the

ability to call special meetings of stockholders is advisable and in the best interests of the Company and its stockholders.

The description of the proposed amendment to provide stockholders with the ability to call special meetings of stockholders

above is only a summary and is qualified in its entirety by reference to, and should be read in conjunction with, the actual

text of the proposed amendment included in Appendix A to this Proxy Statement.

We intend to file the Proposed Amended and Restated Certificate attached to this Proxy Statement as Appendix A with the

Secretary of State of the State of Delaware promptly following the Annual Meeting if all the Proposed Certificate

Amendments are approved by our stockholders. If this Proposal 7 is approved, but less than all the Proposed Certificate

Amendments are approved, then we intend to file a revised amended and restated Certificate with the Secretary of State of


		2024 Proxy Statement 39
		2024 Proxy Statement 39

PROPOSAL NO. 8: AMENDMENT TO THE CERTIFICATE

TO ELIMINATE THE SPRINGING SUPERMAJORITY

VOTING STANDARD WITH RESPECT TO THE

AMENDMENT OF THE BYLAWS AND CERTAIN

PROVISIONS OF THE CERTIFICATE

Our Certificate currently provides that prior to the “Amendment Trigger Date” (as defined below) the Bylaws may be

amended (i) by the Board or (ii) upon the affirmative vote of a majority of the voting power of the Voting Stock and that

certain articles of the Certificate may be amended upon the affirmative vote of a majority of the voting power of the Voting

Stock. The “Amendment Trigger Date” is the date on which the Ryan Parties cease to beneficially own at least forty percent

(40%) of the then outstanding shares of Voting Stock. On and after the Amendment Trigger Date, the Bylaws may be

amended (i) by the Board or (ii) upon the affirmative vote of sixty-six and two-thirds percent (66⅔%) of the voting power of

the then outstanding shares of Voting Stock and that certain articles of the Certificate may be amended upon the affirmative

vote of sixty-six and two-thirds percent (66⅔%) of the voting power of the then outstanding shares of Voting Stock. The

Amendment Trigger Date has not occurred and, as such, the supermajority voting standard is not currently in effect.

The articles of the Certificate that are subject to the springing supermajority voting standard provisions described above, and

in Appendix A are Articles Five, Six, Seven, Nine, Ten, and Eleven which relate to:

•the powers, size, election, term, vacancies and removal of members of the Board;

•limitation on liability of directors and officers;

•action by written consent and holding special meetings of stockholders;

•amendments to the Bylaws and Certificate; and

•exclusivity of forum.

After considering the advantages and disadvantages, on April 3, 2025, our Board unanimously approved and declared

advisable, and hereby recommends that stockholders approve, an amendment to our Certificate to eliminate the springing

supermajority voting standard with respect to the amendment of our Bylaws and those certain articles of our Certificate that

would have otherwise gone into effect upon the Amendment Trigger Date to the extent an Amendment Trigger Date had

occurred, thereby providing stockholders with the power to amend our Bylaws or those certain articles of our Certificate with

the affirmative vote of a majority of the then outstanding shares of Voting Stock regardless of the number of shares

beneficially owned by the Ryan Parties.

As part of our ongoing review of our corporate governance practices, the Board determined that removing the springing

voting standard described above is in the best interests of the Company and our stockholders. The springing supermajority

voting standard was intended to provide corporate governance stability in the future when the Ryan Parties no longer own

40% or more of the then outstanding Voting Stock, reducing the likelihood that third parties institute corporate governance

changes that may be inconsistent with the best interest of, or otherwise harmful to, the Company and its stockholders and

require that a broad base of stockholder support exists before certain governance matters are approved and implemented.

While the Board acknowledges these important benefits, the Board also recognizes that the springing supermajority voting

standard may have the effect of reducing the Board’s accountability to stockholders and can limit stockholder participation in

our corporate governance. The Board also acknowledges that other public companies perceived to be market leaders in the

area of corporate governance have transitioned away from similar supermajority voting standards.

For the reasons described above, our Board believes that the benefits of removing the springing supermajority voting

standard, described above and in Appendix A, provide more accountability to stockholders and promote stronger corporate

governance and outweigh the benefits of retaining such springing supermajority voting standard.

The description of the proposed amendment to our Certificate to eliminate the springing supermajority voting standard with

respect to the amendment of our Bylaws and certain articles of our Certificate above is only a summary and is qualified in its

entirety by reference to, and should be read in conjunction with, the actual text of the proposed amendment included in

Appendix A to this Proxy Statement.

We intend to file the Proposed Amended and Restated Certificate attached to this Proxy Statement as Appendix A with the

Secretary of State of the State of Delaware promptly following the Annual Meeting if all the Proposed Certificate

Amendments are approved by our stockholders. If this Proposal 8 is approved, but less than all the Proposed Certificate

Amendments are approved, then we intend to file a revised amended and restated Certificate with the Secretary of State of

the State of Delaware that contains only those amendments that have been approved by our stockholders, see the section

entitled “Proposed Certificate Amendments - Partial Stockholder Approval of Recommended Certificate Amendments.”


		2024 Proxy Statement 41
		2024 Proxy Statement 41

PROPOSAL NO. 9: AMENDMENT TO THE CERTIFICATE

TO PROVIDE FOR THE EXCULPATION OF CERTAIN

OFFICERS OF THE COMPANY TO THE FULLEST EXTENT

PROVIDED UNDER DELAWARE LAW

The State of Delaware, which is our state of incorporation, recently amended Section 102(b)(7) of the Delaware General

Corporation Law (“DGCL”) to permit a corporation to eliminate or limit the personal liability of certain officers to the

corporation or its stockholders for breaches of the fiduciary duty of care as an officer in certain limited circumstances. We

sometimes refer to this elimination or limitation of personal liability as “exculpation” in this Proxy Statement. Prior to the

amendment of Section 102(b)(7) of the DGCL, Delaware law authorized such exculpation for directors but not for officers.

Consequently, plaintiffs have employed a tactic of bringing certain claims that would otherwise be exculpated if brought

against directors against individual officers to avoid dismissal of such claims and extract settlements from defendant

corporations. The amendment of Section 102(b)(7) of the DGCL was adopted to address the inconsistent treatment between

officers and directors and rising litigation and insurance costs.

As with directors, exculpation protection under Section 102(b)(7) of the DGCL does not apply to an officer’s breaches of the

duty of loyalty, acts or omissions not in good faith, or that involve intentional misconduct or a knowing violation of law, or any

transaction in which the officer derived an improper personal benefit. The protection for officers under Section 102(b)(7) of

the DGCL only permits officer exculpation for direct claims brought by stockholders for breach of an officer’s fiduciary duty of

care, including class actions, but does not eliminate an officer’s monetary liability for breach of fiduciary duty claims brought

by the corporation itself or for derivative claims brought by stockholders in the name of the corporation. In addition, the

exculpation protection under Section 102(b)(7) of the DGCL only applies to certain officers, namely a person who (during the

course of conduct alleged to be wrongful) (i) is or was president, chief executive officer, chief operating officer, chief financial

officer, chief legal officer, controller, treasurer, or chief accounting officer, (ii) is or was identified in the corporation’s public

filings with the SEC as one of the most highly compensated executive officers of the corporation, or (iii) has, by written

agreement with the corporation, consented to be identified as an officer for purposes of accepting service of process.

After considering the advantages and disadvantages, on April 3, 2025, our Board unanimously approved and declared

advisable, and hereby recommends that stockholders approve, an amendment to our Certificate to provide for the

exculpation of certain officers of the Company to the fullest extent provided under Delaware law.

The Board believes it is appropriate for the Company to allow for such exculpation for the following reasons:

•The nature of the role of officers often requires them to make decisions on crucial matters. Frequently, officers must

make decisions in response to time-sensitive opportunities and challenges, which can create substantial risk of

investigations, claims, actions, suits or proceedings seeking to impose liability on the basis of hindsight, especially

in the current litigious environment and regardless of merit. Limiting concern about personal risk would empower

officers to best exercise their business judgment in furtherance of stockholder interests.

•The Board believes the proposed amendment could reduce the instances in which the Company is required to

indemnify its officers by reducing their exposure to lawsuits.

•The Board believes the proposed amendment would align the protections for our officers with those protections

currently afforded to our directors, although it would not eliminate officers’ monetary liability for breach of fiduciary

duty claims brought by the Company itself or for derivative claims brought by stockholders in the name of the

Company. In addition, the proposed amendment will not apply to acts or omissions of officers occurring prior to the

date when the amendment becomes effective.

•The Board expects our peers and other companies with whom we compete for officer talent to adopt exculpation

clauses that limit the personal liability of officers in their certificates of incorporation. We believe failing to adopt the

proposed amendment could impact our recruitment and retention of exceptional officer candidates who conclude

that the potential exposure to liabilities, costs of defense, and other risks of proceedings exceed the benefits of

serving as an officer of the Company.

•The Board believes the proposed amendment could better position us to attract top officer candidates and retain

our current officers and enable our officers to exercise their business judgment in furtherance of the interests of our

stockholders without the potential for distraction posed by the risk of personal liability.

The proposed amendment is not being proposed in response to any specific resignation, threat of resignation, or refusal to

serve by any officer. In addition, the Company is not proposing the amendment to our Certificate to provide for exculpation of

certain officers of the Company to the fullest extent provided under Delaware law in anticipation of any specific litigation. The

amendment is being proposed on a prospective basis to help mitigate potential future harm to the Company and our

stockholders.


		2024 Proxy Statement 42
		2024 Proxy Statement 42

Our executive officers and other employees may be considered as having an interest in the approval of this proposal as they

may receive the personal liability exculpation protections afforded by the amendment if it is adopted by our stockholders.

For the reasons described above, our Board believes that the amendment to our Certificate to provide for exculpation of

certain officers of the Company to the fullest extent provided under Delaware law is advisable and in the best interests of the

Company and its stockholders.

The description of the proposed amendment to our Certificate to provide for exculpation of certain officers of the Company to

the fullest extent provided under Delaware law above is only a summary and is qualified in its entirety by reference to, and

should be read in conjunction with, the actual text of the proposed amendment included in Appendix A to this Proxy

Statement.

We intend to file the Proposed Amended and Restated Certificate attached to this Proxy Statement as Appendix A with the

Secretary of State of the State of Delaware promptly following the Annual Meeting if all the Proposed Certificate

Amendments are approved by our stockholders. If this Proposal 9 is approved, but less than all the Proposed Certificate

Amendments are approved, then we intend to file a revised amended and restated Certificate with the Secretary of State of

the State of Delaware that contains only those amendments that have been approved by our stockholders, see the section

entitled “Proposed Certificate Amendments - Partial Stockholder Approval of Recommended Certificate Amendments.”

Vote Required

The affirmative vote of the majority of the holders of the voting power of the outstanding shares of capital stock of the

Company entitled to vote generally thereon, voting together as a single class, is required for approval of the amendment to

our Certificate to provide for the exculpation of certain officers of the Company to the fullest extent provided under Delaware

law. Votes to “Abstain” and broker non-votes are treated as cast “Against” this proposal.

Holders of proxies solicited by this Proxy Statement will vote the proxies received by them as directed on the proxy card or, if

no direction is given, then FOR the amendment to our Certificate to provide for the exculpation of certain officers of the

Company to the fullest extent provided under Delaware law.


	The Board recommends a vote “FOR” the amendment to our Certificate to provide for the exculpation of certain officers of the Company to the fullest extent provided under Delaware law.


		2024 Proxy Statement 43
		2024 Proxy Statement 43

PROPOSAL NO. 10: AMENDMENT TO THE CERTIFICATE

TO INCORPORATE CERTAIN NON-SUBSTANTIVE

AMENDMENTS

The Board believes various non-substantive amendments to our Certificate are necessary to update the current Certificate

to remove obsolete provisions and incorporate administrative modifications (the “Non-Substantive Amendments”). We

therefore propose to amend and restate our current Certificate to effect these Non-Substantive Amendments.

After considering the advantages and disadvantages, on April 3, 2025, our Board unanimously approved and declared

advisable, and hereby recommends that stockholders approve, the Non-Substantive Amendments.

Proposed Non-Substantive Amendments

The Board is asking our stockholders to approve the following Non-Substantive Amendments to our Certificate:

1.Delete obsolete or update references as needed, including:

a.update the reference from Ryan Specialty, LLC to New Ryan Specialty, LLC and reference the as revised

operating agreement in Article IV, Section 3(d) and 3(e);

b.remove the initial number of directors in Article V, Section 2; and

c.move the definition of “Ryan Parties” from Article V, Section 6 to Article V, Section 9.

2.Eliminate all references to Class X common stock which was needed for certain IPO reorganizational transactions

but is no longer necessary, including under:

a.Article IV, Section 1; and

b.Article IV, Section 3(a)(iii), 3(b), 3(c), 3(d), and 3(f)(ii).

The Board believes that the current Certificate should be updated to remove obsolete provisions and incorporate other

administrative modifications that the Board believes will simplify and streamline the document for stockholders. The

amendments set forth in this proposal are administrative and will not have a substantive impact on the rights of the

stockholders of the Company.

The description of the proposed Non-Substantive Amendments above is only a summary and is qualified in its entirety by

reference to, and should be read in conjunction with, the actual text of the proposed Non-Substantive Amendments included

in Appendix A to this Proxy Statement.

We intend to file the Proposed Amended and Restated Certificate attached to this Proxy Statement as Appendix A with the

Secretary of State of the State of Delaware promptly following the Annual Meeting if all the Proposed Certificate

Amendments are approved by our stockholders. If this Proposal 10 is approved, but less than all the Proposed Certificate

Amendments are approved, then we intend to file a revised amended and restated Certificate with the Secretary of State of

the State of Delaware that contains only those amendments that have been approved by our stockholders, see the section

entitled “Proposed Certificate Amendments - Partial Stockholder Approval of Recommended Certificate Amendments.”

Vote Required

The affirmative vote of the majority of the holders of the voting power of the outstanding shares of capital stock of the

Company entitled to vote generally thereon, voting together as a single class, is required for approval of the Non-

Substantive Amendments. Votes to “Abstain” and broker non-votes are treated as cast “Against” this proposal.

Holders of proxies solicited by this Proxy Statement will vote the proxies received by them as directed on the proxy card or, if

no direction is given, then FOR the amendment to our Certificate for the Non-Substantive Amendments.


	The Board recommends a vote “FOR” the amendment to our Certificate to incorporate the Non- Substantive Amendments.


		2024 Proxy Statement 44
		2024 Proxy Statement 44

PROPOSAL NO. 11:

RATIFICATION OF APPOINTMENT OF INDEPENDENT

REGISTERED PUBLIC ACCOUNTING FIRM

The Audit Committee of our Board has appointed Deloitte & Touche LLP as our independent registered public accounting

firm for the year ending December 31, 2025, and is seeking ratification of this selection by our stockholders at the Annual

Meeting. Deloitte & Touche LLP has audited our financial statements since the fiscal year ended 2011. Services provided to

the Company and its subsidiaries by Deloitte & Touche LLP for the years ended December 31, 2024 and 2023 are described

below and under “Audit Committee Report.” Representatives of Deloitte & Touche LLP are expected to be present at the

Annual Meeting. They will have an opportunity to make a statement if they so desire, and we expect that they will be

available to respond to appropriate questions.

Neither our Bylaws nor other governing documents or law require stockholder ratification of the selection of Deloitte &

Touche LLP as our independent registered public accounting firm. The Audit Committee, however, is submitting the selection

of Deloitte & Touche LLP to our stockholders for ratification as a matter of good corporate practice. If our stockholders fail to

ratify the selection, the Audit Committee will reconsider whether to retain Deloitte & Touche LLP. Even if the selection is

ratified, the Audit Committee, in its discretion, may direct the appointment of a different independent registered public

accounting firm at any time during the year if they determine that a change would be in the best interests of the Company

and our stockholders.

Audit and Non-Audit Fees and Services

The following table provides information regarding the fees incurred to Deloitte & Touche LLP during the years ended

December 31, 2024 and 2023. All fees described below were approved by the Audit Committee.


	Year Ended December 31,
	2024	2023

Audit Fees(1)	$2,292,640	$1,502,000
Audit Related Fees(2)	12,000	10,000
Tax Fees(3)	—	—
All Other Fees(4)	4,890	14,890
Total Fees	$2,309,530	$1,526,890

(1)Audit Fees paid to Deloitte & Touche LLP for 2024 and 2023 were for professional services associated with the annual audit of our

consolidated financial statements, the reviews of our quarterly consolidated financial statements, and the issuance of consents and

comfort letters in connection with registration statement filings with the SEC or for debt issuances.

(2)Audit-Related Fees consist of fees billed for assurance and related services that are reasonably related to the performance of the

audit or review of our consolidated financial statements and are not reported under “Audit Fees.” Fees include review of a

subsidiary’s financial statements for regulatory reporting purposes.

(3)Tax Fees consist of fees for tax compliance, tax advice, and tax planning. No such services were provided by Deloitte & Touche LLP

in either period.

(4)All Other Fees include any fees billed that are not audit, audit-related, or tax fees.

Audit Committee Pre-Approval Policies and Procedures

Before Deloitte & Touche LLP is engaged by the Company to render audit or non-audit services, our Audit Committee must

review the terms of the proposed engagement and pre-approve the engagement. It is also the policy of the Audit Committee

to pre-approve fees for all audit and permitted non-audit and tax services to be provided by the independent registered

accountant, to review pre-approved fees quarterly, and establish other necessary procedures. Audit Committee pre-approval

of non-audit services (other than review and attest services) are not required if those services fall within available exceptions

established by the SEC. The Audit Committee may delegate authority to one or more of the members of the Audit

Committee to provide these pre-approvals for audit or non-audit services, provided that the person or persons to whom

authority is delegated must report the pre-approvals to the full Audit Committee at its next scheduled meeting.


		2024 Proxy Statement 46
		2024 Proxy Statement 46

AUDIT COMMITTEE REPORT

The Audit Committee is composed of five independent directors (as defined by the NYSE listing standards). Our Audit

Committee operates under a written charter, which is posted on our website at ir.ryanspecialty.com. As provided in the

charter, the Audit Committee’s oversight responsibilities include monitoring the integrity of our financial statements (including

reviewing financial information, the systems of internal controls, the audit process, and the independence and performance

of our internal audit function and independent registered public accounting firm) and our compliance with legal and

regulatory requirements. However, management has the primary responsibility for the financial statements and the reporting

process, including our systems of internal controls. In fulfilling its oversight responsibilities, the Audit Committee:

•reviewed and discussed the audited financial statements for the year ended December 31, 2024, with our

management;

•discussed with our independent auditors, Deloitte & Touche LLP, the matters required to be discussed by the

applicable requirements of the Public Company Accounting Oversight Board (“PCAOB”) and the SEC; and

•received the written disclosures and the letter from Deloitte & Touche LLP required by applicable requirements of

the PCAOB regarding Deloitte & Touche LLP’s communications with the Audit Committee concerning

independence and has discussed with Deloitte & Touche LLP its independence.

Based on the Audit Committee’s review and discussions noted above, the Audit Committee recommended to the Board that

the audited financial statements be included in our Annual Report on Form 10-K for the year ended December 31, 2024.

Respectfully submitted by:

David P. Bolger (Chair)

Henry S. Bienen

Michelle L. Collins

Francesca Cornelli

Anthony J. Kuczinski


		2024 Proxy Statement 47
		2024 Proxy Statement 47

PROPOSAL NO. 12

ADVISORY (NON-BINDING) VOTE ON NAMED

EXECUTIVE OFFICER COMPENSATION

Recognizing that executive compensation is an important matter for our stockholders, and in accordance with SEC rules, we

are asking our stockholders to approve an advisory resolution on the compensation of our named executive officers

(“NEOs”) as disclosed in this Proxy Statement. At our 2022 annual meeting, a majority of stockholders voted, consistent with

the recommendation of the Board, to hold a stockholder vote annually on an advisory resolution to approve the

compensation of our NEOs. The annual vote will continue until the next required vote on the frequency of stockholder votes

on the compensation of our NEOs as required pursuant to Section 14(A) of the Exchange Act and the rules and regulations

promulgated thereunder, which we expect will take place at our 2028 annual meeting of stockholders.

This proposal, commonly known as a “say-on-pay” proposal, is not intended to address any specific item of compensation,

but rather the overall compensation of our NEOs and our executive compensation philosophy, policies, and practices as

described in this Proxy Statement. Although the voting results are not binding, the Board and the Compensation and

Governance Committee will take into account the results of the vote when considering future executive compensation

arrangements.

We encourage our stockholders to read the Compensation Discussion and Analysis, which immediately follows this

proposal. The Compensation Discussion and Analysis describes in more detail our executive compensation program and

related policies and practices and explains the decisions the Compensation and Governance Committee has made under

this program and the factors considered in making those decisions. We also encourage our stockholders to review the 2024

Summary Compensation Table elsewhere in this Proxy Statement and other related compensation tables and narratives,

which provide detailed information on the compensation of our named executive officers.

Therefore, in accordance with Section 14A of the Exchange Act and as a matter of good corporate governance, we are

asking stockholders to approve the following advisory resolution at the Annual Meeting:

RESOLVED, that the stockholders of the Company approve, on an advisory basis, the compensation of the

Company’s named executive officers as disclosed in the Compensation Discussion and Analysis and the tabular

disclosure regarding each named executive officer’s compensation (together with the accompanying narrative

disclosure) in this Proxy Statement, as disclosed pursuant to Item 402 of Regulation S-K, for the 2025 Annual

Meeting of Stockholders.

Vote Required

The affirmative vote of the majority of the voting power of capital stock present or represented by proxy at the virtual Annual

Meeting and entitled to vote thereon is required for approval of the advisory (non-binding) resolution. Votes to “Abstain” are

treated as cast “Against” this proposal and broker non-votes will have no effect on the vote for this proposal.

Holders of proxies solicited by this Proxy Statement will vote the proxies received by them as directed on the Proxy Card or,

if no direction is given, then FOR the advisory (non-binding) resolution to approve the overall compensation of the

Company’s NEOs as described in this Proxy Statement pursuant to the compensation disclosure rules of the SEC.


	The Board recommends a vote “FOR” the advisory (non-binding) resolution to approve the overall compensation of the Company’s named executive officers, described in this Proxy Statement pursuant to the compensation disclosure rules of the SEC.


		2024 Proxy Statement 48
		2024 Proxy Statement 48

EXECUTIVE COMPENSATION:

COMPENSATION DISCUSSION AND ANALYSIS

This Compensation Discussion and Analysis (“CD&A”) describes our compensation philosophy and provides an overview

analysis of (i) our 2024 compensation programs and policies for our NEOs; (ii) the material compensation decisions made by

the Compensation and Governance Committee of our Board under those programs and policies as reflected in the executive

compensation tables that appear following this CD&A; and (iii) the material factors that the Compensation and Governance

Committee considered and the process it utilized in making those decisions.

Our Named Executive Officers

Our 2024 Named Executive Officers (“NEOs”), as defined under applicable SEC rules, are:

•Patrick G. Ryan (Executive Chairman of the Board, and former Chief Executive Officer)

•Timothy W. Turner (Chief Executive Officer)

•Jeremiah R. Bickham (President and former Chief Financial Officer)

•Janice M. Hamilton (Chief Financial Officer)

•Michael L. Conklin (Executive Vice President and Chief Human Resources Officer)

•Brendan M. Mulshine (Executive Vice President and Chief Revenue Officer)

•Benjamin M. Wuller (CEO, Ryan Specialty Underwriting Managers)

Summary of Our Executive Compensation Practices

We developed and maintain a comprehensive compensation and governance framework that we believe is aligned with

market practices and standards.

What We Do:


ü	Annual “say-on-pay” vote (as recommended by the Board and management).

ü	Independent compensation consultant selected, engaged, and overseen by the Compensation and Governance Committee.

ü	A substantial majority of total compensation for executives tied to performance.

ü	Clawback policy in place in case of an accounting restatement.

ü	Compensation and Governance Committee oversight of risks associated with compensation policies and practices.

ü	Long-term incentive program with long-term vesting schedules.

ü	Stock ownership guidelines to align interests of executives with our stockholders.

ü	Majority of executive compensation delivered in the form of long-term incentives.

ü	Compensation and Governance Committee consists only of independent Board members.

What We Don’t Do:


x	No backdating of share options and no option repricing without stockholder approval.

x	No excise tax gross-ups.

x	No guaranteed annual incentive payouts without regard to performance.

x	No pledging (absent Board approval) or hedging of Company stock by directors, executive officers, or employees.


		2024 Proxy Statement 49
		2024 Proxy Statement 49

Compensation Philosophy

Our compensation philosophy is focused on the following objectives:


Objective	How we accomplish this objective

Alignment with Stockholders	•Annual short-term cash incentive program tied to key business objectives, which objectives lead to long-term stockholder value creation •Long-term incentives vest over multiple years and reward sustained stockholder value creation •IPO awards are subject to lock-up provisions

Attract and Retain	•Competitive compensation for executives is based upon job responsibilities, experience, individual performance, and comparisons to the market

Pay for Performance	•Majority of executive compensation is delivered in the form of variable, at-risk compensation •Annual incentive plan payouts are determined based on financial performance •The Compensation and Governance Committee establishes rigorous targets for the annual incentive plan •Long-term incentives are delivered in the form of performance-based awards, stock options or restricted equity grants, which reward participants for increasing the stock price and directly align executives to the stockholder experience

Sound Risk Management	•Conduct an annual risk assessment of our executive compensation programs •Compensation and Governance Committee is made up of independent directors and retains an independent compensation consultant •Incorporate a variety of corporate governance and compensation best practices

Our Executive Compensation Program in Detail

Our Pay Philosophy

Base Salary

We strive to be the employer of choice for the top-talent in our industry and our goal is to always hire top tier talent

throughout our Company, including our executive officers. As a result, our Compensation and Governance Committee sets

base salary for executives above the median of the compensation landscape. In line with the Compensation and

Governance Committee’s compensation philosophy, exceptional performance by executive officers is generally rewarded

through short-term incentives (“STI”) and/or long-term incentive (“LTI”) awards and not through base salaries. Adjustments to

base salaries are made by the Compensation and Governance Committee to reflect changes in responsibilities or when

competitive market or internal conditions warrant.

The following table sets forth the base salary for each of our NEOs for 2024 as approved by the Compensation and

Governance Committee.


Named Executive Officer	2024 Base Salary

Patrick G. Ryan	$1,375,000
Timothy W. Turner	1,200,000
Jeremiah R. Bickham	675,000
Janice M. Hamilton	600,000
Michael L. Conklin	560,000
Brendan M. Mulshine	685,011
Benjamin M. Wuller	750,000


		2024 Proxy Statement 50
		2024 Proxy Statement 50

In April 2024, the Compensation and Governance Committee reexamined Mr. Bickham’s 2024 compensation and based on

his current and future expected contributions to the Company increased his base salary for 2024 to $675,000 which was

retroactively applied to be effective in March 2024 with our normal pay raise cycle.

The Compensation and Governance Committee reviewed each NEO’s base salary in January 2025. They considered the

new positions and responsibilities of certain of our NEOs and compared their current compensation with our peer group.

Based on our philosophy of targeting base salary at or above the 75th percentile when compared to the members of our peer

group, the Compensation and Governance Committee approved the following compensation changes to be effective in

March 2025: Mr. Ryan - $1,200,000, Mr. Turner - $1,500,000, Mr. Bickham - $850,000, Mr. Conklin - $600,000, Mr.

Mulshine - $725,000 and Mr. Wuller - $850,000. The base salary for Ms. Hamilton was not increased (or otherwise adjusted)

from 2024 to 2025.

Short-Term Incentive Compensation

STI awards are an integral component of our NEOs’ total compensation and are based on our financial results and individual

performance. They are intended to deliver exceptional pay for exceptional performance and provide a well-timed link

between recent performance and individual compensation.

Each NEO is eligible to receive an annual STI award expressed as a percentage of their base salary. STI targets for the

Company’s executive officers, other than Ms. Hamilton, were established by the Compensation and Governance Committee

in early 2024 following a thorough evaluation of our executive officers’ total compensation and market practices. Ms.

Hamilton, who became our Chief Financial Officer on October 1, 2024, was compensated in 2024 based on a legacy short-

term incentive plan established for her as the Company’s Controller which was 100% discretionary. Ms. Hamilton will

commence participation in the Executive Incentive Corporate Plan in 2025.

The Compensation and Governance Committee considers an NEO’s total compensation when determining any change to a

particular component of compensation. In addition to modifying Mr. Bickham’s base salary in April 2024, the Compensation

and Governance Committee approved an increase in Mr. Bickham’s STI target percentage from 150% to 200% to be

effective in 2024.


Named Executive Officer	2024 Bonus Target %

Patrick G. Ryan	200%
Timothy W. Turner	200%
Jeremiah R. Bickham	200%
Janice M. Hamilton	150%
Michael L. Conklin	150%
Brendan M. Mulshine	150%
Benjamin M. Wuller	200%

The 2024 Executive Incentive Corporate Plan

In early 2024, the Compensation and Governance Committee determined that the actual amount of the 2024 bonuses

payable to those NEOs on our Executive Incentive Corporate Plan, which include all of our NEOs other than Ms. Hamilton

and Mr. Wuller, would be determined based on the following criteria, which include both Company-based performance

metrics and individual, merit-based achievement:


Metric	Percent of Bonus

Organic Revenue Growth	35%
Adjusted EBITDAC Margin	35%
Individual Merit-Based Achievement	30%

During the first quarter of 2024, we changed our methodology of calculating Organic Revenue Growth. The actual Organic

Revenue Growth achieved in 2024, presented below, is based on the legacy calculation methodology in order to align with

the targets below that were established by the Compensation and Governance Committee based on the legacy

methodology. Pursuant to the legacy calculation methodology, Organic Revenue Growth equals the percentage change in

the Company’s total revenue, as compared to the prior fiscal year, adjusted for revenue attributable to recent acquisitions


		2024 Proxy Statement 51
		2024 Proxy Statement 51

during the first 12 months of Ryan Specialty’s ownership, and other adjustments (such as contingent commissions, fiduciary

investment income, and the impact of changes in foreign exchange rates).

For the Organic Revenue Growth metric, payment was based on the following scale:


Organic Revenue Growth	Target Payout %

<5%	0%
10-12%	100%
>16%	150%

Target payout percentage for Organic Revenue Growth between the benchmarks set forth above was determined based on

a graduated basis.

For the Adjusted EBITDAC Margin metric, payment was based on the following scale:


Adjusted EBITDAC Margin	Target Payout %

<30.00%	0%
31.00-31.25%	100%
>31.75%	150%

Target payout percentage for Adjusted EBITDAC Margin between the benchmarks set forth above was determined based on

a graduated basis.

Adjusted EBITDAC Margin is calculated by taking our Adjusted EBITDAC as a percentage of our Total revenue. Adjusted

EBITDAC, for the purposes of Short-Term Incentive Compensation, is calculated by taking our Net income before Interest

expense, net, Income tax expense, Depreciation, Amortization, and Change in contingent consideration, adjusted to reflect

items such as (i) equity-based compensation, (ii) exclusion of the results of M&A completed in 2024 as the targets were set

prior to the M&A being completed, (iii) exclusion of the impact of any higher (or lower) than target discretionary incentive

accruals, and (iv) other exceptional or non-recurring items, as applicable.

Individual Merit-Based achievement is linked to an individual’s contribution towards (i) culture, (ii) results, (iii) client centricity,

(iv) teamwork, and (v) inclusion.

The 2024 Executive Incentive Business Unit Plan

In early 2024, the Compensation and Governance Committee determined that the actual amount of the 2024 bonus payable

to Mr. Wuller pursuant to the Executive Incentive Business Unit Plan would be determined based on the following criteria,

which include both Company based performance metrics, business unit based performance metrics, and individual merit-

based achievement:


Metric	Percent of Bonus

Organic Revenue Growth	15%
Adjusted EBITDAC Margin	15%
Business Unit Organic Revenue Growth	20%
Business Unit Compensation and T&E Margin	20%
Individual Merit-Based Achievement	30%

The Organic Revenue Growth and the Adjusted EBITDAC Margin metrics and applicable targets are the same as described

above for the Executive Incentive Corporate Plan.


		2024 Proxy Statement 52
		2024 Proxy Statement 52

For the Business Unit Organic Revenue Growth metric, payment was based on the following scale:


Business Unit Revenue Growth	Target Payout %

<5%	0%
10-12%	100%
>16%	150%

Target payout percentage for Business Unit Organic Revenue Growth between the benchmarks set forth above was

determined based on a graduated basis. Business Unit Organic Revenue Growth is an organic revenue growth calculation

undertaken on the same basis as Consolidated Organic Revenue Growth but only for a select number of operating MGUs

and Programs.

For the Business Unit Compensation and T&E Margin metric, payment was based on the following scale:


Business Unit Compensation and T&E Margin	Target Payout %

>44.75%	0%
42.25-43.25%	100%
<42.25%	150%

Target payout percentage for Business Unit Compensation and T&E Margin between the benchmarks set forth above was

determined based on a graduated basis. Business Unit Compensation & T&E Margin is the Compensation and T&E of a

select number of operating MGUs and Programs divided by the revenue generated by those MGUs and Programs,

excluding revenue and expense from investments and acquisitions.

Individual Merit-Based Achievement is linked to an individual’s contribution towards (i) culture, (ii) results, (iii) client centricity,

(iv) teamwork, and (v) inclusion.

2024 Bonus Determination

Organic Revenue Growth for 2024 was 12.1%, resulting in an STI award of 101.7% of target. Adjusted EBITDAC Margin,

based on compensation amounts accrued throughout the year at target, was 31.5%, resulting in an STI award of 120.3% of

target. The Business Unit Organic Revenue Growth for 2024 was 13.7%, resulting in an STI award of 121.6% of target. The

Business Unit Compensation and T&E Margin was 43.24%, resulting in an STI award of 100% of target.

The Compensation and Governance Committee, in reviewing the Merit-Based Achievement component of each NEO’s STI

award, other than for Ms. Hamilton who was on a legacy plan in 2024, relied on input from Mr. Ryan for each NEO other

than Mr. Ryan. For the NEOs on the Executive Incentive Corporate Plan, which included Messrs. Ryan, Turner, Bickham,

Conklin, and Mulshine, the Compensation and Governance Committee determined that based on each NEO’s contribution

to the Company’s achievement, the Individual Merit-Based Achievement component of each such NEO’s STI award for 2024

would be 55.8% of target, with the primary contributing factor of such determination being that the Company did not achieve

the Organic Revenue Growth guidance that the Company provided in its quarterly earnings releases during 2024. As a

result, the total STI award for each of our NEOs on our Executive Incentive Corporate Plan for 2024 was approximately

94.4% of target.

Ms. Hamilton’s STI award for 2024 was determined by the Compensation and Governance Committee with input from Mr.

Ryan and was set at 94.4% of target.

For Mr. Wuller, who is on the Executive Incentive Business Unit Plan, the Compensation and Governance Committee

determined, based on input from Mr. Ryan, that based on the business unit’s contribution to the Company’s achievement,

the Individual Merit-Based Achievement component of Mr. Wuller’s STI award for 2024 would be 150.0% of target. As a

result, the total STI award for Mr. Wuller for 2024 was approximately 122.6% of target.


		2024 Proxy Statement 53
		2024 Proxy Statement 53

The following table sets forth the STI award payments earned by each of our NEOs in 2024.


Named Executive Officer	2024 Bonus Payment

Patrick G. Ryan	$2,597,237
Timothy W. Turner	2,266,679
Jeremiah R. Bickham	1,275,007
Janice M. Hamilton	850,005
Michael L. Conklin	793,338
Brendan M. Mulshine	970,437
Benjamin M. Wuller	1,839,399

2025 STI Compensation Plans and Bonus Target Percentages

The Compensation and Governance Committee increased the target bonus percentage for 2025 (that will be paid in 2026)

for Ms. Hamilton to 200% based on her new role as Chief Financial Officer. The target bonus percentages for all other NEOs

will remain the same as they were in 2024. For all NEOs, other than Mr. Wuller, STI compensation for 2025 will be

determined based on the Company achieving predetermined metrics for Organic Revenue Growth and Adjusted EBITDAC

Margin, as well as the Individual Merit-Based Achievement component as determined by the Compensation and

Governance Committee. Mr. Wuller’s STI compensation for 2025 will be determined based on the Company achieving

predetermined metrics for Organic Revenue Growth, Adjusted EBITDAC Margin, Business Unit Organic Revenue Growth,

Business Unit Profit Commission Revenue, and Business Unit Expense Margin, as well as the Individual Merit-Based

Achievement component as determined by the Compensation and Governance Committee.

Long-Term Incentive Compensation

All equity holdings in Ryan Specialty, LLC were converted to equity in a new holding company, New Ryan Specialty, LLC

(“New LLC ”), that was formed as a Delaware limited liability company on April 20, 2021, for the purpose of becoming an

intermediate holding company between Ryan Specialty Holdings, Inc., and Ryan Specialty, LLC. On September 30, 2021,

the equity interest holders of Ryan Specialty, LLC exchanged equity interests in Ryan Specialty, LLC for LLC Common Units

(as defined below) in New LLC. All new incentive equity relating to LLC Common Units granted after September 30, 2021,

will be issued in New LLC. As Ryan Specialty, LLC is substantively the same as New LLC, as previously noted, for the

purpose of this document we will refer to both New LLC and Ryan Specialty, LLC as the “LLC”.

Our publicly traded stock differentiates Ryan Specialty from most of our competition by providing us with a unique currency

to attract and retain talent. We believe that our executive officers, including our NEOs, should have a significant equity stake

in the Company to incentivize performance, align their interest with one another and our stockholders, and facilitate

retention. Many of our executive officers held significant equity in the Company prior to our IPO. Due to the change in our

structure made in connection with the IPO, all vested and unvested incentive equity outstanding prior to the IPO was

exchanged for new units at the IPO as described herein. The equity received in exchange for existing equity was on

substantially the same terms and conditions (including vesting terms) as the pre-IPO equity. We further used the IPO as an

opportunity to provide significant new “staking grants” to some of our executive officers in order to bring them on par with

their similarly situated colleagues. The staking grants vest over five or ten year periods, depending on the nature of the grant

and the particular circumstances of each recipient. As the current equity grants vest over time, we will need to consider ad

hoc grants and an annual grant program for executive officers in order to maintain our objectives. The outstanding LTI

awards currently held by our NEOs consist of (i) LLC Common Units (as defined below), (ii) Class C Units (as defined

below), (iii) RLUs and RSUs (each, as defined below), and (iv) PLUs and PSUs (each, as defined below).

Common Units

Prior to our IPO, some of our NEOs held awards of common units pursuant to the Limited Liability Company Agreement of

Ryan Specialty, LLC (the “Original Units”). The Original Units were profits interests that represented actual voting equity

interests meant to enable certain employees to share in our financial success after our preferred unitholders received a

certain level of return on their investment. The Original Units entitled unitholders to a percentage of future distributions, but

only after all preferred unitholders had received cumulative cash distributions of a certain multiple return and only to the

extent that distributions exceeded the return threshold associated with such Original Units.

The Original Units were subject to time-based vesting and generally vested in five equal annual installments beginning on

the first anniversary of the date of grant, subject to the NEO’s continued employment with us through each vesting date.


		2024 Proxy Statement 54
		2024 Proxy Statement 54

In connection with the IPO, the Original Units were converted into non-voting common units in the LLC (“LLC Common

Units”), subject to the same vesting and forfeiture provisions as the Original Units. Vested LLC Common Units are

exchangeable into Class A common stock at the election of the holder, provided that the Company may elect (determined by

a majority of the Company’s disinterested directors) to deliver cash in lieu of stock only to the extent that the Company has

received cash proceeds pursuant to a secondary offering. Each holder of LLC Common Units also holds one share of Class

B common stock for each LLC Common Unit they hold.

Class C Common Incentive Units

Certain of our NEOs hold Class C Common Incentive Units in the LLC (“Class C Units”), which are profits interests that

entitle the holder to a percentage of future distributions of the LLC, but only after a specified return threshold is met.

Certain of these Class C Units were granted in connection with the conversion of the Original Units into LLC Common Units

(such Class C Units, the “Reload Class C Units”) and were intended to ameliorate the recipients’ otherwise reduced

percentage of future value accretion following the conversion of their “appreciation only” Original Units into a smaller number

of “full value” LLC Common Units. The Reload Class C Units are subject to time-based vesting, and vest either 1/3 on each

of the third, fourth, and fifth anniversaries of the IPO or 100% on the third anniversary of the IPO, in each case subject to the

NEO’s continued employment through each vesting date (other than for those exceptions provided in the award agreement).

Other Class C Units were granted as new awards to certain NEOs in connection with the IPO (the “Staking Class C Units”)

and are intended to reward future performance. The Staking Class C Units are subject to time vesting and vest 10% on each

of the third through ninth anniversaries of the IPO, with the final 30% vesting on the tenth anniversary of the IPO, in each

case, subject to the NEO’s continued employment through each vesting date (other than for those exceptions provided in

the award agreement). In 2023, we granted a new award to Mr. Mulshine and Mr. Wuller (the “2023 Class C Units”) and

such award is intended to reward future performance. The 2023 Class C Units are subject to time vesting and vest 20% on

April 1, 2026, 2027, 2028, 2029 and 2030 in each case, subject to continued employment through each vesting date (other

than for those exceptions provided in the award agreement).

Vested Class C Units (Reload Class C Units, Staking Class C Units and 2023 Class C Units) are exchangeable into a

number of shares of Class A common stock of equivalent economic value at the election of the holder, provided that the

Company may elect (as determined by a majority of the Company’s disinterested directors) to deliver cash in lieu of stock

only to the extent that the Company has received cash proceeds pursuant to a secondary offering.

Restricted LLC Units and Restricted Stock Units

Awards of Restricted LLC Units (“RLUs”) were granted as new awards to certain NEOs in connection with the IPO (the

“Staking RLUs”) and are intended to reward future performance. The Staking RLUs are subject to time vesting and vest 10%

on each of the third through ninth anniversaries of the IPO, with the final 30% vesting on the tenth anniversary of the IPO, in

each case, subject to the NEO’s continued employment through each vesting date (other than for those exceptions provided

in the award agreement). In 2022, each of the NEOs, other than Messrs. Ryan and Conklin, received a grant of RLUs (the

“2022 RLUs”) in recognition of the exceptional performance achieved by the Company in 2021. Each 2022 RLU represents

the right to receive one LLC Common Unit upon vesting of the RLU. The 2022 RLUs vested in equal installments on April 1,

2023, 2024 and 2025, in each case subject to the NEO’s continued employment through each vesting date (other than for

those exceptions provided in the award agreement). In 2024, we granted an initial award of Restricted Stock Units in the

Company (“RSUs”) to Mr. Conklin (the “2024 RSUs”) and such award is intended to reward future performance. The 2024

RSUs vest in equal installments, with the first tranche vesting on April 1, 2025 and the remaining tranches vesting on April 1,

2026, 2027, 2028, and 2029, in each case, subject to Mr. Conklin’s continued employment through each vesting date (other

than for those exceptions provided in the award agreement).

Performance LLC Units and Performance Stock Units

In March 2024, each of the NEOs, other than Mr. Ryan and Ms. Hamilton, received a grant of long-term performance-based

awards which vest either into LLC Common Units (“PLUs”) or shares of Class A common stock (“PSUs”). Ms. Hamilton

received a grant of PSUs on the same terms in November 2024, shortly after her promotion to CFO. These awards are

intended to align the recipients’ compensation with Company performance and our key financial metrics, promoting

leadership goal continuity and retention, and driving shareholder value. Each PLU or PSU represents the right to receive

one LLC Common Unit or one share of Class A common stock upon vesting, respectively. The PLUs and PSUs vest on April

1, 2029 (the “Certification Date”) upon, and subject to, the attainment of certain performance-based targets and subject to

the NEO’s continued employment through January 1, 2029 (other than for those exceptions provided in the award

agreement). The performance-based metrics that must be met are the following: (i) achievement of an Adjusted EBITDAC

Margin Target by 2027 and maintained through 2028, (ii) achievement of a four-year Organic Revenue Growth Compound

Annual Growth Rate (“CAGR”) target from 2024 through 2027, and (iii) stock price CAGR targets measured from the closing

stock price on February 29, 2024 of the Class A common stock to the average of (a) the volume weighted average price

(“VWAP”) of the Class A common stock for the fourth quarter of 2027 and (b) the VWAP of the Class A common stock for the

first quarter of 2028. Both the Adjusted EBITDAC Margin and the Organic Revenue Growth CAGR targets must be met for


		2024 Proxy Statement 55
		2024 Proxy Statement 55

the awards to vest. The stock price CAGR targets will determine how many LLC Common Units the PLUs vest into and how

many shares of Class A common stock the PSUs vest into. If the Adjusted EBITDAC Margin and the Organic Revenue

Growth CAGR targets have been met, then at the threshold stock price CAGR, the PLUs and PSUs will vest into 75% of the

LLC Common Units or Class A common stock subject to the award; at the target stock price CAGR the PLUs and PSUs will

vest into 100% of the LLC Common Units or Class A common stock subject to the award; and at the Maximum stock price

CAGR, the PLUs and PSUs will vest into 150% of the LLC Common Units or Class A common stock subject to the award. If

the actual stock price CAGR is below the threshold amount, the PLUs and PSUs will be forfeited. Payout percentage based

on a stock price CAGR between the benchmarks discussed above will be determined based on a graduated basis.

Treatment of Long-Term Incentive Awards Upon a Termination of Employment

For LTI awards issued in conjunction with the IPO (LLC Common Units, Staking Class C Units, Reload Class C Units and

Staking RLUs), if an NEO’s employment is terminated (i) by us without “cause,” (ii) due to the NEO’s death or disability, or

(iii) the NEO retires in good standing (as determined by the Board) after reaching the age of 65 (a “Qualified Retirement”),

and, in each case, subject to the NEO’s continued compliance with the restrictive covenants set forth in the applicable grant

agreement, the unvested LLC Common Units and Class C Units held by the NEO will continue to vest as if the NEO

remained employed with us through each vesting date. Upon any other termination of employment, any unvested LLC

Common Units, Staking Class C Units, Reload Class C Units, and Staking RLUs will be forfeited.

For the RLUs or RSUs granted post-IPO, the award agreements provide that (i) in the event an NEO’s employment with us

is terminated by us without “Cause,” then the portion of RLUs or RSUs eligible to vest on the next vesting date following the

termination will immediately vest and (ii) in the event of an NEO's death or disability, vesting of all unvested RLUs or RSUs

will fully accelerate. The concept of a Qualified Retirement has been eliminated from the RLU and RSU grant agreements

and upon any other termination of employment, the RLUs and RSUs will be forfeited.

For the 2023 Class C Units, the award agreements provide that (i) in the event the NEO's employment with us is terminated

by us without “Cause,” then the portion of 2023 Class C Units eligible to vest on the next vesting date following the

termination will continue to vest as if the NEO remained employed with us through such next vesting date and (ii) in the

event of the NEO's death or disability, then all of the unvested 2023 Class C Units will continue to vest as if the NEO

remained employed with us through each vesting date. The concept of a Qualified Retirement has been eliminated from the

grant agreements for the 2023 Class C Units and upon any other termination of employment, any unvested 2023 Class C

Units will be forfeited.

For the PLUs or PSUs, the award agreements provide that (i) in the event an NEO’s employment with us is terminated by us

without “Cause,” then the PLUs or PSUs will remain outstanding and eligible to vest on the Certification Date in accordance

with the performance-based metrics described above, but the number of PLUs or PSUs earned will be pro-rated based on

the applicable date of termination and (ii) in the event of an NEO’s death or disability, a number of PLUs or PSUs equal to

the actual number of PLUs or PSUs earned as of the date of termination will vest in accordance with the performance

metrics described above generally based on actual performance (with the applicable performance period deemed to have

ended as of the date of termination, and the Adjusted EBITDAC Margin Targets deemed achieved as of the date of

termination).

Policies and Practices Related to the Grant of Certain Equity Awards Close in Time to

the Release of Material Nonpublic Information

The Company grants awards of stock options and Class C Units, which are profits interests that entitle the holder to a

percentage of future distributions of the LLC, but only after a specified return threshold is met. Despite the fact that the Class

C Units do not require the payment of an exercise price, they are most similar economically to stock options and are

generally categorized as an instrument with an “option-like feature.” While the Company does not have a written policy

regarding its equity grants, it is the Company’s practice to make grants no more than once per quarter and for each quarterly

grant of equity to be effective on the third business day following the announcement of earnings for that quarter or as soon

thereafter as is reasonably practicable under the circumstances.

Neither the Board nor the Compensation and Governance Committee seeks to time equity grants to take advantage of

information, either positive or negative, about our Company that has not been publicly disclosed. During the fiscal year

ended December 31, 2024, we did not award any stock options or Class C Units to our NEOs.

Stock Ownership Guidelines

The Board adopted stock ownership guidelines that apply to all of our executive officers. The guidelines require our Chief

Executive Officer to accumulate Company stock with a value equivalent to six times their annual base salary and all other

executive officers are required to accumulate Company stock with a value equivalent to four times their annual base salary,

all within five years of the adoption of the requirement or within five years of being appointed as an executive officer of the


		2024 Proxy Statement 56
		2024 Proxy Statement 56

Company. If an executive officer does not hold sufficient shares of the Company’s stock to meet the guideline requirements,

they will then be required to hold 100% of their current Company stock plus any future grants until they have met the

requirement.

The guidelines were adopted on June 7, 2022, such that each executive officer serving at that time has until June 7, 2027 to

meet the guidelines. For all other executive officers, the required compliance date is based on the date that such individual

became an executive officer of the Company.

Each of our executive officers’ respective compliance date is set forth in the table below:


Executive Officer	Stock Ownership Guidelines Compliance Date

Patrick G. Ryan	June 7, 2027
Timothy W. Turner	June 7, 2027
Jeremiah R. Bickham	June 7, 2027
Janice M. Hamilton	October 1, 2029
Michael L. Conklin	August 14, 2028
Mark S. Katz	June 7, 2027
Brendan M. Mulshine	June 7, 2027
Benjamin M. Wuller	October 30, 2029

Accordingly, all of our executive officers are currently in compliance with the guidelines.

Other Benefits for Named Executive Officers

Employee Welfare Benefit Plans

Our NEOs are eligible to participate in the medical, life insurance, and other welfare benefits available to all other

colleagues. There are no special medical plans or other welfare plans for our NEOs.

Retirement Benefits

We have not maintained, and do not currently maintain, a defined benefit pension plan. We currently make available a

retirement plan intended to provide benefits under Section 401(k) of the Internal Revenue Code, pursuant to which

employees (including our NEOs) may elect to defer a portion of their compensation on a pre-tax or post-tax basis and have it

contributed to the plan. Contributions are allocated to each participant’s individual account and are then invested in selected

investment alternatives according to the participant’s directions. We have historically matched 50% of elective deferrals up to

a maximum per participant per calendar year. All employee contributions to our 401(k) plan are 100% vested at all times.

Employer contributions vest over three years, such that all employer contributions to our 401(k) plan are fully vested for

employees who remain employed by us for at least three years. All contributions under our 401(k) plan are subject to certain

annual dollar limitations in accordance with applicable laws, which are periodically adjusted for changes in the cost of living.

Matching employer contributions are not guaranteed for any year.

We also sponsor the Ryan Specialty Nonqualified Deferred Compensation Plan (the “Nonqualified Deferred Compensation

Plan”), which allows certain highly compensated employees to defer a portion of their base salary and STI bonus to a later

date pursuant to an advance deferral election. As of December 31, 2024, none of our NEOs have participated in the

Nonqualified Deferred Compensation Plan.

Our LTI awards granted at the IPO provide for continued vesting on their original vesting schedule (or, in the case of RLUs

granted in connection with the IPO, accelerated vesting) in the case of a Qualified Retirement. See “Long-Term Incentive

Compensation — Treatment of Long-Term Incentive Upon a Termination of Employment” above for more information.


		2024 Proxy Statement 57
		2024 Proxy Statement 57

Severance Plan

The Compensation and Governance Committee believes that severance benefits are a necessary component of a

competitive compensation program because they minimize distraction and ensure continuity during times of uncertainty or

transition, including during a change in control. In certain circumstances, such benefits are consideration for an executive’s

agreement not to compete. Set forth below is a summary of the termination arrangements we have with our NEOs. All NEOs

are participants in the Executive Severance Plan (the “Severance Plan”) as further described below.

Under the Severance Plan, the Company will provide different benefits depending on whether the severance to be provided

relates to a qualifying termination within six months prior to, or 18 months following, a “Change in Control” (as defined in the

Severance Plan) (a “Change-in-Control Termination”) or a termination outside of such time period (a “Non-Change-in-Control

Termination”). For a qualifying termination, our NEOs will be entitled to the following benefits:


	Non-Change-in Control Termination	Change-in-Control Termination
Qualifying Termination	Termination without cause or by employee for good reason	Termination without cause or by employee for good reason
Cash Severance	Executive Chairman and CEO: 1.5 X Base Salary and Target Bonus All other NEOs: 1.0 X Base Salary and Target Bonus	All NEOs: 2.0 X Base Salary and Target Bonus
Pro-Rata Bonus in Year of Termination	Pro-rated and paid at the end of the period based on actual performance	Pro-rated and paid in a lump sum following the qualifying termination based on Target Bonus
Equity Award Acceleration	The treatment of unvested equity incentive awards is determined in accordance with the terms of the applicable award agreement	All unvested equity incentive awards that vest solely based on continued employment will accelerate and vest and the treatment of unvested PLUs and PSUs will be determined in accordance with the terms of the applicable award agreement
Benefits	Health and welfare benefits will be provided for: •18 Months for the Executive Chairman and CEO •12 Months for all other NEOs	Health and welfare benefits will be provided for: •24 Months for all NEOs
Restrictive Covenants	Post-employment non-compete and non-solicit for: •18 Months for the Executive Chairman and CEO •12 Months for all other NEOs	Post-employment non-compete and non- solicit for: •24 Months for all NEOs

For additional details on payments that may be due to our NEOs in certain termination scenarios, see “Compensation

Tables — Potential Payments to Named Executive Officers Upon Termination and/or Change of Control.”

Compensation Decision Process and Methodology

Role of the Compensation and Governance Committee

The Compensation and Governance Committee is responsible for evaluating the compensation levels for each of our NEOs

and for administering the Company’s executive compensation program. The Compensation and Governance Committee

reviews and approves all components of executive compensation for our NEOs, including our CEO. In addition, each year

the Compensation and Governance Committee reviews and approves the corporate goals and key objectives related to our

NEOs’ compensation, evaluates their performance in light of those goals and objectives, and determines and approves their

compensation, including for our CEO. Each year the Compensation and Governance Committee also reviews, among other

things, proxy season trends and stockholder feedback and the compensation risk assessment. The Compensation and


		2024 Proxy Statement 58
		2024 Proxy Statement 58

Governance Committee also reviews talent, culture, diversity, equity, and inclusion initiatives; as well as its charter and

annual calendar.

Compensation Risk Analysis

In reviewing the Company’s pay programs, the Compensation and Governance Committee considers whether the programs

encourage unnecessary or excessive risk taking that might have an adverse impact on the Company. At the request of the

committee, the Company’s independent compensation consultant, Frederic W. Cook & Co. (“FW Cook”), assisted the

committee in completing the annual compensation risk assessment of the Company’s compensation programs. The risk

assessment included a review of the design and features of the Company’s incentive compensation programs in place, as

well as an evaluation of program structure and philosophy, design characteristics, performance management, and

governance practices relative to compensation risk factors. The compensation risk assessment resulted in FW Cook and the

Compensation and Governance Committee agreeing that the Company’s compensation programs do not create risks that

are reasonably likely to have a material adverse effect on the Company.

Role of External Compensation and Governance Committee Consultant

The Compensation and Governance Committee has the independent authority to hire external consultants as well as the

sole authority to retain and terminate the services of its consultant. As noted, in 2024 the committee engaged FW Cook as

its independent consultant.

During the course of 2024, FW Cook worked directly under the guidance of the Compensation and Governance Committee,

in cooperation with management, to assist the committee with executing its executive compensation-related responsibilities.

In such role, the Compensation and Governance Committee’s consultant served as an objective third-party advisor in

assessing the reasonableness of compensation levels and the appropriateness of the design of the evolving compensation

program structure in supporting the current and future business strategy and human resource objectives. FW Cook attended

four of the five formal meetings of the Compensation and Governance Committee during 2024.

During 2024, FW Cook supported the Compensation and Governance Committee by assisting with the design and

administration of the Company’s executive compensation pay practices, including:

•reviewing and providing input on the peer group used to benchmark executive pay;

•assessing the market pay data used to inform 2024 pay decisions;

•providing input on the pay decisions for the Company’s executive officers, including pay mix and levels;

•reviewing and providing input on the Company’s STI and LTI plan designs;

•preparing the Company’s compensation risk assessment;

•reviewing and providing input on the Company’s compensation philosophy;

•providing a review and recommendation for non-employee director compensation; and

•keeping the Compensation and Governance Committee informed of changes in the regulatory or governance

environment for executive compensation issues.

The Compensation and Governance Committee was provided compensation market data and analysis from FW Cook. The

committee used that data and analysis to ensure that the compensation practices were consistent with the compensation

philosophy and objectives for both the amount and composition of executive compensation. Based on the data and analysis

provided by FW Cook, as well as information from management and outside counsel, the committee applied business

judgment in recommending and approving compensation awards, taking into account the dynamic nature of the businesses

and the adaptability and response required by senior leadership to manage change.

Other than serving as the consultant to the Compensation and Governance Committee, FW Cook provides no other services

to the Company. The committee determined that, based on the factors specified in the NYSE listing rules, FW Cook’s

services produced no conflicts of interest, and it is an independent advisor to the Compensation and Governance

Committee.

Role of our CEO and Management

Our CEO does not participate in the Compensation and Governance Committee’s determination of his own compensation.

He does, however, make recommendations to the committee for each of the other NEOs. The CEO bases these

recommendations on overall Company financial performance for the fiscal year as described above along with his informed

assessment of each NEO’s individual performance and contributions. The Compensation and Governance Committee


		2024 Proxy Statement 59
		2024 Proxy Statement 59

reviews and considers the CEO’s recommendations, makes adjustments, if any, as it determines appropriate, and approves

compensation in its sole discretion.

Use of Peer Company Data

In making its determinations for fiscal year 2024, the Compensation and Governance Committee considered publicly

available information of a select group of peer companies as well as survey data from the Company’s compensation surveys

to inform the pay levels and structures for the Company’s executives. All compensation data used was supported by FW

Cook as the Compensation and Governance Committee’s independent compensation consultant.

The peer group was selected by the Compensation and Governance Committee, in consultation with FW Cook and input

from management, on the comparability of the business operations of potential peer group companies, including reasonably

comparable size (based on revenue and market capitalization) and industry. Information about the peer group companies

was used to inform decisions regarding pay levels and mix and program design.

For conducting a competitive assessment of the compensation levels for the Company’s executives for fiscal year 2024, the

Compensation and Governance Committee approved the below peer group of 16 companies. The companies are the same

as the prior year peer group list.


•Aon PLC •Argo Group International Holdings, Ltd. •Arthur J. Gallagher & Co. •AXIS Capital Holdings Limited •Brown & Brown, Inc. •BRP Group, Inc. •CBIZ, Inc. •Crawford & Co.	•Erie Indemnity Company •Goosehead Insurance, Inc. •Hanover Insurance Group, Inc. •Marsh & McLennan Companies, Inc. •Primerica, Inc. •RLI Corp. •Selective Insurance Group, Inc. •Willis Towers Watson PLC


		2024 Proxy Statement 61
		2024 Proxy Statement 61

EXECUTIVE COMPENSATION:

COMPENSATION TABLES AND DISCLOSURE

Summary Compensation Table

The following table sets forth the total compensation earned for services rendered in 2024 by Patrick G. Ryan (former CEO),

Timothy W. Turner (CEO), Jeremiah R. Bickham (former CFO), Janice M. Hamilton (CFO), and the Company’s three other

most highly compensated executive officers, collectively our NEOs, for the fiscal year ended December 31, 2024.


Name and Principal Position(1)	Year	Salary ($)	Bonus ($)(2)	Stock Awards ($)(3)	Option Awards ($)	Non-Equity Incentive Plan Compen- sation ($)(4)	All Other Compen- sation ($)(5)	Total ($)

Patrick G. Ryan	2024	1,375,000	—	—	—	2,597,237	13,014	3,985,251
Founder and Executive Chairman of the Board	2023	1,375,000	—	—	—	2,870,450	11,250	4,256,700
Founder and Executive Chairman of the Board	2022	1,375,000	—	—	—	3,093,745	10,250	4,478,995
Timothy W. Turner	2024	1,200,000	—	2,470,256	—	2,266,679	11,500	5,948,435
Chief Executive Officer	2023	1,200,000	194,880	—	—	2,505,120	47,529	3,947,529
Chief Executive Officer	2022	1,200,000	—	729,620	—	2,699,996	68,836	4,698,452
Jeremiah R. Bickham	2024	649,045	—	2,349,097	—	1,275,007	12,940	4,286,089
President	2023	600,019	85,550	—	—	939,450	11,250	1,636,269
President	2022	600,019	—	191,501	—	1,012,531	10,250	1,814,301
Janice M. Hamilton	2024	429,845	850,005	2,756,259	—	—	12,940	4,698,451
Chief Financial Officer
Chief Financial Officer
Michael L. Conklin	2024	560,000	—	2,626,396	—	793,338	12,940	3,992,674
EVP and Chief Human Resources Officer
EVP and Chief Human Resources Officer
Brendan M. Mulshine	2024	685,011	—	926,346	—	970,437	13,174	2,594,968
EVP and Chief Revenue Officer	2023	673,472	—	—	1,499,997	1,072,522	51,398	3,297,389
	2022	625,010	—	128,248	—	1,054,703	61,781	1,869,742
Benjamin M. Wuller	2024	725,962	—	2,349,097	—	1,839,399	12,940	4,927,398
CEO Ryan Specialty Underwriting Managers
CEO Ryan Specialty Underwriting Managers

(1)On October 1, 2024, Patrick G. Ryan, our Founder and our CEO since our inception, became our Executive Chairman and therefore

was a former CEO during the 2024 reporting period. Jeremiah R. Bickham, our CFO since our IPO in 2021, became our President

and therefore was a former CFO during the 2024 reporting period. Ms. Hamilton and Messrs. Conklin and Wuller were not NEOs prior

to 2024.

(2)The amount reported in this column for 2024 for Ms. Hamilton is for her discretionary bonus awarded by the Compensation and

Governance Committee. She will commence participation in the Executive Incentive Corporate STI Plan in 2025.

(3)Other than for Mr. Conklin, the amounts reported in this column for 2024 represent the aggregate grant date fair value of the PLUs or

PSUs calculated in accordance with Financial Accounting Standards Board ASC Topic 718. The estimated fair value of each grant of

PLUs or PSUs is established on the date of grant using a Monte Carlo simulation model in a manner that is consistent with generally

accepted valuation principles. The value ultimately realized by the executive upon the actual vesting of the award may or may not be

equal to the FASB ASC Topic 718 determined value. For Mr. Conklin, the amounts reported in this column represent the aggregate

grant date fair value of the 2024 RSUs ($1,999,973) and the aggregate grant date fair value of the PSUs ($629,423) each as

calculated in accordance with Financial Accounting Standards Board ASC Topic 718. The assumptions used in calculating the grant

date fair value reported for the respective PLUs, PSUs, or RSUs in this column are set forth in Note 11 to the consolidated financial

statements included in our Annual Report on Form 10-K for the year ended December 31, 2024. The value of the PSUs or PLUs on

the grant date, assuming achievement of the maximum performance level of 150% would be: Mr. Turner - $3,705,384; Mr. Bickham -

$3,523,633; Ms. Hamilton - $4,134,410; Mr. Conklin - $939,634; Mr. Mulshine - $1,389,531; and Mr. Wuller - $3,523,633.


		2024 Proxy Statement 62
		2024 Proxy Statement 62

(4)The amounts reported in this column for 2024 reflect the short-term incentive bonus for each NEO, other than Ms. Hamilton,

determined pursuant to the performance metrics set by the Compensation and Governance Committee. See “Compensation

Discussion and Analysis — Our Executive Compensation Program in Detail — Our Pay Philosophy — Short-Term Incentive

Compensation” for additional information. Bonuses were paid in early 2025.

(5)Amounts reported in this column for “All Other Compensation” in 2024 include, for (i) Mr. Ryan, Company contributions under our

401(k) plan of $12,476 and the incremental cost to the Company of personal travel expenses of $538, (ii) Mr. Turner, Company

contributions under our 401(k) plan of $11,500, (iii) Mr. Bickham, Company contributions under our 401(k) plan of $12,940, (iv) Ms.

Hamilton, Company contributions under our 401(k) plan of $12,940, (v) Mr. Conklin, Company contributions under our 401(k) plan of

$12,940, (vi) Mr. Mulshine, Company contributions under our 401(k) plan of $12,636 and the incremental cost to the Company of

personal travel expenses of $538, and (vii) Mr. Wuller, Company contributions under our 401(k) plan of $12,940. On occasion, guests

of Mr. Ryan and Mr. Turner also may accompany them, at no incremental cost to the Company, on chartered aircraft used for

business purposes.

Grants of Plan-Based Awards

The following table sets forth the grants of plan-based awards made to our NEOs during 2024.


		Estimated Future Payouts Under Non-Equity Incentive Plan Awards(1)			Estimated Future Payouts Under Equity Incentive Plan Awards(2)			All Other Stock Awards: Number of Shares of Stock or Units (#)(3)	Grant Date Fair Value of Stock and Option Awards ($)(4)
Name	Grant Date	Threshold ($)	Target ($)	Maximum ($)	Threshold (#)	Target (#)	Maximum (#)		Grant Date Fair Value of Stock and Option Awards ($)(4)

Patrick G. Ryan	2/23/2024	—	2,750,000	4,125,000
Timothy W. Turner	2/23/2024	—	2,400,000	3,600,000
	3/1/2024				75,930	101,240	151,860		2,470,256
Jeremiah R. Bickham	2/23/2024	—	1,350,000	2,025,000
	3/1/2024				71,185	94,913	142,369		2,349,097
Janice M. Hamilton	11/4/2024				47,456	63,275	94,913		2,756,259
Michael L. Conklin	2/23/2024	—	840,000	1,260,000
	3/1/2024				18,983	25,310	37,965		629,423
	3/15/2024							38,182	1,999,973
Brendan M. Mulshine	2/23/2024	—	1,027,517	1,541,276
	3/1/2024				28,474	37,965	56,948		923,346
Benjamin M. Wuller	2/23/2024	—	1,500,000	2,250,000
	3/1/2024				71,185	94,913	142,369		2,349,097

(1)Represents the short-term incentive bonus for 2024 for each NEO, other than Ms. Hamilton whose bonus for 2024 was discretionary.

There is no threshold value associated with these short-term bonuses. See the column captioned “Non-Equity Incentive Plan

Compensation” in the Summary Compensation Table for actual payout amounts in the 2024 fiscal year.

(2)Amounts represent grants of PSUs or PLUs made in 2024. These awards cliff vest on April 1, 2029 if the performance criteria are

met. See “Compensation Discussion and Analysis — Our Executive Compensation Program in Detail — Our Pay Philosophy —

Long-Term Incentive Compensation” for our discussion on the PLUs and PSUs.

(3)Each RSU vests into an equivalent number of shares of Class A common stock. The award vests in equal installments on each of

April 1, 2025, 2026, 2027, 2028, and 2029, subject to continuous service through each vesting date other than for those exceptions

provided in the award agreement.

(4)Amounts in this column represent the aggregate grant date fair value of the respective PLUs, PSUs, or RSUs calculated in

accordance with Financial Accounting Standards Board ASC Topic 718. The assumptions used in calculating the grant date fair value

reported for the respective PLUs, PSUs, or RSUs in this column are set forth in Note 11 to the consolidated financial statements

included in our Annual Report on Form 10-K for the year ended December 31, 2024.


		2024 Proxy Statement 63
		2024 Proxy Statement 63

Outstanding Equity Awards at Fiscal Year-End

The following table sets forth the options and share-based awards held by our NEOs as of December 31, 2024.


		Option Awards				Stock Awards
Name	Grant Date	Number of Securities Underlying Unexercised Options (#) Exercisable	Number of Securities Underlying Unexercised Options (#) Unexercisable	Option Exercise Price ($)(1)	Option Expiration Date	Number of Shares or Units of Stock That Have Not Vested (#)	Market Value of Shares or Units of Stock That Have Not Vested ($)(2)	Equity Incentive Plan Awards: Number of Shares, Units or Other Rights That Have Not Vested (#)	Equity Incentive Plan Awards: Market or Payout Value of Unearned Shares, Units or Other Rights That Have Not Vested ($)

Patrick G. Ryan	—
Timothy W. Turner	7/22/2021(3)	387,942		23.34	n/a
	3/18/2022(4)					6,978	447,708
	3/1/2024(5)							151,860	9,743,338
Jeremiah R. Bickham	7/22/2021(6)	66,666	600,001	23.34	n/a
	7/22/2021(7)	8,004	16,010	23.34	n/a
	3/18/2022(4)					1,831	117,477
	3/1/2024(5)							142,369	9,134,395
Janice M. Hamilton	7/22/2021(8)					52,389	3,361,278
	7/22/2021(7)	9,439	18,879	23.34	n/a
	3/18/2022(4)					458	29,385
	11/4/2024(5)							94,913	6,089,618
Michael L. Conklin	3/1/2024(5)							37,965	2,435,834
	3/15/2024(9)					38,182	2,449,757
Brendan M. Mulshine	7/22/2021(7)	18,956	37,912	23.34	n/a
	3/18/2022(4)					1,226	78,660
	3/3/2023(10)		65,274	40.74	n/a
	3/1/2024(5)							56,948	3,653,784
Benjamin M. Wuller	7/22/2021(3)	64,945		23.34	n/a
	3/18/2022(4)					2,726	174,900
	3/3/2023(10)		65,274	40.74	n/a
	3/1/2024(5)							142,369	9,134,395

(1)Represents the return threshold applicable to the Class C Units. The Class C Units’ return threshold is used to determine the value of

such units and, by extension, the number of shares of Class A Common Stock into which such units may be converted. The current

return threshold is based on the return threshold when issued, which, pursuant to the terms of the operating agreement of the LLC, is

reduced on a 1-for-1 basis for each distribution from the LLC with respect to its common units. As of December 31, 2024, the LLC has

made four distributions for a total amount of $0.16 per unit with respect to its common units since each of the applicable Class C Units

were issued.

(2)Amounts in this column were calculated by multiplying the number of units that have not vested by the closing price of the Company’s

Class A common stock of $64.16 as reported on the NYSE on December 31, 2024.

(3)Represents fully vested Reload Class C Units in the LLC granted in connection with the conversion of Original Units into LLC

Common Units.

(4)Represents an award of RLUs granted in March 2022. Each RLU represents the right to receive one LLC Common Unit. The RLUs

vested on April 1, 2025.

(5)Represents the grant of PSUs or PLUs which vest on April 1, 2029, the date that the Compensation and Governance Committee

ratifies the satisfaction of the performance metrics for the performance periods ending December 31, 2027 and December 31, 2028,

subject to continued employment through January 1, 2029. The number reflects the maximum number of PSUs or PLUs that may

vest if the maximum level of performance is achieved and the dollar value reflects such maximum number of PLUs or PSUs multiplied

by the closing price of the Company’s Class A common stock of $64.16 as reported on the NYSE on December 31, 2024.

(6)Represents Staking Class C Units in the LLC. These Staking Class C Units vest 10% on each July 22, 2024 through July 22, 2030

and 30% on July 22, 2031, in each case, subject to continuous service through each vesting date other than for those exceptions

provided in the award agreement.


		2024 Proxy Statement 64
		2024 Proxy Statement 64

(7)Represents Reload Class C Units in the LLC granted in connection with the conversion of Original Units into LLC Common Units.

These Reload Class C Units vested or vest equally on each of July 22, 2024, 2025, and 2026, in each case, subject to continuous

service through each vesting date other than for those exceptions provided in the award agreement.

(8)Represents Staking RLUs in the LLC. 5,821 Staking RLUs vest on each July 22, 2025 through July 22, 2030 and 17,463 Staking

RLUs vest on July 22, 2031, in each case, subject to continuous service through each vesting date other than for those exceptions

provided in the award agreement.

(9)Represents RSUs granted to Mr. Conklin on March 15, 2024. Each RSU represents the right to receive one share of Class A

Common Stock. The RSUs vest in equal annual installments on April 1, 2025 through April 1, 2029, in each case, subject to

continuous service through each vesting date other than for those exceptions provided in the award agreement.

(10)Represents Class C Units in the LLC granted on March 3, 2023. These Class C Units vest in equal annual installments on April 1,

2026 through April 1, 2030, in each case, subject to continuous service through each vesting date other than for those exceptions

provided in the award agreement.

Option Exercises and Shares Vested

The following table sets forth the vesting of RLUs held by our NEOs during 2024.


	Share-Based Awards
Name	Number of Shares Acquired on Vesting (#)	Value Realized On Vesting ($)

Patrick G. Ryan	—	—
Timothy W. Turner(1)	6,979	387,335
Jeremiah R. Bickham(1)	1,832	101,676
Janice M. Hamilton(2)	6,279	358,788
Michael L. Conklin	—	—
Brendan M. Mulshine(1)	1,227	68,099
Benjamin M. Wuller(1)	2,726	151,293

(1)Number of Shares Acquired on Vesting represent the number of shares of the 2022 RLUs that vested on April 1, 2024. The Value

Realized on Vesting equals the closing price of the Company’s Class A common stock as reported on the NYSE on the trading day

immediately prior to the vesting date, or $55.50 on March 28, 2024, multiplied by the number of RLUs vested.

(2)Number of Shares Acquired on Vesting represent (i) 458 shares of the 2022 RLUs that vested on April 1, 2024 and (ii) 5,821 shares of

the Staking RLUs that vested on July 22, 2024. The Value Realized on Vesting equals the closing price of the Company’s Class A

common stock as reported on the NYSE on the trading day immediately prior to the vesting date, or (i) $55.50 on March 28, 2024 and

(ii) $57.27 on July 21, 2024, respectively, multiplied by the number of RLUs vested.

Narrative Disclosure to Summary Compensation Table and Grants of Plan-Based

Awards Table

Named Executive Officer Employment Agreements

Agreement with Timothy W. Turner

In January 2010, we entered into an employment agreement with Mr. Turner. The agreement provided for an initial five-year

term that automatically renews for successive five-year periods until terminated by either party at least 30 days prior to a

renewal date. The agreement provides Mr. Turner with an annual base salary of $800,000 or such higher amount as

determined by the Board, and eligibility to earn an annual target bonus of $700,000. Mr. Turner’s employment agreement

also provides for a car allowance and condominium allowance, in each case, of $2,000 per month. In the third quarter of

2023, Mr. Turner voluntarily agreed to forfeit his entitlement to the car and housing allowances.

Under the terms of Mr. Turner’s employment agreement, in the event that his employment with us is terminated by us

without “cause,” he will be entitled to receive, subject to his execution and non-revocation of a release of claims in favor of

the Company, continued payment of his base salary through the end of the then-current five-year term. In addition, if Mr.

Turner’s employment is terminated by us without “Cause” or due to his death or disability and the applicable performance

metrics are achieved, Mr. Turner will be entitled to receive a prorated portion of his annual bonus, with 50% of the estimated


		2024 Proxy Statement 65
		2024 Proxy Statement 65

amount of such prorated bonus to be paid on July 31 of the year it is earned and the remaining portion paid on January 31 of

the following year.

Under the Company’s Severance Plan, Mr. Turner would be entitled to payments in excess of those set forth in his

employment agreement under certain circumstances. See “— Termination Benefits” below.

Termination Benefits

Each of our NEOs is entitled to certain payments and benefits upon a termination of employment under certain

circumstances. Under the Severance Plan, severance payments and benefits are payable upon a termination without

“Cause” or for “Good Reason,” and such payments and benefits are enhanced if such termination occurs within six months

prior to, or 18 months following, a “Change in Control” (such period, the “Change in Control Period”). Under the terms of the

award agreements evidencing the NEOs’ LTI awards issued prior to or in conjunction with our IPO (LLC Common Units,

Stacking Class C Units, Reload Class C Units and Staking RLUs), the NEOs are eligible for continued vesting of all of the

unvested units in the event their employment with us is terminated (i) by us without “Cause,” (ii) due to death or disability, or

(iii) upon a Qualified Retirement. Under the terms of the award agreements evidencing the NEOs’ LTI awards issued after

our IPO (2022 RLUs, RSUs, and 2023 Class C Units), the NEOs are eligible for continued vesting (for the Class C Units) or

acceleration (for the 2022 RLUs and RSUs) of (a) the next tranche of unvested 2023 Class C Units, 2022 RLUs, or RSUs,

respectively, in the event their employment is terminated by us without “Cause,” or (b) all unvested 2023 Class C Units, 2022

RLUs, or RSUs, respectively, in the event their employment with us is terminated due to death or disability. Under the terms

of the award agreements evidencing the NEOs’ LTI awards issued after our IPO (PSUs and PLUs), the NEOs are eligible for

(i) continued vesting of all of the unvested shares or units in the event their employment with us is terminated by us without

“Cause” or (ii) acceleration for all of the unvested shares or units in the event their employment is terminated due to death or

disability. See “Long-Term Incentive Compensation — Treatment of Long-Term Incentive Upon a Termination of

Employment” above for more information.

Under the Severance Plan, in the event of a termination without “Cause” or for “Good Reason” during the Change in Control

Period, all unvested equity incentive awards that vest solely based on the NEO’s continued employment will fully accelerate

and vest as of the date of such termination. For further details regarding these payments and benefits, see “— Potential

Payments to Named Executive Officers Upon Termination and/or Change of Control” below.

For purposes of the Severance Plan and the equity award agreements, “Cause” generally means, subject to notice and cure

periods, any of the following: (a) any act or omission which constitutes a breach by the NEO of the terms of their

employment agreement with the Company or any of its affiliates (the “Company Group”) that adversely impacts the business

or reputation of the Company Group, (b) the NEO’s conviction of a felony or commission of any act that would rise to the

level of a felony, (c) the NEO’s conviction or commission of a lesser crime or offense that adversely impacts or potentially

could impact the business or reputation of the Company Group in a material way, (d) the NEO’s failure to meet the expected

standard of performance as communicated by such NEO’s supervisor, (e) the NEO’s violation of specific lawful directives of

the Company, (f) the NEO’s commission of a dishonest or wrongful act involving fraud, misrepresentation, or moral turpitude

causing damage or potential damage to any member of the Company Group, (g) the NEO’s failure to perform a substantial

part of his or her duties, or (h) the NEO’s breach of fiduciary duty.

For purposes of the Severance Plan and the equity award agreements, “Good Reason” generally means, subject to notice

and cure periods, any of the following: (a) a reduction by more than 10% in the NEO’s base salary, other than a general

reduction in base salary that affects all similarly situated employees, or failure to pay the NEO’s compensation payable

under their employment agreement, or a material reduction in benefits payable under their employment agreement or any

amounts otherwise vested and/or due under the Company’s employee benefit plans or employee benefit programs, (b) a

reduction by more than 10% in the NEO’s target bonus opportunity, (c) during the Change in Control Period, the reduction of

the NEO’s duties or responsibilities that are inconsistent in a material and adverse respect with the NEO’s position with the

Company, or (d) if the NEO is required to report regularly to an office or primary work location, the relocation of the NEO’s

office or primary work location more than 50 miles from the current location.

For purposes of the Severance Plan and the equity award agreements, a “Change in Control” generally means the

occurrence of any of the following: (a) any “person” (as defined in the Exchange Act) becoming the “beneficial owner” (as

defined in the Exchange Act), directly or indirectly, of securities of the Company representing 50% or more of the combined

voting power of the Company’s then outstanding voting securities (other than pursuant to a transaction that would not be a

Change in Control pursuant to the following clause (b)), (b) a merger or consolidation of the Company or a subsidiary with

any other entity, other than (i) a merger or consolidation which would result in the voting securities of the Company

outstanding immediately prior thereto continuing to represent (either by remaining outstanding or by being converted into

voting securities of the surviving entity) more than 50% of the combined voting power of the voting securities of the

Company or such surviving entity or its ultimate parent company outstanding immediately after such merger or consolidation

in substantially the same proportions as prior to such merger or consolidation or (ii) a merger or consolidation effected to

implement a recapitalization of the Company (or similar transaction) in which no person acquires more than 50% of the

combined voting power of the Company’s then outstanding securities, (c) at any time, incumbent directors cease to

constitute a majority of the Company’s Board (with any member of the Board being considered an incumbent director if his

or her election or nomination for election to the Board is approved by a majority of the incumbent directors), or (d) a


		2024 Proxy Statement 66
		2024 Proxy Statement 66

complete liquidation or dissolution of the Company or the consummation of a sale or disposition by the Company of all or

substantially all of the Company’s assets (in one or a series of related transactions), other than to a person or persons who

beneficially own, directly or indirectly, 50% or more of the combined voting power of the outstanding voting securities of the

Company at the time of the sale. A Change in Control will not be deemed to have occurred if Onex or one of its affiliates

directly or indirectly controls the Company.

Potential Payments to Named Executive Officers Upon Termination and/or Change in

Control

The below table reflects the severance benefits that Messrs. Ryan, Turner, Bickham, Conklin, Mulshine, and Wuller and Ms.

Hamilton would have received under the Severance Plan and LTI award agreements as in effect as of December 31, 2024.


Name	Involuntary Termination(5)	Involuntary Termination — Change in Control(6)	Termination due to Death, Disability or Qualified Retirement(7)	Voluntary Resignation

Patrick G. Ryan
Cash Severance(1)	$6,187,500	$8,250,000	$—	$—
Pro-Rata Bonus(2)	2,597,237	2,750,000	—	—
Benefits Continuation(3)	—	—	—	—
Equity Acceleration(4)	—	—	—	—
Total:	8,784,737	11,000,000	—	—
Timothy W. Turner
Cash Severance(1)	5,400,000	7,200,000	—	—
Pro-Rata Bonus(2)	2,266,679	2,400,000	—	—
Benefits Continuation(3)	47,535	63,380	—	—
Equity Acceleration(4)	447,708	10,191,046	10,191,046	—
Total:	8,161,922	19,854,426	10,191,046	—
Jeremiah R. Bickham
Cash Severance(1)	2,025,000	4,050,000	—	—
Pro-Rata Bonus(2)	1,275,007	1,350,000	—	—
Benefits Continuation(3)	13,639	18,185	—	—
Equity Acceleration(4)	117,477	35,857,451	9,251,936	—
Total:	3,431,123	41,275,636	9,251,936	—
Janice M. Hamilton
Cash Severance(1)	1,500,000	3,000,000	—	—
Pro-Rata Bonus(2)	850,005	900,000	—	—
Benefits Continuation(3)	13,639	18,185	—	—
Equity Acceleration(4)	3,390,664	10,295,666	9,480,282	—
Total:	5,754,308	14,213,851	9,480,282	—
Michael L. Conklin
Cash Severance(1)	1,400,000	2,800,000	—	—
Pro-Rata Bonus(2)	793,338	840,000	—	—
Benefits Continuation(3)	27,679	55,358	—	—
Equity Acceleration(4)	489,990	4,885,592	4,885,592	—
Total:	2,711,007	8,580,950	4,885,592	—


		2024 Proxy Statement 67
		2024 Proxy Statement 67


Name	Involuntary Termination(5)	Involuntary Termination — Change in Control(6)	Termination due to Death, Disability or Qualified Retirement(7)	Voluntary Resignation

Brendan M. Mulshine
Cash Severance(1)	1,712,527	3,425,054	—	—
Pro-Rata Bonus(2)	970,437	1,027,516	—	—
Benefits Continuation(3)	31,690	63,380	—	—
Equity Acceleration(4)	78,660	7,053,280	3,732,444	—
Total:	2,793,314	11,569,230	3,732,444	—
Benjamin M. Wuller
Cash Severance(1)	2,250,000	4,500,000	—	—
Pro-Rata Bonus(2)	1,839,399	1,500,000	—	—
Benefits Continuation(3)	32,788	43,717	—	—
Equity Acceleration(4)	174,900	10,992,776	9,309,359	—
Total:	4,297,087	17,036,493	9,309,359	—

(1)Represents cash severance payable under our Severance Plan. See “Compensation Discussion and Analysis — Severance Plan” for

more information.

(2)Represents the pro-rata bonus payment under the Severance Plan. Because the termination is assumed to have occurred on

December 31, 2024 for purposes of this disclosure, amounts are pro-rated at 100%. For a termination that occurs outside of the

Change in Control Period, the amount represents the annual bonus based on actual achievement. For a termination that occurs

during the Change in Control Period, the amount represents the annual bonus based on target performance.

(3)Represents benefits continuation payments under the Severance Plan. Mr. Ryan does not receive benefits through any health, dental,

or vision plan of the Company.

(4)Represents the value of equity awards held by our NEOs as of December 31, 2024, that are subject to accelerated vesting pursuant

to the applicable award agreements or the Severance Plan, as applicable. The value of RSUs and RLUs is based upon the closing

price of the Company’s Class A common stock of $64.16 as reported on the NYSE on December 31, 2024. The value of the Class C

Units is based on an exchange value of $66.53, which is the volume weighted average trading price of the Class A common stock for

the 20 trading days preceding December 31, 2024. The value of PSUs and PLUs is determined by calculating the number of shares

or units to be issued based on the achievement of the performance metrics through the date of termination and then multiplied by the

closing price of the Company’s Class A common stock of $64.16 as reported on the NYSE on December 31, 2024. Pursuant to the

applicable award agreements for LTI awards granted during or prior to 2024, (i) upon a termination without “Cause,” due to death or

disability, or as a result of a Qualified Retirement(a) LLC Common Units, Staking Class C Units, and Reload Class C Units will remain

outstanding and continue to vest pursuant to their original vesting schedule and (b) Staking RLUs will will accelerate, (ii) upon a

termination without “Cause,” (A) the next tranche of the 2022 RLUs and RSUs will accelerate and the remaining tranches will be

forfeited, (B) the next tranche of the 2023 Class C Units will continue to vest and the remaining tranches will be forfeited, and (C) the

PLUs or PSUs will remain outstanding and eligible to vest on the Certification Date in accordance with the performance-based

metrics, but the number of PLUs or PSUs earned will be pro-rated based on the applicable date of termination, (iii) upon a termination

due to death or disability, unvested 2022 RLUs, RSUs, PLUs, and PSUs will accelerate and vest in full and unvested 2023 Class C

Units will continue to vest in full. Other than during the Change in Control Period, “Good Reason” does not apply to the LLC Common

Units, Class C Units, or RLUs. Pursuant to the Severance Plan, upon a termination without “Cause” or resignation by the Named

Executive Officer for “Good Reason” during the Change in Control Period, all outstanding equity awards will fully vest. Where equity

awards would remain outstanding and continue to vest pursuant to their original vesting schedule, no amounts are shown. See

“Compensation Discussion and Analysis — Our Executive Compensation Program in Detail — Our Pay Philosophy — Long Term

Incentive Compensation” for more information.

(5)Represents amounts payable upon a termination by us without “Cause” or, for purposes of cash severance and benefits continuation

under the Severance Plan only, upon a resignation by the NEO for “Good Reason,” in each case, other than during the Change in

Control Period. Amounts in the “Equity Acceleration” row of this column represent amounts payable on a termination without “Cause”

only.

(6)Represents amounts and benefits payable pursuant to the Severance Plan upon a termination by us without “Cause” or upon a

resignation by the Named Executive Officer for “Good Reason,” in each case, during the Change in Control Period.

(7)Represents amounts payable upon a termination due to death, disability, or a Qualified Retirement. As of December 31, 2024, only

Mr. Ryan was eligible for a Qualified Retirement.

CEO Pay Ratio

Under the SEC rules adopted pursuant to the Dodd-Frank Act of 2010, the Company is required to calculate and disclose

the total compensation paid to its median paid employee, as well as the ratio of the total compensation paid to the median


		2024 Proxy Statement 68
		2024 Proxy Statement 68

employee as compared to the total compensation paid to Mr. Turner, the Company’s CEO as of the date the median

employee was selected.

We calculated our median employee’s fiscal year 2024 total compensation in accordance with the requirements of Item

402(c)(2)(x) of Regulation S-K, the same way we calculated the total compensation of our CEO as disclosed in our

Summary Compensation Table. Using this methodology, we determined that our median employee’s fiscal year 2024 total

compensation was $90,828. Based on this information, we estimate that for 2024 our CEO’s annual total compensation was

approximately 65 times that of the median employee’s total compensation.

Although the calculation of the ratio should be considered an estimate, we believe the ratio is a reasonable estimate

calculated in a manner consistent with SEC rules (Item 402(u) of Regulation S-K). We caution stockholders and other

readers against comparing our ratio to those of other companies. The SEC has stated that it did not believe a purpose of the

pay ratio rule was to facilitate comparisons among companies and, in adopting the rule, the SEC stated its belief that

comparability of the ratio across registrants has significant limits due to the variety of factors that could influence the ratio.

The discussion below describes our methodology for how we determined our median employee for 2024.

Determining Our Median Employee

To identify the median employee in 2024, we used our global population of regular and temporary employees, as of

December 31, 2024, comprising approximately 5,250 employees. We did not exclude any employees.

We did not annualize or otherwise adjust compensation for temporary employees and did not make any full-time

adjustments for anyone. Additionally, we made no cost-of-living adjustments in our calculations. For our U.S. employee

population, we collected 2024 W-2 data from our payroll system, whether employed on a full-time, part-time, or temporary

basis. For our international employee population, we collected comparable paid income data from our payroll system in local

currency, whether employed on a full-time, part-time, or temporary basis and then converted such amounts to U.S. dollars

based upon the exchange rate published by Bloomberg for December 31, 2024. We then compiled both the U.S. and the

international payroll information and used this data as our consistently applied compensation measure.

We then determined the 10 median employees based on the W-2 and international data that we collected. From that group,

we removed anyone who was no longer currently employed by the Company and selected as our median employee a

reasonably representative colleague who had relatively consistent employment and total compensation history.

Pay Versus Performance

The following table sets forth information concerning the compensation of our Principal Executive Officers (“PEOs”) and

other NEOs (“Non-PEO NEOs”) for each of the fiscal years ending December 31, 2024, 2023, 2022 and 2021 and our

financial performance for each such fiscal year:


							Value of Initial Fixed $100 Investment Based On:
Year(1)	Summary Compen- sation Table Total for PEO Ryan ($)(2)	Compen- sation Actually Paid to PEO Ryan ($)(3)	Summary Compen- sation Table Total for PEO Turner ($)(4)	Compen- sation Actually Paid to PEO Turner ($)(5)	Average Summary Compen- sation Table Total for Non- PEO NEOs ($)(6)	Average Compen- sation Actually Paid to Non- PEO NEOs ($)(7)	Total Stock- holder Return ($)(8)	Peer Group Total Stock- holder Return ($)(9)	Net Income ($ ,000)	Organic Revenue Growth (%)(10)

2024	3,985,251	3,985,251	5,948,435	13,961,632	4,099,916	8,944,994	236	142	229,913	12.1%
2023	4,256,700	4,256,700			2,613,734	3,088,497	156	109	194,480	15.0%
2022	4,478,995	4,478,995			2,530,394	3,369,573	151	97	163,257	16.4%
2021	2,456,731	2,456,731			8,972,955	22,246,054	147	109	56,632	22.4%

(1)Only four years of compensation and performance history are provided since the Company’s IPO was on July 21, 2021.


		2024 Proxy Statement 69
		2024 Proxy Statement 69

(2)Patrick G. Ryan was our PEO in 2021, 2022, 2023, and for part of 2024. Prior to our IPO, Mr. Ryan did not receive any salary for his

role as our Chief Executive Officer.

(3)Since Mr. Ryan (our PEO through October 1, 2024) has never received incentive equity grants and the Company does not have a

pension plan, Compensation Actually Paid (“CAP”) to Mr. Ryan is the same amount as reported as total compensation in our

Summary Compensation Table (“SCT”) for each year.

(4)Timothy W. Turner became our PEO on October 1, 2024.

(5)The following table provides a reconciliation calculation of our PEO (Mr. Turner) CAP back to his SCT:


Year	SCT Total	SCT Grant Date Fair Value Deduction	Year End Value of Equity Granted During Year and Unvested at End of Year	Fair Value as of Vesting Date of Equity Granted During Year and Vested During Year	Change in Fair Value of Equity Granted in Prior Year and Unvested at End of Year	Change in Fair Value of Equity Granted in Prior Year and Vested During Year	CAP

2024	$5,948,435	$(2,470,256)	$3,803,587	$—	$146,747	$6,533,119	$13,961,632

(6)Our NEOs (other than our PEOs) for 2024 included Jeremiah R. Bickham, Janice M. Hamilton, Michael L. Conklin, Brendan M.

Mulshine, and Benjamin M. Wuller. Our NEOs (other than our PEO) for 2023 and 2022 included Timothy W. Turner, Jeremiah R.

Bickham, Mark S. Katz, and Brendan M. Mulshine. Our NEOs (other than our PEO) for 2021 included Timothy W. Turner, Jeremiah R.

Bickham, Mark S. Katz, Michael T. VanAcker, and Diane M. Aigotti. Diane M. Aigotti was our Chief Financial Officer until she resigned

from the Company on March 1, 2021.

(7)The following table provides a reconciliation calculation of the average Non-PEO NEOs’ CAP back to the average Non-PEO NEOs’

SCT total:


Year	Average SCT Total	SCT Grant Date Fair Value Deduction	Year End Value of Equity Granted During Year and Unvested at End of Year	Fair Value as of Vesting Date of Equity Granted During Year and Vested During Year	Change in Fair Value of Equity Granted in Prior Year and Unvested at End of Year	Change in Fair Value of Equity Granted in Prior Year and Vested During Year	Average CAP

2024	$4,099,916	$(2,201,439)	$2,888,360	$—	$3,686,548	$471,609	$8,944,994
2023	2,613,734	(374,999)	392,166	—	439,155	18,441	3,088,497
2022	2,530,394	(308,222)	367,125	—	928,526	(148,250)	3,369,573
2021	8,972,955	(4,324,316)	17,418,303	179,112	—	—	22,246,054

(8)Total Stockholder Return (“TSR”) is calculated based on a fixed investment of $100 at the applicable measurement point on the same

cumulative basis as is used in Item 201(e) of Regulation S-K. The TSR is calculated from July 22, 2021, the first trading date of our

Class A Common Stock after our IPO, through the end of the applicable year.

(9)Our Peer Group TSR for the relevant fiscal year represents the cumulative TSR of the S&P 500 Financials Sector Index, consistent

with the industry index used in our “Performance Graph” pursuant to Section 201(e) of regulation S-K as presented in Item 5 of our

Annual Report on Form 10-K. The Peer Group TSR is calculated from July 22, 2021, the first trading date of our Class A Common

Stock after our IPO, through the end of the applicable year.

(10)Ryan Specialty’s most important financial performance measure used to link CAP to our NEOs to Company performance for fiscal

year 2024 is Organic Revenue Growth. In the first quarter of 2024 the Company modified the methodology that it uses to calculate

Organic Revenue Growth. As discussed in the section “Executive Compensation: Compensation Discussion and Analysis — Our

Executive Compensation Program in Detail — Short Term Incentive Compensation,” the Organic Revenue Growth STI targets were

determined based on the original calculation methodology and therefore the actual result for Organic Revenue Growth for the year

ended December 31, 2024 was presented based on the original methodology as well. We have therefore presented the original

methodology in the table above and the graph below. For completeness, Organic Revenue Growth calculated based on the current

calculation methodology was 12.8%, 15.4%, 16.8% and 22.9% for the years ended December 31, 2024, 2023, 2022, 2021,

respectively.

Pay Versus Performance Comparative Disclosure

The below charts depict Compensation Actually Paid, calculated in accordance with Item 402(v) of Regulation S-K (“Item

402(v)”), for our PEOs and the average of our Non-PEO NEOs in relationship to various performance metrics for the same

period. As discussed above, and based on our compensation philosophy, a significant amount of equity was granted to our


		2024 Proxy Statement 71
		2024 Proxy Statement 71

Compensation Actually Paid and Organic Revenue Growth

The below chart depicts CAP to our PEOs and the average of our Non-PEO NEOs in relationship to our Organic Revenue

Growth (based on our original calculation methodology) for the same period. The Company first directly aligned short-term

incentive compensation with Organic Revenue Growth in 2022, where 35% of each NEO’s short-term incentive

compensation was tied to our Organic Revenue Growth performance and such alignment continued in 2023 and 2024. See

“Executive Compensation: Compensation Discussion and Analysis — Our Executive Compensation Program in Detail —

Our Pay Philosophy — Short-Term Incentive Compensation” for further details. An Organic Revenue Growth CAGR also

forms an achievement floor for the PSUs and PLUs that were granted to each of our NEOs, other than Mr. Ryan, in 2024.

Company TSR and Peer Group TSR

As demonstrated by the following graph, the Company’s TSR increased 136% over the presented period in the table, while

the Company’s peer group TSR increased 42% over the same period. The Company’s TSR generally outperformed the peer

group during the period presented in the table, representing the Company’s superior financial performance as compared to

the S&P 500 Financials Sector Index.

Pay Versus Performance Tabular List

For the fiscal year ending December 31, 2024, the most important financial performance measures used to link

Compensation Actually Paid to our NEOs to Company performance were Organic Revenue Growth, Adjusted EBITDAC

Margin, and TSR. Our NEOs’ total compensation is heavily weighted towards short and long-term performance with


		2024 Proxy Statement 72
		2024 Proxy Statement 72

performance goals aligned with our stockholders’ interests. Each NEO’s short-term incentive compensation is primarily

determined by Organic Revenue Growth and Adjusted EBITDAC Margin. See “Executive Compensation: Compensation

Discussion and Analysis — Our Executive Compensation Program in Detail — Our Pay Philosophy —Short-Term Incentive

Compensation” for further detail. Most of our NEOs have significant long-term equity incentive grants that vest over 5 or 10

years and as a result their actual compensation is directly tied to TSR. In addition, each of our NEOs, other than Mr. Ryan,

received a grant of performance-based awards (PLUs or PSUs) the value of which is tied to TSR after achieving a minimum

Organic Revenue Growth CAGR and Target Adjusted EBITDAC Margin. See “Executive Compensation: Compensation

Discussion and Analysis — Our Executive Compensation Program in Detail — Our Pay Philosophy —Long-Term Incentive

Compensation” for further detail.

Most Important Financial Performance Measures

Organic Revenue Growth

Adjusted EBITDAC Margin

Total Stockholder Return

Securities Authorized for Issuance Under Equity Compensation Plans

The following table provides information, as of December 31, 2024, about the securities authorized for issuance under the

Company’s equity compensation plans, categorized according to whether the equity plan was previously approved by

stockholders.


Plan Category	Number of Shares to be Issued Upon Exercise of Outstanding Options, Warrants and Rights(1)	Weighted Average Exercise Price of Outstanding Options, Warrants and Rights(2)	Number of Shares Remaining Available for Future Issuance(3)

Equity Compensation Plans Approved by Security Holders	34,613,006	$24.60	20,460,284
Equity Compensation Plans Not Approved by Security Holders	—	—	—
Total	34,613,006	24.60	20,460,284

(1)These amounts include the number of securities to be issued upon exercise, conversion, or settlement of 4,219,083 outstanding

Options, 6,212,136 outstanding Class C Units, 18,503,194 outstanding LLC Common Units, 1,980,250 outstanding RLUs, 5,123,786

outstanding RSUs. 487,218 outstanding PLUs, and 366.996 outstanding PSUs. The 6,212,136 outstanding Class C Units could have

been exchanged for 3,932,479 shares of Class A common stock on December 31, 2024, based on an exchange value of $66.53,

which is the volume weighted average trading price of the Class A common stock for the 20 trading days preceding December 31,

2024.

(2)The weighted average exercise price does not include outstanding LLC Common Units, RSUs, RLUs, PLUs, and PSUs which do not

have an associated exercise price. Calculated without regard to the shares that will be issued in connection with the settlement of

RSUs, RLUs, PLUs, or PSUs, or the conversion of LLC Common Units, the weighted-average exercise price is $24.60.

(3)Represents the number of securities remaining available under the Ryan Specialty Holdings, Inc. 2021 Omnibus Incentive Plan (the

“Omnibus Plan”) as of December 31, 2024. Beginning January 1, 2022, and on each January 1 thereafter through and including

January 2031, the total number of shares available for issuance under the Omnibus Plan shall automatically increase by an amount

equal to the lesser of (i) 2% of the outstanding shares of Class A and Class B common stock on the last day of the immediately

preceding year or (ii) an amount determined by the Board.


		2024 Proxy Statement 73
		2024 Proxy Statement 73

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL

OWNERS AND MANAGEMENT

The following table sets forth information about the beneficial ownership of our Class A common stock and Class B common

stock as of March 31, 2025, for:

•each person or group known to us who beneficially owns more than 5% of our Class A common stock or Class B

common stock;

•each of our directors and each of our NEOs; and

•all of our directors and executive officers as a group.

The number of shares of Class A common stock and Class B common stock beneficially owned, and the percentages of

beneficial ownership, set forth below are based on 126,032,889 shares of Class A common stock issued and outstanding

and 135,957,649 shares of Class B common stock issued and outstanding on March 31, 2025. These numbers exclude

135,957,649 shares of Class A common stock issuable in exchange for the same number of LLC Common Units and for the

cancellation on a one-to-one ratio of the related shares of our Class B common stock. If all outstanding LLC Common Units

were exchanged and all outstanding shares of Class B common stock were canceled as of March 31, 2025, we would have

261,990,538 shares of Class A common stock outstanding.



Name of Beneficial Owner(1)	Shares of Class A Common Stock(2)	% of Class A Common Stock Outstanding	Shares of Class B Common Stock	% of Class B Common Stock Outstanding	% of Combined Voting Power(3)

5% Stockholders:
Patrick G. Ryan(4)	15,374,941	12.2%	112,048,184	82.4%	76.5%
The Vanguard Group(5)	9,397,569	7.5%	—	*	*
BlackRock, Inc.(6)	9,294,486	7.4%	—	*	*
Capital World Investors(7)	6,588,460	5.2%	—	*	*
Named Executive Officers, Directors and Director Nominees:
Patrick G. Ryan(4)	15,374,941	12.2%	112,048,184	82.4%	76.5%
Timothy W. Turner(8)	8,095	*	2,163,164	1.6%	1.5%
Henry S. Bienen(9)	51,905	*	—	*	*
David P. Bolger(10)	88,967	*	—	*	*
Michelle L. Collins(11)	11,139	*	—	*	*
Francesca Cornelli(12)	2,297	*	—	*
Nicholas D. Cortezi(13)	2,697	*	4,308,271	3.2%	2.9%
D. Cameron Findlay(14)	100,902	*	—	*	*
Anthony J. Kuczinski	1,692	*	—	*
Robert Le Blanc	—	*	—	*	*
Michael D. O’Halleran(15)	812,835	*	—	*	*
John W. Rogers, Jr.(16)	102,353	*	—	*	*
Patrick G. Ryan, Jr. (17)	654,428	*	5,574,738	4.1%	3.8%
Jeremiah R. Bickham(18)	1,078	*	231,339	*	*
Michael L. Conklin(19)	7,637	*	—	*	*
Janice M. Hamilton(20)	4,442	*	142,284	*	*
Brendan M. Mulshine(21)	74,592	*	675,461	*	*
Benjamin M. Wuller(22)	92,577	*	441,206	*	*
All executive officers and directors as a group (19 individuals)(23)	16,738,149	13.3%	120,052,781	88.3%	81.9%

*Denotes less than 1%


		2024 Proxy Statement 74
		2024 Proxy Statement 74

(1)Unless otherwise noted below, the address for each beneficial owner listed on the table is 155 North Wacker Drive, Suite 4000,

Chicago, Illinois 60606. We have determined beneficial ownership in accordance with the rules of the SEC. Except as indicated by

the footnotes below, we believe, based on the information furnished to us, that the persons and entities named in the table above

have sole voting and investment power with respect to all Class A common stock and Class B common stock that they beneficially

own, subject to applicable community property laws.

(2)The reported amount does not reflect shares of Class A common stock issuable on account of vested Class C Units, which are

redeemable by the holder for either, at the option of the Company, cash or a number of Common Units (which are immediately

redeemed on a one-for-one basis for shares of Class A Common Stock), determined by reference to (i) the Class C Units’ return

threshold and (ii) adjustments for certain prior distributions made with respect to such Class C Units.

(3)Each share of Class A common stock is entitled to one vote per share. Each share of Class B common stock is entitled to 10 votes

per share. Each share of Class B common stock then outstanding will be entitled to one vote per share (i) 12 months following the

death or disability of Patrick G. Ryan or (ii) the first trading day on or after such date that the outstanding shares of Class B common

stock represent less than 10% of the then-outstanding Class A and Class B common stock, which, in each instance, may be extended

to 18 months upon affirmative approval of a majority of the Company’s independent directors. The Class A common stock and Class

B common stock will vote as a single class on all matters except as required by law or the Certificate.

(4)Amounts include 13,424,755 shares of Class A common stock and 91,353,821 shares of Class B common stock beneficially owned

by Mr. Ryan and his spouse and 1,950,186 shares of Class A common stock and 20,694,363 shares of Class B common stock

beneficially owned and attributed to Mr. Ryan and his spouse pursuant to certain trusts, entities, and accounts managed by, or for, the

benefit of family members and others.

(5)Number of shares held are derived from the Schedule 13-G/A filed with the Securities and Exchange Commission on February 13,

2024, as reported by The Vanguard Group (“Vanguard”). The address for Vanguard is 100 Vanguard Blvd., Malvern, Pennsylvania

19355. Vanguard reports sole dispositive power with respect 9,237,983 of the shares of Class A common stock reported, shared

voting with respect to 54,534 of the shares of Class A common stock reported, and shared dispositive power with respect to 159,586

of the shares of Class A common stock reported.

(6)Number of shares held are derived from the Schedule 13-G filed with the Securities and Exchange Commission on November 8,

2024, as reported by BlackRock, Inc. (“BlackRock”). The address for BlackRock is 50 Hudson Yards, New York, New York 10001.

BlackRock reports sole dispositive power with respect to all 9,294,486 of the shares of Class A common stock reported, sole voting

power with respect to 9,081,054 of the shares of Class A common stock reported, and no shared dispositive or voting power with

respect of the shares of Class A common stock reported.

(7)Number of shares held are derived from the Schedule 13-G filed with the Securities and Exchange Commission on November 13,

2024, as reported by Capital World Investors (“Capital World”). The address for Capital World is 333 South Hope Street, 55th Floor,

Los Angeles, California 90071.

(8)Includes 6,978 shares of Class B common stock and an equal number of LLC Common Units which are issuable upon the vesting of

an equal number of RLUs that vest within 60 days of March 31, 2025. The remaining shares of Class B common stock and the shares

of Class A common stock are held by Mr. Turner individually.

(9)All shares of Class A common stock are held in trusts beneficially owned and attributed to Mr. Bienen and his spouse.

(10)Includes 12,500 RSUs that were fully vested upon grant for which the director has elected to defer settlement until his separation from

service on the Board. The remaining shares of Class A common stock are held in a trust beneficially owned and attributed to Mr.

Bolger.

(11)Includes 8,139 RSUs that were fully vested upon grant for which the director has elected to defer settlement until her separation from

service on the Board. The remaining shares of Class A common stock are held by Ms. Collins individually.

(12)Includes 2,297 RSUs that were fully vested upon grant for which the director has elected to defer settlement until her separation from

service on the Board.

(13)Includes 2,697 RSUs that were fully vested upon grant for which the director has elected to defer settlement until his separation from

service on the Board. The shares of Class B common stock are held in trusts beneficially owned and attributed to Mr. Cortezi.

(14)Shares of Class A common stock are held by Mr. Findlay individually and by Mr. Findlay and his spouse jointly.

(15)Includes 12,500 RSUs that were fully vested upon grant for which the director has elected to defer settlement until his separation from

service on the Board. The remaining shares of Class A common stock are held by Mr. O’Halleran individually and in a trust

beneficially owned and attributed to Mr. O’Halleran.

(16)Includes 7,190 RSUs that were fully vested upon grant for which the director has elected to defer settlement until his separation from

service on the Board. The remaining shares of Class A common stock are held by Mr. Rogers individually.

(17)Includes 252,460 shares of Class A common stock beneficially owned by Mr. Ryan, Jr. and his spouse, 400,695 shares of Class A

common stock and 5,574,738 shares of Class B common stock beneficially owned and attributed to Mr. Ryan, Jr. and his spouse

pursuant to trusts for the benefit of his family members, and 1,273 RSUs that were fully vested upon grant for which the director has

elected to defer settlement until his separation from service on the Board. All shares and percentages reported for Mr. Ryan, Jr. are

duplicative and included in the share counts and percentages for Patrick G. Ryan, represented in the table above and footnote (4)

thereto, who exercises voting power over the equity held by Mr. Ryan Jr.

(18)Includes 1,831 shares of Class B common stock and an equal number of LLC Common Units which are issuable upon the vesting of

an equal number of RLUs that vest within 60 days of March 31, 2025. The remaining shares of Class B common stock and the shares

of Class A common stock are held by Mr. Bickham individually.

(19)Includes 7,637 shares of Class A common stock issuable upon vesting of an equal number of RSUs that vest within 60 days of March

31, 2025.


		2024 Proxy Statement 75
		2024 Proxy Statement 75

(20)Includes 458 shares of Class B common stock and an equal number of LLC Common Units which are issuable upon the vesting of an

equal number of RLUs that vest within 60 days of March 31, 2025. The remaining shares of Class B common stock and the shares of

Class A common stock are held by Ms. Hamilton individually.

(21)Includes 1,226 shares of Class B common stock and an equal number of LLC Common Units which are issuable upon the vesting of

an equal number of RLUs that vest within 60 days of March 31, 2025. The remaining shares of Class B common stock are held by Mr.

Mulshine individually and the shares of Class A common stock are jointly held by Mr. Mulshine and his spouse.

(22)Includes 2,726 shares of Class B common stock and an equal number of LLC Common Units which are issuable upon the vesting of

an equal number of RLUs that vest within 60 days of March 31, 2025. The remaining shares of Class B common stock and the shares

of Class A common stock are held by Mr. Wuller individually.

(23)Includes (a) 45,323 RSUs that were fully vested upon grant for which directors have elected to defer settlement until such time as the

individual director’s separation from service on the Board, (b) 14,974 shares of Class B common stock and an equal number of LLC

Common Units issuable upon the vesting of an equal number of RLUs that vest within 60 days of March 31, 2025, and (c) 7,637

RSUs that vest into an equivalent number of shares of Class A common stock within 60 days of March 31, 2025. The remaining

shares of Class A common stock and Class B common stock are held directly by the directors or officers other than as specified in the

notes above. The shares of Class A common Stock and Class B common stock held by Patrick G. Ryan, Jr. have been excluded from

the total since they are duplicative and included in the share counts and percentages for Patrick G. Ryan who exercises voting power

over the equity held by Mr. Ryan Jr.

DELINQUENT SECTION 16(a) REPORTS

Section 16(a) of the Exchange Act requires the Company’s directors, executive officers, and persons who beneficially own

more than 10% of a registered class of the Company’s equity securities to file with the SEC reports on Forms 3, 4, and 5

concerning their ownership of, and transactions in, the Class A common stock and other equity securities of the Company.

As a practical matter, the Company assists its directors and executives by monitoring transactions and completing and filing

reports on their behalf. Based solely on the Company’s review of copies of such reports filed with the SEC and written

representations that no other reports are required, the Company believes that all of its executive officers, directors, and

those greater-than-10% stockholders that filed any reports for the year ended December 31, 2024 reported all transactions

on a timely basis, with the exception of one Form 4 filing for each of Messrs. Bolger and Cortezi. Mr. Bolger's filing, which

disclosed the exchange of Class A common stock for ownership of equity in a diversified fund, was delayed by two days due

to the amount of time it took the exchange fund to report the final amounts for the transaction to Mr. Bolger. Mr. Cortezi’s

filing, which disclosed the sale of Class A common stock, was delayed by one day due to an administrative error.


		2024 Proxy Statement 76
		2024 Proxy Statement 76

CERTAIN RELATIONSHIPS AND RELATED PARTY

TRANSACTIONS

Policy for Approval of Related Party Transactions

We have adopted a written policy with respect to the review, approval, and ratification of related party transactions. Under

the policy, our Audit Committee is responsible for reviewing and approving or ratifying related party transactions. In the

course of its review and disapproval, approval, or ratification of related party transactions, our Audit Committee considers the

relevant facts and circumstances and determines whether to approve or ratify such transactions. In particular, our policy

requires our Audit Committee to consider, among other factors it deems appropriate:

•the related person’s relationship to us and interest in the transaction;

•the material facts of the proposed transaction, including the proposed aggregate value of the transaction;

•the impact on a director’s independence in the event the related person is a director or an immediate family

member of a director;

•the benefits to us of the proposed transaction;

•if applicable, the availability of other sources of comparable products or services; and

•an assessment of whether the proposed transaction is on terms that are comparable to the terms available to an

unrelated third party or to employees generally.

The Audit Committee may only approve or ratify those transactions that are in, or are not inconsistent with, our best interests

and those of our stockholders, as the Audit Committee determines in good faith.

In addition, under our Code of Conduct, our employees and directors will have an affirmative responsibility to disclose any

transaction or relationship that reasonably could be expected to give rise to a conflict of interest.

2024 Related Party Transactions

We describe below transactions and series of similar transactions that occurred during our prior fiscal year or that were

ongoing during the year or that are currently proposed, to which we were a party or will be a party, in which:

•the amounts involved exceeded or will exceed $120,000; and

•any of our directors, executive officers, immediate family members of our directors or executive officers, or

beneficial holders of more than 5% of any class of our capital stock had or will have a direct or indirect material

interest.

Other than as described below, there have not been, nor are there any currently proposed, transactions or series of similar

transactions meeting these criteria to which we have been or will be a party other than compensation arrangements, which

are described where required under “Executive Compensation.”

Ryan Investment Holdings, Geneva Re, and Ryan Re

Ryan Investment Holdings

Ryan Investment Holdings, LLC (“RIH”) is an investment holding company that aggregates the funds of the LLC and

Geneva-Ryan Holdings, LLC (“GRH”) for investment in Geneva Re Partners, LLC (“GRP”). GRH is an investment holding

company that aggregates investment funds of Patrick G. Ryan and Patrick G. Ryan Jr. and members of their family, Michael

O’Halleran, and other affiliated investors. The LLC holds a 47% interest in RIH and GRH holds a 53% interest in RIH. RIH

has a 50% non-controlling interest in GRP and the other 50% is owned by Nationwide Mutual Insurance Company

(“Nationwide”). GRP wholly owns Geneva Re, Ltd., a Bermuda-regulated reinsurance company (“Geneva Re”) and GR

Bermuda SAC Ltd. (the “Segregated Account Company”). The Segregated Account Company has one segregated account,

which is beneficially owned by a third-party insurance company (the “Third-party Insurer”).

RIH has committed to contribute additional capital to GRP over the next several years. Patrick G. Ryan, through a trust of

which he is the beneficiary and co-trustee, has committed to personally fund any such additional capital contributions. In


		2024 Proxy Statement 77
		2024 Proxy Statement 77

exchange for any such capital contributions, Mr. Ryan will receive promissory notes from RIH that will not affect the relative

ownership of RIH’s common equity.

Geneva Re

On January 1, 2021, the Company entered into a service agreement with Geneva Re to provide both administrative services

to, as well disburse payments for costs directly incurred by, Geneva Re. These direct costs include compensation expenses

incurred by employees of Geneva Re. The Company had $0.3 million due from Geneva Re under this agreement as of

December 31, 2024.

Ryan Re Preferred Equity

Mr. Ryan and his wife hold preferred equity in Ryan Re Underwriting Managers, LLC (“Ryan Re”), a wholly owned subsidiary

of the Company, with unreturned capital of $3.3 million as of December 31, 2024, which accrues a preferred return at the

rate of 10% annually. In October 2023, the Board approved the payment of all accrued interest through the end of December

31, 2023 and the quarterly payment of accrued interest thereafter. In January of 2024, the Company paid the previously

approved amount of $1.9 million in accrued interest on the preferred equity held by Mr. Ryan and his wife. In addition, the

Company paid $0.2 million in quarterly accrued interest through December 31, 2024.

Ryan Re Services Agreement with Geneva Re

On June 13, 2019, Ryan Re entered into a services agreement with Geneva Re to provide, among other services, certain

underwriting and administrative services to Geneva Re. Ryan Re receives a service fee equal to 115% of the administrative

costs incurred by Ryan Re in providing these services to Geneva Re. Revenue earned from Geneva Re, net of applicable

constraints, was $1.5 million for the year ended December 31, 2024. Receivables due from Geneva Re on the service

agreement, net of applicable constraints, was $0.7 million as of December 31, 2024.

On April 2, 2023, Ryan Re entered into a services agreement with Geneva Re in accordance with which Ryan Re

subcontracted certain services to Geneva Re that Ryan Re is required to provide to the segregated account of the

Segregated Account Company on behalf of the Third-party Insurer. The Company incurred expense of $10.5 million during

the year ended December 31, 2024, and had prepaid expenses of $5.2 million as of December 31, 2024, related to this

services agreement.

Company Charter of Corporate Jets

In the ordinary course of its business, the Company charters executive jets for business purposes from a third-party service

provider, Executive Jet Management (“EJM”). Mr. Ryan indirectly owns aircraft that he leases for remuneration to EJM and

which EJM then charters to third parties. The Company pays market rates for chartering aircraft through EJM, unless the

particular aircraft chartered is one which Mr. Ryan indirectly owns, in which case the Company receives a discount from

market rates. Historically, the Company often has been able to charter Mr. Ryan’s aircraft through EJM thereby benefiting

from this discount as well as having confidence in the maintenance record of the aircraft and skill of the crew. The Company

recognized an expense related to business usage of the aircraft of $1.2 million for the year ended December 31, 2024 (of

which Mr. Ryan indirectly received $0.8 million in remuneration).

Personal Guarantee by Patrick G. Ryan

In April 2021, Mr. Ryan personally guaranteed up to $10.0 million of the financial obligations of the LLC under an agency

agreement with certain insurance companies that are affiliated with National Indemnity Company. The Company did not pay

Mr. Ryan any consideration for this guarantee. Mr. Ryan’s guarantee may be replaced by the Company with a letter of credit

at any time, subject to the prior approval of the insurance companies. It is expected that Mr. Ryan will not personally

guarantee any additional financial obligations of the Company or any of its subsidiaries.

Registration Rights Agreement

In connection with the IPO, we entered into the Registration Rights Agreement with the Ryan Parties and Onex. The Ryan

Parties are entitled to request that we register their shares of capital stock on a long-form or short-form registration

statement on any number of occasions in the future, which registrations may be “shelf registrations.” The Ryan Parties and

Onex are entitled to participate in certain of our registered offerings, subject to the restrictions in the Registration Rights

Agreement. We will pay expenses in connection with the exercise of these rights. The registration rights described in this

paragraph apply to (i) shares of our Class A common stock (including shares issuable to the Ryan Parties upon exchange of


		2024 Proxy Statement 78
		2024 Proxy Statement 78

their LLC Common Units) held by the Ryan Parties and Onex and their affiliates and (ii) any of our capital stock (or that of

our subsidiaries) issued or issuable with respect to the Class A common stock described in clause (i) with respect to any

dividend, distribution, recapitalization, reorganization, or certain other corporate transactions (“Registrable Securities”).

These registration rights are also for the benefit of any subsequent holder of Registrable Securities; provided that any

particular securities will cease to be Registrable Securities when they have been sold in a registered public offering, sold in

compliance with Rule 144 of the Securities Act of 1933 (the “Securities Act”), or repurchased by us or our subsidiaries. In

addition, with the consent of the Company and holders of a majority of Registrable Securities, certain Registrable Securities

will cease to be Registrable Securities if they can be sold without limitation under Rule 144 of the Securities Act.

Tax Receivable Agreement

We entered into a Tax Receivable Agreement with current and certain former LLC Unitholders that will provide for the

payment by us to the current and certain former LLC Unitholders, collectively, of 85% of the amount of tax benefits, if any,

that we actually realize (or under some circumstances are deemed to realize) as a result of (i) certain increases in the tax

basis of assets of the LLC and its subsidiaries resulting from purchases or exchanges of LLC Common Units, (ii) certain tax

attributes of the LLC and its subsidiaries that existed prior to the IPO, (iii) certain favorable “remedial” partnership tax

allocations to which we become entitled (if any), and (iv) certain other tax benefits related to our entering into the Tax

Receivable Agreement, including tax benefits attributable to payments that we make under the Tax Receivable Agreement.

These payment obligations are obligations of Ryan Specialty Holdings, Inc. and not of the LLC.

Director Nomination Agreement

In connection with the IPO, the Company entered into a Director Nomination Agreement with the Ryan Parties and Onex.

The Director Nomination Agreement currently provides the Ryan Parties the right to nominate certain members of our Board

based on the number of shares of the Company’s common stock held by the Ryan Parties. The Director Nomination

Agreement provides the Ryan Parties the right to designate (in each instance, rounded up to the nearest whole number if

necessary): (i) all of the nominees for election to our Board for so long as the Ryan Parties control, in the aggregate, 50% or

more of the total number of shares of our common stock beneficially owned by the Ryan Parties upon completion of the IPO,

as adjusted for any reorganization, recapitalization, stock dividend, stock split, reverse stock split, or similar changes in our